Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,A1BG,Alpha-1B-glycoprotein,3684,142,10.35 [3.95-27.08],1.9216881931033e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AAMDC,Mth938 domain-containing protein,3579,143,0.93 [0.68-1.27],0.6365371612190607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,4212,172,1.09 [0.86-1.38],0.487635412268959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABCA2,ATP-binding cassette sub-family A member 2,3553,138,2.12 [1.53-2.93],5.450243191221513e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABHD14B,Protein ABHD14B,4179,168,1.08 [0.85-1.38],0.5190188201110222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABL1,Tyrosine-protein kinase ABL1,4212,172,1.16 [0.96-1.41],0.1183114261844753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABO,Histo-blood group ABO system transferase,3685,143,0.94 [0.85-1.05],0.2815711395302229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABRAXAS2,BRISC complex subunit Abraxas 2,3553,138,1.05 [0.82-1.36],0.6868266874892097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",4103,164,1.10 [0.95-1.28],0.2025061379367521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",3618,140,1.11 [0.89-1.39],0.3679886270364267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",3670,144,0.85 [0.71-1.03],0.1020440045007021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACAN,Aggrecan core protein,4186,171,0.98 [0.62-1.55],0.9319244271826224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACE,Angiotensin-converting enzyme,3685,143,2.30 [1.32-4.02],0.0034672244308359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACE2,Angiotensin-converting enzyme 2,4152,167,1.11 [0.91-1.34],0.3061943815306165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACHE,Acetylcholinesterase,3611,140,1.40 [0.92-2.11],0.1146019388263649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACOT13,Acyl-coenzyme A thioesterase 13,3652,139,0.95 [0.82-1.09],0.4598738894675721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,4233,173,0.85 [0.65-1.12],0.2515359183334996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,3559,140,0.79 [0.54-1.15],0.2172415522143358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP5,Tartrate-resistant acid phosphatase type 5,4256,174,1.80 [1.23-2.63],0.0024646165141979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP6,Lysophosphatidic acid phosphatase type 6,4259,175,1.07 [0.86-1.32],0.5476851338524005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACRBP,Acrosin-binding protein,3659,142,0.95 [0.63-1.44],0.8186935889039234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACRV1,Acrosomal protein SP-10,3559,140,1.27 [1.09-1.48],0.0022656923892478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,3553,138,0.82 [0.49-1.39],0.4633857463434923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTA2,"Actin, aortic smooth muscle",4152,167,1.97 [1.64-2.37],4.210487063963831e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTN2,Alpha-actinin-2,3553,138,1.24 [0.98-1.58],0.0754545959562724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTN4,Alpha-actinin-4,4131,169,1.11 [0.74-1.67],0.6225203586741861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACVRL1,Serine/threonine-protein kinase receptor R3,4187,169,6.11 [4.38-8.51],1.0582033295629727e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACY1,Aminoacylase-1,4233,173,0.92 [0.77-1.11],0.3972328137910932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,3553,138,1.18 [0.91-1.54],0.2142877259808331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACYP1,Acylphosphatase-1,3602,139,0.93 [0.73-1.19],0.5754108192674778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA,Adenosine deaminase,4281,174,1.37 [0.97-1.95],0.0774269601792743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA2,Adenosine deaminase 2,4210,170,2.84 [2.26-3.58],4.910400637166584e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,3559,140,2.45 [1.75-3.43],1.6588057182902485e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,4152,167,1.35 [0.88-2.07],0.1659487487199893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,4194,169,2.56 [1.80-3.65],1.775450651772291e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,4281,174,2.26 [1.49-3.44],0.0001247543040237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,4258,173,1.98 [1.31-3.00],0.0012805924971144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,3652,139,3.44 [2.38-4.96],4.782476573151403e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,3559,140,2.40 [1.50-3.85],0.0002526888512418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,4283,174,1.21 [0.71-2.06],0.4783668157301644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,4212,172,1.57 [1.17-2.11],0.002547711061823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,4152,167,1.57 [1.15-2.16],0.005006577335868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,3559,140,1.74 [1.17-2.59],0.0062261399450455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,4238,174,0.84 [0.63-1.11],0.2087643522183306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL2,ADAMTS-like protein 2,3683,141,2.28 [1.64-3.16],9.669109594495308e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL4,ADAMTS-like protein 4,3579,143,1.77 [0.92-3.40],0.0844812630655156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL5,ADAMTS-like protein 5,3670,144,1.31 [0.90-1.90],0.1632624465812346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,4103,164,0.98 [0.65-1.49],0.9329988388189896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADD1,Alpha-adducin,3611,140,0.92 [0.73-1.16],0.4641624943683243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRB3,Adhesion G protein-coupled receptor B3,4187,169,3.03 [2.26-4.06],1.454780536626041e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRD1,Adhesion G-protein coupled receptor D1,3611,140,2.35 [1.69-3.26],3.809043089264201e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE1,Adhesion G protein-coupled receptor E1,3652,139,1.26 [0.97-1.65],0.0861809203458605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE2,Adhesion G protein-coupled receptor E2,4248,170,3.57 [2.37-5.37],9.919154775317883e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE5,Adhesion G protein-coupled receptor E5,4266,174,2.92 [2.10-4.06],2.00936908772484e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRF5,Adhesion G protein-coupled receptor F5,3670,144,2.07 [1.13-3.77],0.0177809265648729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG1,Adhesion G-protein coupled receptor G1,4212,172,1.46 [1.31-1.63],4.762056341154922e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG2,Adhesion G-protein coupled receptor G2,4233,173,0.35 [0.22-0.55],7.615058671754151e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRV1,Adhesion G-protein coupled receptor V1,3549,140,0.80 [0.60-1.06],0.1183924799701407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADH1B,All-trans-retinol dehydrogenase,3611,140,0.89 [0.74-1.08],0.2333555919321738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,4152,167,0.77 [0.65-0.89],0.0007590741538991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADIPOQ,Adiponectin,3684,142,0.98 [0.79-1.22],0.873592984017271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADM,Pro-adrenomedullin,4267,175,7.28 [4.51-11.75],4.489653239278832e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADRA2A,Alpha-2A adrenergic receptor,3553,138,0.88 [0.67-1.16],0.3667028374135879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFAP1,Actin filament-associated protein 1,3611,140,0.82 [0.66-1.02],0.0719265557231329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFM,Afamin,3684,142,0.38 [0.19-0.75],0.0053310450361052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFP,Alpha-fetoprotein,4180,169,0.67 [0.54-0.83],0.0003445141097929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGBL2,Cytosolic carboxypeptidase 2,3549,140,1.20 [1.02-1.41],0.0268588144731425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGER,Advanced glycosylation end product-specific receptor,4222,170,1.58 [1.16-2.15],0.0033514339144537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR2,Anterior gradient protein 2 homolog,4073,161,1.47 [1.30-1.67],1.7275438950545702e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR3,Anterior gradient protein 3,4096,164,1.42 [1.13-1.78],0.0026264814719457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRN,Agrin,4248,170,3.02 [2.40-3.81],8.870337408528301e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRP,Agouti-related protein,4281,174,1.99 [1.53-2.58],2.0725570105464454e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGT,Angiotensinogen,3685,143,1.29 [0.68-2.45],0.4308792478434692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGXT,Serine--pyruvate aminotransferase,4233,173,1.01 [0.87-1.19],0.8636373113992848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHCY,Adenosylhomocysteinase,4233,173,0.99 [0.81-1.21],0.9565857577462727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,3579,143,1.06 [0.64-1.75],0.8334739920569123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHNAK2,Protein AHNAK2,3579,143,1.68 [1.08-2.59],0.0201730661581041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,3659,142,0.95 [0.73-1.24],0.7270388535812142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHSG,Alpha-2-HS-glycoprotein,3685,143,1.92 [1.06-3.49],0.0308552616356136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHSP,Alpha-hemoglobin-stabilizing protein,4237,172,0.94 [0.80-1.10],0.4613173884763164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIDA,"Axin interactor, dorsalization-associated protein",3584,138,0.98 [0.81-1.20],0.8721977727201681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIF1,Allograft inflammatory factor 1,4103,164,1.01 [0.77-1.33],0.9172144123739596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIF1L,Allograft inflammatory factor 1-like,3579,143,1.28 [1.00-1.63],0.047826055454211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",4207,172,1.02 [0.90-1.16],0.7504399352768105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AK1,Adenylate kinase isoenzyme 1,4233,173,0.82 [0.67-1.02],0.0759370802452436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AK2,"Adenylate kinase 2, mitochondrial",3657,142,0.94 [0.81-1.10],0.4689421204531299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKAP12,A-kinase anchor protein 12,3611,140,1.06 [0.48-2.36],0.8867855980503245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR1B1,Aldo-keto reductase family 1 member B1,4103,164,1.06 [0.88-1.28],0.5131789767551989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR1B10,Aldo-keto reductase family 1 member B10,3584,138,1.06 [0.88-1.27],0.5674300000906123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR1C4,Aldo-keto reductase family 1 member C4,4152,167,0.89 [0.67-1.19],0.4224321559327288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,3559,140,1.08 [0.88-1.33],0.4590806119219651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKT1S1,Proline-rich AKT1 substrate 1,4101,164,1.11 [0.89-1.37],0.3515896763393313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKT2,RAC-beta serine/threonine-protein kinase,3668,142,0.94 [0.83-1.07],0.3448051457460782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKT3,RAC-gamma serine/threonine-protein kinase,4079,163,1.03 [0.81-1.32],0.8071040977616772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALCAM,CD166 antigen,4283,174,3.48 [1.97-6.15],1.7648679326381485e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH1A1,Retinal dehydrogenase 1,4246,172,0.83 [0.67-1.03],0.084791019644202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",3659,142,1.32 [1.10-1.58],0.0025029727130751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",4218,172,0.95 [0.81-1.12],0.5360292521486696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",3668,142,1.03 [0.73-1.44],0.8859984335594209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALMS1,Alstrom syndrome protein 1,3618,140,1.35 [0.98-1.86],0.0636111968117574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALPI,Intestinal-type alkaline phosphatase,3559,140,1.10 [0.97-1.24],0.1355131189416129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALPP,"Alkaline phosphatase, placental type",4212,172,1.06 [0.93-1.20],0.3789983746996326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBN,Ameloblastin,4131,169,0.79 [0.46-1.38],0.412612019571255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBP,Protein AMBP,4263,175,14.08 [8.23-24.09],4.958418186025831e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,3683,141,1.23 [0.64-2.39],0.5346258019364376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMFR,E3 ubiquitin-protein ligase AMFR,4101,164,1.12 [0.90-1.40],0.3120158929326623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMIGO1,Amphoterin-induced protein 1,3584,138,0.81 [0.56-1.17],0.2681122469315738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMIGO2,Amphoterin-induced protein 2,4212,172,2.14 [1.25-3.68],0.0057366371430612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMN,Protein amnionless,4131,169,1.28 [0.97-1.67],0.0796099963494576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMOT,Angiomotin,3611,140,1.04 [0.70-1.53],0.8591332398027378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMOTL2,Angiomotin-like protein 2,3645,140,1.12 [0.82-1.53],0.4793520634981749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMPD3,AMP deaminase 3,3657,142,1.12 [0.90-1.39],0.3221985235111982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,3451,131,0.82 [0.59-1.14],0.234866389455964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY2A,Pancreatic alpha-amylase,4062,163,0.91 [0.70-1.19],0.4955680499328773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY2B,Alpha-amylase 2B,3936,156,0.90 [0.68-1.17],0.4239496217530494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANG,Angiogenin,4230,170,2.42 [1.72-3.41],3.503510996609926e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT1,Angiopoietin-1,4214,170,1.01 [0.86-1.18],0.9101972332941566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT2,Angiopoietin-2,4267,175,3.28 [2.48-4.35],1.3883784899233462e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL1,Angiopoietin-related protein 1,4163,169,1.64 [1.05-2.56],0.029146058088428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL2,Angiopoietin-related protein 2,4233,169,1.34 [0.98-1.85],0.0689263366047718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL3,Angiopoietin-related protein 3,4240,170,0.94 [0.67-1.34],0.7449519200735333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL4,Angiopoietin-related protein 4,4242,170,3.41 [2.58-4.50],7.266809969125758e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL7,Angiopoietin-related protein 7,4267,175,1.98 [1.47-2.66],7.050846650728376e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANK2,Ankyrin-2,3553,138,1.01 [0.80-1.27],0.9556754729366046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,3559,140,0.97 [0.80-1.19],0.7882685358003475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANKRA2,Ankyrin repeat family A protein 2,3536,140,0.86 [0.64-1.16],0.32826911537436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANKRD54,Ankyrin repeat domain-containing protein 54,4103,164,0.91 [0.71-1.16],0.4413566917598466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,3579,143,0.88 [0.56-1.37],0.5579495425399821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANPEP,Aminopeptidase N,4238,171,1.57 [1.02-2.42],0.0424433949245394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA1,Annexin A1,3594,139,0.99 [0.70-1.41],0.9647680828370668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA10,Annexin A10,4101,164,1.15 [1.00-1.34],0.0552255902513766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA11,Annexin A11,4221,172,0.85 [0.70-1.03],0.093733206992614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA2,Annexin A2,3531,141,0.94 [0.74-1.18],0.5743895840412752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA3,Annexin A3,4258,173,0.99 [0.82-1.20],0.935584491969659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA4,Annexin A4,4211,170,0.88 [0.73-1.07],0.2168107178738022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA5,Annexin A5,4090,164,2.41 [1.80-3.22],4.054273223758917e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],4131,169,0.93 [0.71-1.21],0.597668183868338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC3,Membrane primary amine oxidase,4246,171,5.60 [3.79-8.28],5.261247623636739e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP1G2,AP-1 complex subunit gamma-like 2,3659,142,0.94 [0.77-1.16],0.5749267224266379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP2B1,AP-2 complex subunit beta,3584,138,0.97 [0.69-1.37],0.8601267840606865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP3B1,AP-3 complex subunit beta-1,3652,139,1.05 [0.85-1.30],0.647646129371602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP3S2,AP-3 complex subunit sigma-2,3657,142,0.96 [0.69-1.34],0.809595474978744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,4212,172,1.34 [1.03-1.73],0.0290939648101812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APCS,Serum amyloid P-component,3643,141,0.67 [0.42-1.07],0.0957832101774617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,4254,175,1.01 [0.80-1.27],0.9660951575519178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APLP1,Amyloid-like protein 1,4233,173,0.76 [0.59-0.98],0.0377122705262798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA1,Apolipoprotein A-I,3684,142,0.47 [0.24-0.92],0.026729502646704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA2,Apolipoprotein A-II,3685,143,1.55 [1.15-2.08],0.0034869490265885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA4,Apolipoprotein A-IV,3684,142,3.11 [2.22-4.36],4.6789595337729313e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOB,Apolipoprotein B-100,3685,143,1.01 [0.50-2.03],0.9846656839483952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOBR,Apolipoprotein B receptor,3579,143,0.84 [0.58-1.22],0.3690319432748548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOC1,Apolipoprotein C-I,3674,141,0.57 [0.37-0.89],0.0121154513780299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOD,Apolipoprotein D,3531,134,0.48 [0.29-0.79],0.0040595842501492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOE,Apolipoprotein E,3684,142,0.87 [0.64-1.17],0.3574070148917273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOF,Apolipoprotein F,3685,143,0.88 [0.56-1.37],0.5620601207017086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOH,Beta-2-glycoprotein 1,4246,172,1.58 [1.14-2.20],0.0060577805779814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOL1,Apolipoprotein L1,3685,143,0.88 [0.66-1.18],0.3987188335407043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOM,Apolipoprotein M,4245,171,0.55 [0.35-0.85],0.0079102873622468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APP,Amyloid-beta precursor protein,4240,170,1.14 [0.93-1.39],0.2045025870287656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APPL2,DCC-interacting protein 13-beta,3611,140,0.94 [0.81-1.09],0.3923480755630484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APRT,Adenine phosphoribosyltransferase,4191,169,1.30 [0.96-1.75],0.0947034875238996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARAF,Serine/threonine-protein kinase A-Raf,3618,140,0.97 [0.76-1.24],0.8069745642059376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AREG,Amphiregulin,4212,172,2.63 [2.11-3.28],8.974926953758164e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARF6,ADP-ribosylation factor 6,3652,139,0.95 [0.82-1.11],0.5381011921036982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARFIP1,Arfaptin-1,3668,142,0.98 [0.77-1.25],0.8827489895138936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARG1,Arginase-1,4195,172,0.78 [0.61-1.01],0.0579737679656216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARG2,"Arginase-2, mitochondrial",3659,142,1.34 [0.98-1.83],0.0709753584717859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP1,Rho GTPase-activating protein 1,4103,164,0.71 [0.52-0.96],0.0278037213581156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP25,Rho GTPase-activating protein 25,4103,164,1.09 [0.86-1.37],0.4853373715861865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP30,Rho GTPase-activating protein 30,3618,140,1.11 [0.73-1.67],0.6356137429699034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP45,Rho GTPase-activating protein 45,3611,140,0.97 [0.79-1.18],0.7329499202750399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP5,Rho GTPase-activating protein 5,3536,140,0.95 [0.77-1.18],0.657609075845113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,3657,142,1.00 [0.83-1.20],0.9665965251672656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,3668,142,1.00 [0.84-1.18],0.9772486994933086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,4226,172,1.01 [0.89-1.15],0.8361530638480998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,3549,140,1.27 [1.05-1.54],0.0141202988438217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARID3A,AT-rich interactive domain-containing protein 3A,3549,140,0.96 [0.62-1.49],0.8577809367163359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARID4B,AT-rich interactive domain-containing protein 4B,4101,164,0.94 [0.67-1.32],0.7235861042283771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARL13B,ADP-ribosylation factor-like protein 13B,3553,138,0.96 [0.75-1.21],0.7130080640238339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,3553,138,0.97 [0.64-1.46],0.8673051199518326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,3549,140,0.97 [0.72-1.30],0.8273260044255377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,4131,169,1.42 [1.12-1.81],0.0041799794586272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,3553,138,0.87 [0.61-1.24],0.43857753034198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARSA,Arylsulfatase A,4246,172,1.01 [0.76-1.34],0.9648566057917722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARSB,Arylsulfatase B,4212,172,0.98 [0.77-1.24],0.8587975015981526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ART3,Ecto-ADP-ribosyltransferase 3,4246,171,2.04 [1.47-2.82],1.7480776448210826e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ART5,Ecto-ADP-ribosyltransferase 5,3549,140,1.13 [0.90-1.42],0.2962961854963243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARTN,Artemin,4131,169,1.12 [0.84-1.49],0.4284481359932738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASAH1,Acid ceramidase,3661,141,0.86 [0.61-1.23],0.42072908275358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASAH2,Neutral ceramidase,4194,169,0.99 [0.77-1.26],0.9097586977592864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR1,Asialoglycoprotein receptor 1,4194,169,3.79 [2.74-5.23],6.831784698226689e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR2,Asialoglycoprotein receptor 2,3685,143,4.71 [2.96-7.50],6.552271584901333e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASPN,Asporin,3670,144,2.17 [1.37-3.44],0.0008947122852807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASPSCR1,Tether containing UBX domain for GLUT4,3668,142,0.98 [0.76-1.26],0.8645030306627427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,3579,143,0.93 [0.79-1.09],0.3644274581124067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASS1,Argininosuccinate synthase,3553,138,0.97 [0.80-1.17],0.7303049385144016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,4101,164,1.15 [0.97-1.36],0.0994131312958644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,3536,140,0.87 [0.53-1.41],0.5683739512734867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATG16L1,Autophagy-related protein 16-1,3652,139,1.06 [0.87-1.28],0.5677383987259319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATG4A,Cysteine protease ATG4A,4103,164,0.97 [0.77-1.22],0.7982731736522706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATOX1,Copper transport protein ATOX1,4238,174,1.25 [1.02-1.52],0.0295024270242353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,3553,138,1.06 [0.74-1.51],0.74762576383023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,3553,138,1.13 [0.72-1.76],0.6042229391859735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,3553,138,1.24 [0.83-1.83],0.2904193232254712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B4,Protein ATP1B4,3536,140,0.85 [0.56-1.29],0.441388755192599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,3553,138,0.79 [0.57-1.10],0.169901555338963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",3553,138,1.05 [0.76-1.46],0.7683149920642244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP5IF1,"ATPase inhibitor, mitochondrial",4248,170,1.00 [0.88-1.14],0.9713725969234354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP5PO,"ATP synthase subunit O, mitochondrial",4101,164,1.14 [0.86-1.52],0.356758085039504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6AP2,Renin receptor,4103,164,1.44 [1.07-1.94],0.0167665416939443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1D,V-type proton ATPase subunit D,4212,172,1.37 [0.89-2.10],0.1500170949728279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1F,V-type proton ATPase subunit F,4092,163,1.05 [0.86-1.29],0.6025026225522366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1G1,V-type proton ATPase subunit G 1,3579,143,1.02 [0.82-1.28],0.8598605187698731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1G2,V-type proton ATPase subunit G 2,3553,138,0.97 [0.81-1.17],0.7672190430889266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATRAID,All-trans retinoic acid-induced differentiation factor,3652,139,3.14 [2.26-4.38],1.2954522675369656e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATRN,"Attractin, Isoform 2",3684,142,3.10 [1.25-7.66],0.0143154213559047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN10,Ataxin-10,4101,164,1.02 [0.85-1.23],0.8442553583273597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN2,Ataxin-2,3549,140,0.97 [0.83-1.12],0.6543198007991081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN2L,Ataxin-2-like protein,3668,142,0.88 [0.62-1.24],0.4549639382331741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN3,Ataxin-3,3657,142,1.00 [0.77-1.29],0.9824695759066242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AXIN1,Axin-1,4226,172,0.98 [0.85-1.13],0.8067139522321792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AXL,Tyrosine-protein kinase receptor UFO,4246,171,1.83 [1.17-2.86],0.0078277168833182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AZI2,5-azacytidine-induced protein 2,3668,142,0.96 [0.72-1.28],0.7848751093180872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AZU1,Azurocidin,4121,171,1.03 [0.87-1.21],0.7454775653212481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B2M,Beta-2-microglobulin,3684,142,3.41 [2.41-4.82],3.9213802514040306e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,3553,138,0.99 [0.43-2.27],0.9746473363084994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",3579,143,3.91 [2.57-5.93],1.5436464383190787e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",4248,170,4.38 [2.88-6.66],4.966422245451969e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",4246,172,1.80 [1.03-3.13],0.0386285264800786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BABAM1,BRISC and BRCA1-A complex member 1,3559,140,0.68 [0.35-1.30],0.2407715651504763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BACH1,Transcription regulator protein BACH1,4226,172,0.97 [0.81-1.18],0.7889740183456958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAG3,BAG family molecular chaperone regulator 3,4187,169,0.96 [0.70-1.33],0.8257408366483433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAG4,BAG family molecular chaperone regulator 4,3559,140,0.99 [0.71-1.38],0.9423145054888294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAG6,Large proline-rich protein BAG6,4152,167,1.08 [0.75-1.55],0.6910446190289818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,4103,164,1.36 [1.14-1.62],0.0006488119397979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,4103,164,2.67 [2.04-3.49],1.037851166803958e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BANK1,B-cell scaffold protein with ankyrin repeats,4226,172,0.97 [0.85-1.10],0.6037879922248989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAP18,Chromatin complexes subunit BAP18,3657,142,0.96 [0.76-1.22],0.745937471737024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BATF,Basic leucine zipper transcriptional factor ATF-like,3584,138,0.98 [0.79-1.21],0.8367477945873292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAX,Apoptosis regulator BAX,4095,164,1.11 [0.96-1.30],0.1654003968463161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAM,Basal cell adhesion molecule,4246,172,3.67 [2.21-6.08],4.830577677610631e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAN,Brevican core protein,4194,169,0.62 [0.43-0.89],0.0097920293051713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",3670,144,1.04 [0.64-1.69],0.8886388141243803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",3549,140,0.80 [0.55-1.16],0.2315206910146907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCHE,Cholinesterase,3620,140,0.86 [0.49-1.50],0.5862820120489889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2,Apoptosis regulator Bcl-2,3652,139,1.27 [0.97-1.65],0.0802664653923805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L1,Bcl-2-like protein 1,3657,142,0.93 [0.79-1.10],0.4030929576388143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",4226,172,2.19 [1.51-3.18],3.467063344566498e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L15,Bcl-2-like protein 15,3559,140,1.21 [0.96-1.53],0.111556685985602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,3536,140,0.88 [0.67-1.16],0.374346327704145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,3659,142,0.88 [0.59-1.32],0.5425167139100289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCR,Breakpoint cluster region protein,4226,172,1.02 [0.88-1.18],0.8200227623494405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BDNF,Brain-derived neurotrophic factor,3683,141,1.03 [0.85-1.25],0.7894648059831231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BECN1,Beclin-1,3579,143,1.02 [0.78-1.34],0.8773760515528188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BEX3,Protein BEX3,3536,140,0.98 [0.69-1.41],0.9293139867180328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BGLAP,Osteocalcin,3683,141,0.99 [0.84-1.17],0.893282794644272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BGN,Biglycan,4099,164,0.98 [0.87-1.10],0.7257097668480692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BHLHE40,Class E basic helix-loop-helix protein 40,3549,140,0.92 [0.72-1.18],0.5139317504577547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,3553,138,1.17 [0.60-2.29],0.641095830621281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BID,BH3-interacting domain death agonist,4226,172,0.92 [0.75-1.13],0.4351712833754432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BIN2,Bridging integrator 2,4246,172,0.94 [0.81-1.09],0.4157383834310314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BIRC2,Baculoviral IAP repeat-containing protein 2,4103,164,1.03 [0.83-1.29],0.7733404097179335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLMH,Bleomycin hydrolase,4283,174,0.93 [0.62-1.39],0.7176745565598059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLNK,B-cell linker protein,3559,140,0.74 [0.47-1.17],0.2001143979108225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,3549,140,0.81 [0.63-1.04],0.0954255749752976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,3657,142,0.95 [0.64-1.42],0.7983077929079203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLVRB,Flavin reductase,4246,172,0.92 [0.76-1.13],0.4344372103318107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP10,Bone morphogenetic protein 10,3611,140,2.46 [1.58-3.81],6.017436991959635e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP4,Bone morphogenetic protein 4,4187,169,1.09 [0.83-1.42],0.5483840061569358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP6,Bone morphogenetic protein 6,4148,167,1.39 [0.99-1.96],0.0555556228446998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMPER,BMP-binding endothelial regulator protein,3611,140,3.27 [2.07-5.16],3.858193151310783e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,3670,144,0.82 [0.50-1.35],0.4386751786878266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,3559,140,1.51 [1.09-2.08],0.0129908214842396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOC,Brother of CDO,4152,167,3.40 [1.97-5.87],1.0761158385351691e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOLA1,BolA-like protein 1,3549,140,1.22 [0.96-1.56],0.106372468569091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOLA2_BOLA2B,BolA-like protein 2,3579,143,0.94 [0.69-1.26],0.6646308211006462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BPIFA2,BPI fold-containing family A member 2,3469,137,0.84 [0.73-0.98],0.0244831323484847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BPIFB1,BPI fold-containing family B member 1,4219,172,0.85 [0.69-1.03],0.1022976266731134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BPIFB2,BPI fold-containing family B member 2,3665,144,0.93 [0.75-1.15],0.517575978701366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRAP,BRCA1-associated protein,3612,138,1.05 [0.90-1.22],0.552014620995431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRD1,Bromodomain-containing protein 1,3618,140,0.78 [0.44-1.39],0.3977944439708428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRD2,Bromodomain-containing protein 2,3549,140,0.68 [0.39-1.18],0.1705691654893124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRD3,Bromodomain-containing protein 3,3553,138,0.89 [0.60-1.31],0.5467423121370598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRDT,Bromodomain testis-specific protein,3553,138,0.90 [0.57-1.42],0.6504137682203642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRK1,Protein BRICK1,4101,164,1.18 [0.88-1.58],0.2687469542033373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRME1,Break repair meiotic recombinase recruitment factor 1,3549,140,0.95 [0.62-1.45],0.8120836079053488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRSK2,Serine/threonine-protein kinase BRSK2,3668,142,1.07 [0.71-1.63],0.7407566706555364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BSG,Basigin,4273,174,5.75 [3.61-9.16],1.6205831314893074e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BSND,Barttin,3536,140,1.22 [0.80-1.86],0.3521440745730253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,4264,173,2.67 [1.71-4.18],1.7221236717763467e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BST2,Bone marrow stromal antigen 2,4264,173,1.24 [1.01-1.54],0.0429521463665806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTC,Probetacellulin,4103,164,1.06 [0.87-1.28],0.5623161506183423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTD,Biotinidase,3684,142,3.04 [1.38-6.68],0.0057681902013028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTLA,B- and T-lymphocyte attenuator,3536,140,0.93 [0.77-1.13],0.4700943954797376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN1A1,Butyrophilin subfamily 1 member A1,3653,142,1.15 [0.79-1.65],0.4651886603459784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN2A1,Butyrophilin subfamily 2 member A1,4248,170,4.65 [3.45-6.29],1.1721080196790037e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN3A2,Butyrophilin subfamily 3 member A2,4226,172,2.56 [1.86-3.52],6.726349022074502e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTNL10,Butyrophilin-like protein 10,3536,140,0.81 [0.51-1.30],0.3846243559667264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C19orf12,Protein C19orf12,4101,164,0.91 [0.76-1.08],0.2673786954672371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1GALT1C1,C1GALT1-specific chaperone 1,3553,138,1.55 [1.17-2.04],0.00208467885971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QA,Complement C1q subcomponent subunit A,4259,174,2.95 [1.73-5.02],6.88354466980667e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",3668,142,0.86 [0.65-1.15],0.311166953965673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QL2,Complement C1q-like protein 2,3559,140,0.78 [0.53-1.15],0.2175799046483212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,4246,171,1.80 [1.43-2.27],7.455805371147368e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,3611,140,0.99 [0.64-1.54],0.9782717670716602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,3668,142,1.46 [0.96-2.22],0.0755689296886663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,3606,140,0.96 [0.69-1.33],0.7853396437442426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1R,Complement C1r subcomponent,3684,142,0.70 [0.26-1.89],0.4771578726690675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1RL,Complement C1r subcomponent-like protein,3675,142,1.96 [0.88-4.38],0.0994777142438539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1S,Complement C1s subcomponent,3684,142,1.20 [0.56-2.59],0.6385151694876485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2,Complement C2,4245,171,2.68 [1.36-5.29],0.0044438435577388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2CD2L,Phospholipid transfer protein C2CD2L,4092,163,1.26 [0.93-1.70],0.1360669007362583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2orf69,UPF0565 protein C2orf69,3584,138,0.80 [0.57-1.12],0.1937042988584476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C3,Complement C3,3486,133,0.85 [0.57-1.28],0.4406388712737756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C4BPB,C4b-binding protein beta chain,4238,174,0.90 [0.65-1.24],0.5086587506231027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C5,Complement C5,3684,142,1.91 [0.73-5.00],0.1870037101278534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C7,Complement component C7,3587,139,3.34 [2.27-4.91],9.748481029765884e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C7orf50,Uncharacterized protein C7orf50,3657,142,0.84 [0.37-1.90],0.6732415232918181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C8B,Complement component C8 beta chain,3684,142,1.63 [0.98-2.70],0.0583907471375228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C9,Complement component C9,3685,143,1.19 [0.92-1.54],0.1902822346589191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C9orf40,Uncharacterized protein C9orf40,3652,139,0.97 [0.79-1.18],0.7319754662571953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA1,Carbonic anhydrase 1,4164,169,0.87 [0.70-1.10],0.2409714132418672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA11,Carbonic anhydrase-related protein 11,4103,164,1.26 [0.91-1.74],0.1577090876777989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA12,Carbonic anhydrase 12,4212,172,3.63 [2.90-4.54],1.3168429748001519e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA13,Carbonic anhydrase 13,4190,168,0.98 [0.86-1.12],0.7695418320116172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA14,Carbonic anhydrase 14,4267,175,2.07 [1.51-2.83],4.967492059820758e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA2,Carbonic anhydrase 2,4233,172,0.97 [0.80-1.17],0.7381406619963704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA3,Carbonic anhydrase 3,4279,174,1.43 [1.17-1.75],0.0004722709054274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA4,Carbonic anhydrase 4,4283,174,2.20 [1.35-3.59],0.0016221981208028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",4152,167,1.03 [0.90-1.18],0.6346080949860288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA6,Carbonic anhydrase 6,4231,170,0.74 [0.60-0.91],0.0040537804935206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA7,Carbonic anhydrase 7,3618,140,1.08 [0.68-1.72],0.7379758210932289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA8,Carbonic anhydrase-related protein,3559,140,0.82 [0.41-1.67],0.5917169598718175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA9,Carbonic anhydrase 9,4267,175,1.65 [1.33-2.04],6.497586487990573e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CABP2,Calcium-binding protein 2,3584,138,0.93 [0.71-1.22],0.616209033501684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,3549,140,0.97 [0.57-1.62],0.896529294532332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,3553,138,0.96 [0.72-1.28],0.7754912053085575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,3549,140,0.88 [0.65-1.17],0.3740217022919394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,3668,142,0.93 [0.77-1.12],0.435470521073365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACYBP,Calcyclin-binding protein,3606,139,0.95 [0.81-1.11],0.497323153129323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CADPS,Calcium-dependent secretion activator 1,3584,138,0.88 [0.58-1.33],0.5484686373560805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB1,Calbindin,4212,172,2.03 [1.55-2.66],2.5380431151822373e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB2,Calretinin,4101,164,2.66 [1.83-3.86],3.220928607924936e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCA,Calcitonin,4185,168,1.48 [1.25-1.76],4.658161953047669e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCB,Calcitonin gene-related peptide 2,3657,142,1.78 [1.43-2.21],2.061322150978726e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,4251,175,1.01 [0.89-1.16],0.8252589302302337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,3579,143,0.93 [0.75-1.15],0.4870817298165243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALY,Neuron-specific vesicular protein calcyon,3553,138,1.04 [0.69-1.57],0.840661849063022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,4103,164,1.37 [1.02-1.83],0.0363040187512746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,3584,138,1.14 [0.85-1.52],0.3882912178939355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,3668,142,0.98 [0.84-1.14],0.822658473582845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CANT1,Soluble calcium-activated nucleotidase 1,4217,171,2.74 [1.48-5.10],0.0014120687110784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAPG,Macrophage-capping protein,4202,175,1.23 [1.00-1.53],0.0535882956691454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAPN3,Calpain-3,3659,142,1.12 [0.75-1.67],0.5933859082757593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAPS,Calcyphosin,3657,142,1.02 [0.87-1.19],0.8100482608658129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CARHSP1,Calcium-regulated heat-stable protein 1,4101,164,0.90 [0.69-1.18],0.463688981735462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASC3,Protein CASC3,3584,138,0.85 [0.57-1.25],0.4055636182252946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP1,Caspase-1,4101,164,0.94 [0.78-1.14],0.5446521926921628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP10,Caspase-10,4101,164,1.03 [0.85-1.25],0.7410443437315184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP2,Caspase-2,4226,172,0.98 [0.81-1.20],0.8767732457908084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP3,Caspase-3,4283,174,0.98 [0.84-1.14],0.8163174049365511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP4,Caspase-4,3618,140,0.99 [0.90-1.09],0.8129667507176321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP7,Caspase-7,3657,142,0.99 [0.81-1.20],0.9053244869448216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP8,Caspase-8,4255,175,0.97 [0.78-1.20],0.7719465019481301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP9,Caspase-9,3559,140,0.93 [0.71-1.23],0.6115696931235253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASQ2,Calsequestrin-2,3553,138,1.14 [0.81-1.60],0.4635096227988572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAT,Catalase,3625,140,1.06 [0.79-1.42],0.6792000359941273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLIF,Cobalamin binding intrinsic factor,4233,173,1.43 [1.22-1.66],5.835772940479065e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLN1,Cerebellin-1,3549,140,1.03 [0.86-1.23],0.7817240047574247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLN4,Cerebellin-4,4267,175,0.60 [0.41-0.88],0.0085072040642371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBS,Cystathionine beta-synthase,3579,143,0.85 [0.64-1.14],0.2834220855567991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBX2,Chromobox protein homolog 2,3553,138,1.01 [0.65-1.56],0.965495709643154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,4194,169,1.10 [0.92-1.32],0.2975326710839713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCAR2,Cell cycle and apoptosis regulator protein 2,3657,142,1.00 [0.76-1.33],0.984872726552878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC134,Coiled-coil domain-containing protein 134,3659,142,0.92 [0.66-1.30],0.6517332826093598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC28A,Coiled-coil domain-containing protein 28A,3584,138,0.70 [0.41-1.21],0.2015058584306065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC50,Coiled-coil domain-containing protein 50,3668,142,1.11 [0.92-1.34],0.2898528802669791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC80,Coiled-coil domain-containing protein 80,4233,173,1.77 [1.28-2.46],0.0006125450776702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,3579,143,1.22 [0.98-1.53],0.0809804154843679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL11,Eotaxin,4281,174,2.40 [1.72-3.37],3.257272583489734e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL13,C-C motif chemokine 13,4273,173,1.22 [1.01-1.48],0.043913184756253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL14,C-C motif chemokine 14,4230,170,2.55 [1.97-3.30],8.963779262848946e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL15,C-C motif chemokine 15,4283,174,2.38 [1.88-3.03],1.151717238977628e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL16,C-C motif chemokine 16,4283,174,1.67 [1.30-2.16],7.378252513718354e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL17,C-C motif chemokine 17,4225,170,1.05 [0.91-1.21],0.5370282968875175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL18,C-C motif chemokine 18,4190,170,1.19 [1.01-1.41],0.0412040766341316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL19,C-C motif chemokine 19,4264,173,1.02 [0.92-1.12],0.7480217281884102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL2,C-C motif chemokine 2,4187,169,1.36 [1.06-1.75],0.0167699906201901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL20,C-C motif chemokine 20,4281,174,1.07 [0.94-1.23],0.3029500703447487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL21,C-C motif chemokine 21,4248,170,1.57 [1.29-1.91],8.057182385269948e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL22,C-C motif chemokine 22,4192,167,1.35 [1.05-1.73],0.0178642372178155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL23,C-C motif chemokine 23,4248,170,1.48 [1.10-2.00],0.0089384955069356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL24,C-C motif chemokine 24,4242,170,1.04 [0.89-1.22],0.6224106339624988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL25,C-C motif chemokine 25,4281,174,1.92 [1.47-2.50],1.2433827986295944e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL26,C-C motif chemokine 26,4226,172,0.84 [0.72-0.99],0.040750424642693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL27,C-C motif chemokine 27,4233,173,0.92 [0.75-1.14],0.4630698499160181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL28,C-C motif chemokine 28,4211,170,1.23 [0.99-1.53],0.0556065350491336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL3,C-C motif chemokine 3,4226,172,1.35 [1.20-1.53],1.2970793430152652e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL4,C-C motif chemokine 4,4238,170,1.16 [0.97-1.39],0.1091387247179439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL5,C-C motif chemokine 5,4246,171,1.14 [1.00-1.30],0.0499431766250698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL7,C-C motif chemokine 7,4226,172,1.37 [1.10-1.71],0.0043624167068334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL8,C-C motif chemokine 8,4263,175,1.35 [1.07-1.69],0.0104124326316035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN1,CCN family member 1,4208,172,1.25 [1.03-1.52],0.0253655528658938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN2,CCN family member 2,4229,170,1.26 [0.99-1.60],0.0565370567087586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN3,CCN family member 3,4269,174,2.90 [2.18-3.84],1.6965695543940757e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN4,CCN family member 4,4267,175,3.09 [2.35-4.06],5.194159730445726e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN5,CCN family member 5,4246,172,2.95 [2.20-3.97],6.8084578693521e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCND2,G1/S-specific cyclin-D2,3618,140,0.97 [0.63-1.50],0.904794708139875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCNE1,G1/S-specific cyclin-E1,3559,140,1.09 [0.92-1.29],0.3378919697172837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCS,Copper chaperone for superoxide dismutase,4194,169,0.73 [0.54-0.97],0.0321891956812192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCT5,T-complex protein 1 subunit epsilon,4103,164,0.94 [0.68-1.30],0.7066546607854041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD101,Immunoglobulin superfamily member 2,3652,139,1.25 [0.88-1.77],0.2077781486938113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD109,CD109 antigen,4246,172,1.97 [1.35-2.87],0.0004351401923848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD14,Monocyte differentiation antigen CD14,4164,165,2.63 [1.98-3.49],1.8457479254917208e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD160,CD160 antigen,4281,174,2.24 [1.79-2.80],1.7859263032633688e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,4246,171,1.43 [1.08-1.90],0.0139395318809691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD164,Sialomucin core protein 24,4246,172,1.69 [1.38-2.07],3.209224120507883e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD164L2,CD164 sialomucin-like 2 protein,3584,138,1.14 [0.75-1.75],0.5405345368083345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD177,CD177 antigen,4235,172,0.99 [0.89-1.09],0.7871228178424594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD1C,T-cell surface glycoprotein CD1c,4238,174,0.69 [0.42-1.11],0.121220721529392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD2,T-cell surface antigen CD2,3553,138,1.32 [0.98-1.78],0.0718012706237529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD200,OX-2 membrane glycoprotein,4226,172,2.55 [1.77-3.67],4.437386159062227e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,4212,171,1.25 [0.85-1.83],0.2562629964696594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD207,C-type lectin domain family 4 member K,4143,170,2.43 [1.78-3.33],2.9004733336086204e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD209,CD209 antigen,4241,169,1.01 [0.70-1.47],0.9408145235387628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD22,B-cell receptor CD22,4281,174,1.29 [0.97-1.72],0.0827153749035535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD226,CD226 antigen,3559,140,1.33 [0.91-1.95],0.1452343934065228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD244,Natural killer cell receptor 2B4,4281,174,2.20 [1.44-3.37],0.0002959859453731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD248,Endosialin,3683,141,0.97 [0.67-1.41],0.867807505144365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD27,CD27 antigen,4238,174,3.48 [2.81-4.32],4.6054470687920525e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD274,Programmed cell death 1 ligand 1,4194,169,2.25 [1.72-2.95],4.140859709069515e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD276,CD276 antigen,4226,170,5.18 [3.86-6.96],9.036525005661602e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD28,T-cell-specific surface glycoprotein CD28,4103,164,2.16 [1.59-2.94],8.945350812722201e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD2AP,CD2-associated protein,4233,173,0.92 [0.75-1.14],0.4461216153383244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300A,CMRF35-like molecule 8,3611,140,2.72 [1.68-4.39],4.500040567228181e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300C,CMRF35-like molecule 6,4264,173,3.63 [2.60-5.07],3.532010663999403e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300E,CMRF35-like molecule 2,4254,175,2.67 [2.07-3.43],3.63558119585792e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LF,CMRF35-like molecule 1,4267,175,1.66 [1.32-2.09],1.5288508955528523e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LG,CMRF35-like molecule 9,4246,172,2.58 [1.89-3.51],1.899901106982033e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD302,CD302 antigen,4212,172,3.57 [2.70-4.74],8.587266020233864e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD33,Myeloid cell surface antigen CD33,4238,174,1.11 [0.93-1.32],0.2437266371012463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD34,Hematopoietic progenitor cell antigen CD34,4253,172,1.68 [0.99-2.85],0.0544512220566635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD36,Platelet glycoprotein 4,3559,140,1.44 [1.03-2.01],0.0321587611191142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4212,172,2.36 [1.66-3.36],1.859886747969565e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD3D,T-cell surface glycoprotein CD3 delta chain,3549,140,0.97 [0.56-1.68],0.9239309397152192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,3618,140,0.86 [0.51-1.46],0.5749755968949282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,3559,140,1.07 [0.91-1.25],0.4163458377185309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD4,T-cell surface glycoprotein CD4,4219,170,2.55 [1.88-3.47],2.4151687896371446e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD40,Tumor necrosis factor receptor superfamily member 5,4232,170,1.48 [1.17-1.86],0.0010509654070089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD40LG,CD40 ligand,4281,174,1.02 [0.86-1.20],0.8416046219509522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD46,Membrane cofactor protein,4213,169,3.15 [2.21-4.47],1.7666546644220512e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD48,CD48 antigen,4242,170,3.39 [2.24-5.13],7.1691859020422445e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD5,T-cell surface glycoprotein CD5,4263,175,2.53 [1.94-3.31],1.158056778105554e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD55,Complement decay-accelerating factor,4083,164,3.18 [2.22-4.57],3.306162642435575e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD58,Lymphocyte function-associated antigen 3,4218,170,2.31 [1.08-4.95],0.0317441519548384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD59,CD59 glycoprotein,4074,170,4.49 [3.17-6.36],3.2845769274036655e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD5L,CD5 antigen-like,3664,141,1.47 [1.07-2.01],0.0180338578661881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD6,T-cell differentiation antigen CD6,4273,174,1.11 [0.86-1.44],0.4302576190924256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD63,CD63 antigen,4187,169,1.16 [0.88-1.53],0.2947498637205538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD69,Early activation antigen CD69,4213,172,0.95 [0.81-1.11],0.5122954702712245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD7,T-cell antigen CD7,3549,140,1.99 [1.47-2.69],8.622924125408107e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD70,CD70 antigen,4226,172,1.51 [1.12-2.03],0.0068186582789226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD72,B-cell differentiation antigen CD72,3611,140,1.80 [1.29-2.52],0.0005310376335298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD74,HLA class II histocompatibility antigen gamma chain,4264,173,4.81 [3.53-6.55],1.8195230741123494e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,4281,174,2.48 [1.98-3.11],3.2775071477312e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD80,T-lymphocyte activation antigen CD80,3670,144,2.77 [1.91-4.02],8.853063264449633e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD82,CD82 antigen,3618,140,0.99 [0.68-1.44],0.971140814690646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD83,CD83 antigen,4226,172,2.65 [1.94-3.62],1.0001069870492108e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD84,SLAM family member 5,4226,172,1.06 [0.69-1.62],0.7833596961563148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD86,T-lymphocyte activation antigen CD86,3652,139,0.98 [0.57-1.68],0.9531437074670636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,4264,173,1.31 [1.02-1.66],0.0313486624592697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD93,Complement component C1q receptor,4090,159,2.85 [1.98-4.08],1.2628719543197724e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD99,CD99 antigen,4246,172,4.94 [2.76-8.86],8.021481163359733e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD99L2,CD99 antigen-like protein 2,4246,172,3.36 [2.04-5.53],1.9434911776665355e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDA,Cytidine deaminase,3666,144,0.91 [0.66-1.25],0.5464554268824255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDAN1,Codanin-1,3657,142,0.50 [0.23-1.09],0.0817510433685376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC123,Cell division cycle protein 123 homolog,3536,140,0.89 [0.67-1.17],0.3986616751357594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC25A,M-phase inducer phosphatase 1,3536,140,0.85 [0.54-1.34],0.4865834513617614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC26,Anaphase-promoting complex subunit CDC26,3646,138,1.04 [0.81-1.32],0.7673309836612774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC27,Cell division cycle protein 27 homolog,4103,164,1.02 [0.82-1.28],0.8450165088479065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC37,Hsp90 co-chaperone Cdc37,4238,174,0.96 [0.82-1.13],0.6418996841844453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,3652,139,1.03 [0.88-1.20],0.7320159175674141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDCP1,CUB domain-containing protein 1,4194,169,1.35 [1.09-1.68],0.005692395668449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH1,Cadherin-1,4083,165,2.22 [1.81-2.71],1.0463823557319922e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH15,Cadherin-15,4255,172,1.27 [1.09-1.47],0.0021242172156093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH17,Cadherin-17,4233,173,1.44 [1.21-1.71],2.823174873940837e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH2,Cadherin-2,4233,173,1.58 [1.14-2.19],0.0057882960010788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH22,Cadherin-22,3618,140,1.19 [0.67-2.12],0.5501141512204952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH23,Cadherin-23,3657,142,0.93 [0.49-1.76],0.8195877059728945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH3,Cadherin-3,4264,173,2.90 [2.18-3.87],2.6936027210725674e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH4,Cadherin-4,3549,140,1.02 [0.73-1.43],0.9164102884269236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH5,Cadherin-5,4283,174,1.70 [1.12-2.58],0.0121868394497123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH6,Cadherin-6,4233,173,1.79 [1.31-2.43],0.0002295782876595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDHR1,Cadherin-related family member 1,4101,164,0.99 [0.72-1.37],0.974227712026291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDHR2,Cadherin-related family member 2,4212,172,0.94 [0.78-1.13],0.4901976367147914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDHR5,Cadherin-related family member 5,4233,173,0.87 [0.62-1.22],0.4187870213236433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDK1,Cyclin-dependent kinase 1,3536,140,1.18 [0.77-1.83],0.4472557718692519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,3668,142,0.86 [0.64-1.16],0.3175069404154901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDKL5,Cyclin-dependent kinase-like 5,3549,140,0.90 [0.64-1.28],0.5626371815120583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,4212,172,1.11 [0.98-1.26],0.1026595495375876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,4212,172,0.98 [0.85-1.13],0.7558539138155556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDNF,Cerebral dopamine neurotrophic factor,4212,172,1.70 [1.39-2.07],1.706016784360182e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,4235,170,1.87 [1.14-3.06],0.0132951458361412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDSN,Corneodesmosin,4262,174,1.67 [1.26-2.22],0.0003701923430789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,4228,173,1.33 [0.79-2.23],0.2858024267951202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,3652,139,0.89 [0.73-1.09],0.2467677969881915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,3618,140,1.01 [0.82-1.25],0.9035450952176816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,3652,139,1.29 [0.89-1.89],0.1815455698805719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,3618,140,1.13 [0.81-1.59],0.4603849884606267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,4226,172,1.16 [1.01-1.35],0.0403479094187703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,4103,164,1.22 [0.94-1.59],0.1380850016954843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,4055,159,1.42 [1.16-1.73],0.0007974706944779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,3683,141,1.34 [0.91-1.96],0.1364075786409186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,4152,167,1.34 [1.03-1.74],0.0311588980782346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEBPA,CCAAT/enhancer-binding protein alpha,3559,140,1.05 [0.68-1.61],0.8380114920680439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEBPB,CCAAT/enhancer-binding protein beta,4152,167,0.80 [0.56-1.16],0.2454283324300196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELA2A,Chymotrypsin-like elastase family member 2A,3683,141,0.84 [0.68-1.05],0.119871426538295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELA3A,Chymotrypsin-like elastase family member 3A,4277,174,0.89 [0.73-1.08],0.2481189638656004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,3611,140,2.21 [1.33-3.66],0.002165488036658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEMIP2,Cell surface hyaluronidase,3559,140,1.53 [1.10-2.14],0.0116729824637084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,3549,140,1.02 [0.78-1.33],0.9041638736196952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CENPF,Centromere protein F,3618,140,0.94 [0.69-1.27],0.6806498120989115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CENPJ,Centromere protein J,3618,140,1.04 [0.83-1.30],0.7468275293913773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP112,Centrosomal protein of 112 kDa,3553,138,0.98 [0.69-1.41],0.9175230047934272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP152,Centrosomal protein of 152 kDa,3536,140,1.35 [1.00-1.82],0.0473011376744922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP164,Centrosomal protein of 164 kDa,4131,169,1.05 [0.86-1.27],0.6557805325477064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP170,Centrosomal protein of 170 kDa,3579,143,1.04 [0.84-1.29],0.6928595799900468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP20,Centrosomal protein 20,4103,164,1.01 [0.84-1.22],0.8924970572095329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP290,Centrosomal protein of 290 kDa,3618,140,1.00 [0.74-1.35],0.9986889437705438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP350,Centrosome-associated protein 350,3536,140,1.56 [1.18-2.07],0.0018377495067246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP43,Centrosomal protein 43,4122,162,0.96 [0.78-1.17],0.6688095023096086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP85,Centrosomal protein of 85 kDa,4103,164,1.02 [0.83-1.26],0.8450882338073439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CERT,Ceramide transfer protein,4101,164,1.04 [0.83-1.31],0.7247407673031404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES1,Liver carboxylesterase 1,4238,172,0.95 [0.83-1.08],0.4167545057789882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES2,Cocaine esterase,4212,172,1.54 [1.25-1.90],5.168649310401641e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES3,Carboxylesterase 3,4212,172,0.88 [0.72-1.08],0.2272999054134847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CETN2,Centrin-2,4101,164,1.09 [0.89-1.33],0.4113569183684279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CETN3,Centrin-3,3652,139,0.88 [0.70-1.09],0.2431840787518271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFB,Complement factor B,3615,139,1.90 [1.16-3.13],0.0112626467975857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFC1,Cryptic protein,4103,164,1.49 [1.19-1.86],0.0005201858137505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFD,Complement factor D,3684,142,4.01 [2.49-6.46],1.2140501001097324e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFH,Complement factor H,3457,133,2.53 [1.22-5.24],0.0128435100675143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFHR2,Complement factor H-related protein 2,3657,140,1.28 [0.95-1.74],0.107878775074854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFHR4,Complement factor H-related protein 4,3677,142,0.88 [0.72-1.09],0.2466836492890323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFHR5,Complement factor H-related protein 5,3626,139,1.23 [0.84-1.80],0.2910590796269062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFI,Complement factor I,3684,142,1.83 [0.82-4.08],0.139500037504242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFP,Properdin,3684,142,0.55 [0.26-1.16],0.1151574498801484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGA,Glycoprotein hormones alpha chain,4246,172,1.51 [1.28-1.79],9.935158555401543e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,3685,143,1.18 [0.88-1.59],0.2647144207792574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGN,Cingulin,3584,138,0.77 [0.49-1.22],0.2677577787277045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGREF1,Cell growth regulator with EF hand domain protein 1,4233,173,2.48 [1.92-3.20],3.2379534462582965e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,4103,164,1.12 [0.89-1.41],0.3457140910850329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHAD,Chondroadherin,3611,140,0.49 [0.36-0.65],1.1647039699327696e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",3657,142,2.86 [2.14-3.83],1.4797678027165496e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD6,MICOS complex subunit MIC25,3659,142,1.67 [1.21-2.30],0.0016197363884996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHEK2,Serine/threonine-protein kinase Chk2,4152,167,0.89 [0.58-1.36],0.5866030632284509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGA,Chromogranin-A,3683,141,1.41 [1.26-1.59],4.639162299330549e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGB,Secretogranin-1,4246,172,2.72 [2.12-3.48],3.2009683185602097e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHI3L1,Chitinase-3-like protein 1,4132,166,1.59 [1.39-1.82],2.3827626395905918e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHIT1,Chitotriosidase-1,4248,171,1.06 [0.96-1.17],0.2494222706304059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHL1,Neural cell adhesion molecule L1-like protein,4236,167,1.44 [0.94-2.19],0.0911216262821307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHM,Rab proteins geranylgeranyltransferase component A 1,3584,138,0.87 [0.66-1.16],0.3423192714933017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHMP1A,Charged multivesicular body protein 1a,4194,169,1.07 [0.89-1.28],0.4708826431150803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHMP6,Charged multivesicular body protein 6,3670,144,0.93 [0.70-1.23],0.6207932868881314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHP1,Calcineurin B homologous protein 1,3549,140,0.96 [0.76-1.22],0.7535936216404497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL1,Chordin-like protein 1,4242,170,4.69 [3.31-6.66],4.668148506827997e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL2,Chordin-like protein 2,4233,173,0.81 [0.62-1.05],0.1167506157114257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRM1,Muscarinic acetylcholine receptor M1,3584,138,0.86 [0.54-1.37],0.5208583401376243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CIAPIN1,Anamorsin,4238,174,1.08 [0.86-1.34],0.5122248659977855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CILP,Cartilage intermediate layer protein 1,3683,141,1.89 [1.42-2.51],1.3342966789866712e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CINP,Cyclin-dependent kinase 2-interacting protein,3618,140,0.79 [0.52-1.19],0.2559433587855634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CIRBP,Cold-inducible RNA-binding protein,3652,139,0.98 [0.82-1.16],0.8024905994087321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CIT,Citron Rho-interacting kinase,3584,138,1.03 [0.73-1.45],0.8635304309157898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKAP4,Cytoskeleton-associated protein 4,4264,174,3.53 [2.81-4.44],2.514332130224722e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKB,Creatine kinase B-type,3683,141,2.01 [1.60-2.51],1.0651859049070402e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",4215,170,1.25 [1.02-1.55],0.0352810151520372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLASP1,CLIP-associating protein 1,3536,140,0.89 [0.71-1.13],0.3373599859181875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLC,Galectin-10,4226,173,1.25 [1.03-1.51],0.0216308359876686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC10A,C-type lectin domain family 10 member A,4194,169,2.36 [1.64-3.41],4.487073681460495e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC11A,C-type lectin domain family 11 member A,4237,171,1.10 [0.84-1.45],0.4762422342725003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC12A,C-type lectin domain family 12 member A,3559,140,1.54 [0.70-3.38],0.2840181138740454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC14A,C-type lectin domain family 14 member A,4246,172,3.31 [2.35-4.66],8.999560952815424e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC1A,C-type lectin domain family 1 member A,4152,167,2.27 [1.63-3.16],1.2994337439457795e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC1B,C-type lectin domain family 1 member B,4264,173,1.03 [0.89-1.18],0.7241824828471672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC2L,C-type lectin domain family 2 member L,3584,138,0.96 [0.68-1.36],0.824302978803309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC3B,Tetranectin,3595,139,0.30 [0.16-0.57],0.0002572575090257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4A,C-type lectin domain family 4 member A,4226,172,0.61 [0.43-0.86],0.0049789596191523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4C,C-type lectin domain family 4 member C,4226,172,0.86 [0.66-1.14],0.2954266905572105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4D,C-type lectin domain family 4 member D,4226,172,1.50 [1.24-1.82],3.228233558923956e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4G,C-type lectin domain family 4 member G,4226,172,1.22 [0.82-1.81],0.3365735996885717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4M,C-type lectin domain family 4 member M,3679,141,0.74 [0.52-1.05],0.0952421330847451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC5A,C-type lectin domain family 5 member A,4224,173,2.40 [1.65-3.49],4.4756859597177145e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC6A,C-type lectin domain family 6 member A,4103,164,1.52 [1.17-1.97],0.0014751981886071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC7A,C-type lectin domain family 7 member A,4281,174,1.93 [1.48-2.51],1.0655229456123592e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLGN,Calmegin,3584,138,1.30 [0.91-1.85],0.1483570424847245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLIC5,Chloride intracellular channel protein 5,3584,138,1.09 [0.70-1.71],0.7021115163759051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLINT1,Clathrin interactor 1,3536,140,0.88 [0.59-1.31],0.537157128454075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLIP2,CAP-Gly domain-containing linker protein 2,4226,172,1.01 [0.89-1.14],0.895252939801859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLMP,CXADR-like membrane protein,4267,175,6.32 [3.98-10.03],5.138972609827839e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLNS1A,Methylosome subunit pICln,3584,138,0.66 [0.39-1.12],0.1221937655012707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",4185,168,1.11 [0.96-1.28],0.1441033726864038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLPS,Colipase,4237,172,0.91 [0.77-1.07],0.2620433931146255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSPN,Claspin,4092,163,0.80 [0.52-1.25],0.3336806193503655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN1,Calsyntenin-1,4101,164,0.85 [0.63-1.13],0.265764998552187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN2,Calsyntenin-2,4281,174,1.84 [1.45-2.35],7.420183689707415e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN3,Calsyntenin-3,3657,142,1.59 [0.97-2.59],0.0652192588550036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLTA,Clathrin light chain A,4152,167,0.96 [0.71-1.32],0.8189199846746167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLU,Clusterin,3684,142,1.41 [0.82-2.44],0.2159572331890162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLUL1,Clusterin-like protein 1,4226,173,1.06 [0.80-1.41],0.690068076720225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CMC1,COX assembly mitochondrial protein homolog,3670,144,0.93 [0.78-1.12],0.4518224520013395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CMIP,C-Maf-inducing protein,3659,142,0.98 [0.81-1.19],0.8537677612807186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNDP1,Beta-Ala-His dipeptidase,4246,171,1.22 [0.91-1.63],0.1795791307841716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,3549,140,1.20 [0.99-1.46],0.0616151212064542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",3571,143,0.97 [0.79-1.19],0.769897041181789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNPY2,Protein canopy homolog 2,4152,167,1.11 [0.91-1.36],0.3056525740195154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNPY4,Protein canopy homolog 4,4212,172,1.06 [0.88-1.27],0.5354110170852828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNST,Consortin,4233,173,0.94 [0.84-1.07],0.3488914591403601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTF,Ciliary neurotrophic factor,3549,140,0.73 [0.45-1.16],0.1824792934634228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN1,Contactin-1,4283,174,1.94 [1.21-3.12],0.0058378300336131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN2,Contactin-2,4267,175,1.51 [1.14-2.00],0.0036766543832646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN3,Contactin-3,4246,172,1.70 [1.10-2.62],0.01634083734601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN4,Contactin-4,4246,172,2.09 [1.22-3.56],0.0072122756266783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN5,Contactin-5,4236,170,0.69 [0.48-0.98],0.0403482597442621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTNAP2,Contactin-associated protein-like 2,4226,172,1.61 [1.22-2.11],0.0007221922625052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTNAP4,Contactin-associated protein-like 4,3584,138,0.95 [0.80-1.12],0.5233821652348343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COCH,Cochlin,3670,144,1.21 [0.87-1.66],0.2533197906553389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL15A1,Collagen alpha-1(XV) chain,3683,141,1.41 [0.85-2.33],0.1817270700394836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL18A1,Collagen alpha-1(XVIII) chain,4244,172,8.80 [5.61-13.80],2.5382848925997018e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL1A1,Collagen alpha-1(I) chain,4283,174,0.85 [0.49-1.45],0.543372355902457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL24A1,Collagen alpha-1(XXIV) chain,3652,139,1.51 [1.13-2.03],0.0060181730013457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL28A1,Collagen alpha-1(XXVIII) chain,3584,138,1.19 [0.98-1.44],0.0734340526505398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL2A1,Collagen alpha-1(II) chain,3579,143,1.02 [0.84-1.24],0.8487453213509256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL3A1,Collagen alpha-1(III) chain,3683,141,1.57 [0.84-2.92],0.1573297106188481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A1,Collagen alpha-1(IV) chain,4233,173,1.98 [1.57-2.51],1.0241171563608792e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A4,Collagen alpha-4(IV) chain,3609,140,0.84 [0.62-1.14],0.2609600890920237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL5A1,Collagen alpha-1(V) chain,3611,140,1.56 [1.21-2.01],0.0005624041501492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL6A3,Collagen alpha-3(VI) chain,4283,174,3.83 [2.98-4.93],1.9647246109652329e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL9A1,Collagen alpha-1(IX) chain,4226,172,1.09 [0.84-1.42],0.5075970612184866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL9A2,Collagen alpha-2(IX) chain,3618,140,1.07 [0.76-1.52],0.6987373447918886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COLEC12,Collectin-12,4226,170,6.02 [4.26-8.51],3.0656955007800664e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMMD1,COMM domain-containing protein 1,3579,143,1.08 [0.82-1.41],0.5816402935594474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMMD9,COMM domain-containing protein 9,3659,142,1.05 [0.72-1.53],0.7997879465149548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMP,Cartilage oligomeric matrix protein,4187,169,0.85 [0.58-1.25],0.4193224010270832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMT,Catechol O-methyltransferase,4109,160,0.97 [0.81-1.16],0.7495043334467485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COPB2,Coatomer subunit beta',3553,138,0.99 [0.68-1.45],0.969462561980947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COPE,Coatomer subunit epsilon,4101,164,1.11 [0.85-1.45],0.4334699847012826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",3579,143,1.19 [0.81-1.73],0.3751966600902036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CORO1A,Coronin-1A,4153,170,1.02 [0.88-1.19],0.7646931435194577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CORO6,Coronin-6,3549,140,1.14 [0.81-1.60],0.4554193677822912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",4212,172,1.26 [1.05-1.53],0.0155130484373583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COX6B1,Cytochrome c oxidase subunit 6B1,3670,144,0.85 [0.52-1.40],0.5239414913357198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA1,Carboxypeptidase A1,4283,174,0.89 [0.74-1.06],0.1852386392718047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA2,Carboxypeptidase A2,4251,171,1.37 [1.16-1.61],0.0001926721676259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA4,Carboxypeptidase A4,3525,136,0.99 [0.68-1.44],0.9644627343914788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPB1,Carboxypeptidase B,4283,174,0.92 [0.76-1.12],0.4194278774703963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPB2,Carboxypeptidase B2,3674,141,1.54 [0.76-3.11],0.2326324662863574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPE,Carboxypeptidase E,4232,174,0.88 [0.63-1.22],0.4395039504418117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPLX2,Complexin-2,3536,140,0.97 [0.56-1.68],0.9126229232025264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPM,Carboxypeptidase M,4242,173,2.39 [1.68-3.40],1.1998451343811906e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",3559,140,0.73 [0.40-1.36],0.3264048551394118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,4264,173,0.83 [0.67-1.02],0.0806658207918998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPQ,Carboxypeptidase Q,3680,141,1.97 [1.29-3.02],0.0018271849850322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPTP,Ceramide-1-phosphate transfer protein,3553,138,1.00 [0.64-1.57],0.9902756957448376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPVL,Probable serine carboxypeptidase CPVL,4260,174,1.91 [1.35-2.68],0.0002158853792577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPXM1,Probable carboxypeptidase X1,4238,174,1.11 [0.92-1.34],0.2685188067001484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPXM2,Inactive carboxypeptidase-like protein X2,3670,144,4.62 [2.79-7.65],2.514515053408279e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CR1,Complement receptor type 1,3674,142,1.78 [1.17-2.69],0.0070011410735721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CR2,Complement receptor type 2,4246,171,1.51 [1.16-1.97],0.0023094591167821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,4103,164,1.10 [0.94-1.28],0.2293746594547213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRADD,Death domain-containing protein CRADD,4185,168,1.05 [0.87-1.27],0.5994612258919108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CREB3,Cyclic AMP-responsive element-binding protein 3,3536,140,0.93 [0.67-1.27],0.6320375427094151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CREBZF,CREB/ATF bZIP transcription factor,3536,140,1.07 [0.55-2.08],0.8432278379726443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CREG1,Protein CREG1,4183,174,0.71 [0.51-0.97],0.0333787410101734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRELD1,Protein disulfide isomerase CRELD1,3611,140,2.56 [1.72-3.82],3.5719449757025904e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRELD2,Protein disulfide isomerase CRELD2,4242,170,1.39 [1.10-1.76],0.005685331669493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRH,Corticoliberin,4096,163,0.84 [0.71-1.00],0.0470276506894568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRHBP,Corticotropin-releasing factor-binding protein,4226,170,2.44 [1.52-3.91],0.0002207245699173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRHR1,Corticotropin-releasing factor receptor 1,4152,167,0.80 [0.62-1.03],0.0874948471968864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIM1,Cysteine-rich motor neuron 1 protein,4248,170,8.45 [4.95-14.43],5.716679811870309e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIP2,Cysteine-rich protein 2,4194,169,2.07 [1.55-2.77],7.637807596943612e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRISP2,Cysteine-rich secretory protein 2,4267,175,0.95 [0.76-1.18],0.6184847894252679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRISP3,Cysteine-rich secretory protein 3,3650,142,0.65 [0.36-1.16],0.1414716521470314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRKL,Crk-like protein,4234,170,1.02 [0.89-1.16],0.7975149144720022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRLF1,Cytokine receptor-like factor 1,4248,170,2.57 [1.54-4.29],0.0003174120462029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRNN,Cornulin,4103,168,1.13 [0.93-1.36],0.2193034566348191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAC1,Cartilage acidic protein 1,4283,174,0.82 [0.54-1.24],0.3417577426621392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAM,Cytotoxic and regulatory T-cell molecule,4194,169,1.58 [1.22-2.05],0.0005148110629393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAP,Cartilage-associated protein,3584,138,0.90 [0.62-1.29],0.5579708935774961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRX,Cone-rod homeobox protein,4152,167,0.96 [0.83-1.11],0.5508439799474902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYBB1,Beta-crystallin B1,3670,144,1.03 [0.80-1.32],0.8194420253877729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYBB2,Beta-crystallin B2,3657,142,1.07 [0.91-1.27],0.4164957373426642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYGD,Gamma-crystallin D,3657,142,1.02 [0.86-1.20],0.841711733043899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYM,Ketimine reductase mu-crystallin,3549,140,1.04 [0.83-1.31],0.7214022157727746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYZL1,Quinone oxidoreductase-like protein 1,3579,143,0.94 [0.78-1.13],0.5073274490091333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSDE1,Cold shock domain-containing protein E1,3553,138,0.97 [0.84-1.12],0.680092579314509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1,Macrophage colony-stimulating factor 1,4248,170,4.22 [2.83-6.31],2.094669313059391e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,3685,143,1.69 [1.19-2.40],0.003430633921654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2,Granulocyte-macrophage colony-stimulating factor,3553,138,0.97 [0.63-1.52],0.908937763414933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,4194,169,1.36 [1.11-1.66],0.0031585412657166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2RB,Cytokine receptor common subunit beta,3559,140,0.90 [0.62-1.31],0.5881993862256978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF3,Granulocyte colony-stimulating factor,4131,169,0.91 [0.68-1.21],0.4967782812825722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF3R,Granulocyte colony-stimulating factor receptor,3559,140,1.27 [0.81-2.00],0.2919948345712905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSH1,Chorionic somatomammotropin hormone 1,3685,143,1.03 [0.59-1.79],0.9154457672408868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSNK1D,Casein kinase I isoform delta,3559,140,1.04 [0.80-1.35],0.7819433318807645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSNK2A1,Casein kinase II subunit alpha,3668,142,0.97 [0.68-1.40],0.8821759775740594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSPG4,Chondroitin sulfate proteoglycan 4,3683,141,2.51 [1.61-3.93],5.426287991188005e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSPG5,Chondroitin sulfate proteoglycan 5,3549,140,1.35 [1.04-1.77],0.0266232003762262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSRP3,Cysteine and glycine-rich protein 3,3553,138,1.15 [0.99-1.34],0.0695329457163476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST1,Cystatin-SN,3219,118,0.81 [0.67-0.97],0.0215851240549815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST3,Cystatin-C,4230,170,3.99 [2.87-5.55],1.8502848748759504e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST5,Cystatin-D,4156,168,1.45 [1.15-1.83],0.0017792020865878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST6,Cystatin-M,4114,171,1.48 [1.15-1.91],0.0022339435276106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST7,Cystatin-F,4238,170,1.06 [0.92-1.22],0.3996817210646131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSTB,Cystatin-B,4178,167,1.75 [1.30-2.36],0.000239967447191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,3610,140,0.95 [0.68-1.33],0.7820703876826242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTBS,Di-N-acetylchitobiase,3622,140,1.47 [0.83-2.59],0.1870980757228698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTF1,Cardiotrophin-1,4152,167,0.92 [0.78-1.09],0.3308103796995839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTHRC1,Collagen triple helix repeat-containing protein 1,3683,141,2.44 [1.57-3.80],7.736532385578128e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTLA4,Cytotoxic T-lymphocyte protein 4,3683,141,1.06 [0.64-1.77],0.8199209441041594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTNNA1,Catenin alpha-1,3549,140,0.74 [0.41-1.35],0.3224282237131195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRB1,Chymotrypsinogen B,4246,172,0.86 [0.71-1.04],0.1177370492922291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRC,Chymotrypsin-C,4230,170,0.70 [0.59-0.83],3.277048403725768e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRL,Chymotrypsin-like protease CTRL-1,3657,142,0.70 [0.58-0.84],0.0001477476344878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSB,Cathepsin B,4233,174,1.88 [1.49-2.36],7.745163357215007e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSC,Dipeptidyl peptidase 1,4225,170,1.04 [0.77-1.39],0.8122037781793985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSD,Cathepsin D,3971,156,1.46 [1.10-1.95],0.0093811051491993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSE,Cathepsin E,3611,140,1.70 [1.29-2.24],0.000148805406949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSF,Cathepsin F,4238,174,1.49 [1.08-2.07],0.015416101966541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSH,Pro-cathepsin H,4146,167,1.22 [1.01-1.47],0.0397873865567744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSL,Cathepsin L1,4233,173,2.23 [1.38-3.59],0.0010581332639792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSO,Cathepsin O,4281,174,2.51 [1.72-3.66],1.7185747974883777e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSS,Cathepsin S,3342,138,3.40 [1.80-6.40],0.0001548432742745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSV,Cathepsin L2,4253,174,0.76 [0.56-1.04],0.0829956966058893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSZ,Cathepsin Z,4235,171,2.89 [2.00-4.17],1.7652113017628686e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,3584,138,1.16 [0.84-1.60],0.3682710030379577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CWC15,Spliceosome-associated protein CWC15 homolog,3632,138,1.06 [0.82-1.36],0.6631704547341208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CX3CL1,Fractalkine,4194,169,2.97 [2.17-4.06],8.888575986827284e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXADR,Coxsackievirus and adenovirus receptor,4226,172,1.83 [1.45-2.31],3.523374015751588e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL1,Growth-regulated alpha protein,4232,170,1.09 [0.95-1.26],0.2112744007471983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL10,C-X-C motif chemokine 10,4248,170,1.26 [1.04-1.52],0.016796550635874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL11,C-X-C motif chemokine 11,4264,173,1.19 [1.02-1.39],0.0274022412177812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL12,Stromal cell-derived factor 1,4131,169,1.21 [0.87-1.68],0.2573184262798396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL13,C-X-C motif chemokine 13,4264,173,1.21 [1.01-1.46],0.03959978764391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL14,C-X-C motif chemokine 14,4131,169,1.18 [0.96-1.44],0.1133379576755451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL16,C-X-C motif chemokine 16,4279,174,4.63 [2.87-7.48],3.87960327881142e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL17,C-X-C motif chemokine 17,4281,174,1.26 [0.93-1.70],0.133844275541183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL3,C-X-C motif chemokine 3,4232,170,1.02 [0.88-1.17],0.8259135440231524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL5,C-X-C motif chemokine 5,4221,171,1.05 [0.94-1.18],0.3715032301773086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL6,C-X-C motif chemokine 6,4281,174,1.29 [1.09-1.53],0.0034188061492389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL8,Interleukin-8,4196,174,1.30 [1.12-1.51],0.0005554355370134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL9,C-X-C motif chemokine 9,4248,170,1.51 [1.27-1.79],2.8214892258492494e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYB5A,Cytochrome b5,3536,140,1.04 [0.83-1.32],0.7108820191016925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYB5R2,NADH-cytochrome b5 reductase 2,3608,136,1.24 [0.94-1.64],0.1303841470137642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",3553,138,0.77 [0.60-0.98],0.0350582682351813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYTH3,Cytohesin-3,3536,140,1.03 [0.83-1.29],0.7744647482035453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYTL1,Cytokine-like protein 1,3683,141,1.88 [1.06-3.35],0.0316779402449875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAAM1,Disheveled-associated activator of morphogenesis 1,3611,140,0.87 [0.71-1.07],0.1817232377690406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAB2,Disabled homolog 2,4267,175,1.01 [0.90-1.14],0.8260201298712699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAG1,Dystroglycan,4248,170,1.54 [1.15-2.06],0.004018395671456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAND5,DAN domain family member 5,3559,140,0.97 [0.76-1.24],0.8243172836133456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAPK2,Death-associated protein kinase 2,3559,140,0.93 [0.69-1.25],0.6246151772024862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,4226,172,0.94 [0.85-1.05],0.2742629091037276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",4185,168,0.96 [0.79-1.16],0.6797688890377755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBH,Dopamine beta-hydroxylase,3681,143,0.96 [0.84-1.10],0.5432096501405619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBI,Acyl-CoA-binding protein,4220,170,1.21 [1.01-1.45],0.0439529721022456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBN1,Drebrin,3559,140,1.13 [0.82-1.54],0.4510929359954487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBNL,Drebrin-like protein,4248,170,1.00 [0.87-1.16],0.9643356969673031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",4238,174,3.44 [2.45-4.82],8.439464628151607e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCC,Netrin receptor DCC,3584,138,1.25 [0.62-2.52],0.5371166586133644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCDC2C,Doublecortin domain-containing protein 2C,3536,140,0.99 [0.77-1.29],0.9673573378152994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCLRE1C,Protein artemis,3536,140,0.87 [0.50-1.52],0.6318182458559584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCN,Decorin,4152,167,4.93 [3.04-8.00],1.06449059589013e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTD,Deoxycytidylate deaminase,3611,140,0.92 [0.78-1.10],0.3555330858393741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTN1,Dynactin subunit 1,4267,175,1.04 [0.84-1.29],0.6982475522318435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTN2,Dynactin subunit 2,4212,172,1.12 [0.97-1.28],0.1207302524172459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTN6,Dynactin subunit 6,4101,164,1.01 [0.84-1.22],0.9198906232912978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTPP1,dCTP pyrophosphatase 1,4233,173,1.02 [0.67-1.56],0.9122181840287592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCUN1D1,DCN1-like protein 1,3549,140,0.94 [0.75-1.19],0.6207628025494385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCUN1D2,DCN1-like protein 2,3536,140,0.86 [0.68-1.08],0.1944623534321718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCXR,L-xylulose reductase,4238,174,0.82 [0.66-1.04],0.0977230665957398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDA1,DET1- and DDB1-associated protein 1,3553,138,1.01 [0.65-1.55],0.9780501634349972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",4212,172,1.50 [1.13-1.98],0.0043792548828529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDC,Aromatic-L-amino-acid decarboxylase,4233,173,0.73 [0.57-0.95],0.0178969933625404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDHD2,Phospholipase DDHD2,3668,142,0.99 [0.77-1.27],0.9274375625530132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDI2,Protein DDI1 homolog 2,3611,140,0.99 [0.80-1.21],0.8849386351703173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDR1,Epithelial discoidin domain-containing receptor 1,4264,173,4.14 [2.64-6.48],5.859949935709154e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDT,D-dopachrome decarboxylase,3683,141,0.98 [0.67-1.43],0.9212409765300896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX1,ATP-dependent RNA helicase DDX1,3652,139,1.13 [0.82-1.55],0.4536690893570505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX25,ATP-dependent RNA helicase DDX25,3584,138,1.30 [0.89-1.91],0.1771208492599437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX39A,ATP-dependent RNA helicase DDX39A,3559,140,1.09 [0.55-2.17],0.8082701493000488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX4,Probable ATP-dependent RNA helicase DDX4,3559,140,0.76 [0.52-1.10],0.1447359213488877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX53,Probable ATP-dependent RNA helicase DDX53,3584,138,0.66 [0.41-1.08],0.0955902506885076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX58,Antiviral innate immune response receptor RIG-I,4103,164,0.95 [0.75-1.20],0.659890622390127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",4226,172,0.97 [0.84-1.12],0.6990707930277159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFA1_DEFA1B,Neutrophil defensin 1,4136,166,1.73 [1.43-2.09],1.4012788201804129e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB103A_DEFB103B,Beta-defensin 103,3538,139,1.20 [0.89-1.63],0.231201735191998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB104A_DEFB104B,Beta-defensin 104,3549,140,1.00 [0.73-1.37],0.9967437411882304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB116,Beta-defensin 116,3549,140,0.97 [0.78-1.21],0.8113331725859371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB118,Beta-defensin 118,3549,140,1.00 [0.76-1.31],0.9960499547260698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB4A_DEFB4B,Beta-defensin 4A,4181,171,1.05 [0.97-1.15],0.2339447935342389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DENND2B,DENN domain-containing protein 2B,3553,138,1.24 [0.95-1.63],0.1094386476954753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DENR,Density-regulated protein,3559,140,0.97 [0.72-1.30],0.831667301802347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DFFA,DNA fragmentation factor subunit alpha,4281,174,1.04 [0.85-1.28],0.6903177301860824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGCR6,Protein DGCR6,3549,140,1.11 [0.75-1.63],0.609481736784859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGKA,Diacylglycerol kinase alpha,3559,140,1.06 [0.79-1.42],0.7005956990964985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGKZ,Diacylglycerol kinase zeta,4131,169,0.87 [0.59-1.30],0.5034048847649097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DHODH,Dihydroorotate dehydrogenase,3553,138,1.02 [0.71-1.45],0.9269432888284624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DHPS,Deoxyhypusine synthase,3659,142,1.11 [0.76-1.62],0.5767855948261147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,3657,142,0.99 [0.70-1.42],0.9728580108183968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DIABLO,"Diablo homolog, mitochondrial",4224,173,0.90 [0.80-1.02],0.0997447382873194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DIPK1C,Divergent protein kinase domain 1C,3584,138,0.58 [0.36-0.93],0.0251734279630634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DIPK2B,Divergent protein kinase domain 2B,3611,140,1.16 [0.67-2.02],0.5907125635331065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK1,Dickkopf-related protein 1,4264,173,1.19 [0.95-1.49],0.1242023010576185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK3,Dickkopf-related protein 3,4283,174,3.24 [2.13-4.93],4.178996117075013e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK4,Dickkopf-related protein 4,4189,169,2.60 [2.12-3.20],1.2394832742936375e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKKL1,Dickkopf-like protein 1,4212,172,0.97 [0.83-1.13],0.6642367769644526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLG4,Disks large homolog 4,3657,142,0.95 [0.75-1.19],0.630464463266567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLGAP5,Disks large-associated protein 5,3668,142,1.18 [0.89-1.58],0.2522891651014015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLK1,Protein delta homolog 1,4283,174,1.00 [0.80-1.25],0.9890807912251316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL1,Delta-like protein 1,4238,174,5.32 [3.86-7.33],1.4170126904356695e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL4,Delta-like protein 4,3579,143,1.04 [0.87-1.24],0.6692885056333941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMD,Dystrophin,3579,143,1.49 [1.15-1.93],0.0025268150643154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMP1,Dentin matrix acidic phosphoprotein 1,3579,143,0.54 [0.44-0.66],7.150468838647121e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJA1,DnaJ homolog subfamily A member 1,3536,140,0.86 [0.56-1.33],0.5109336631237567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJA2,DnaJ homolog subfamily A member 2,4272,174,1.01 [0.85-1.19],0.9140157771644138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJA4,DnaJ homolog subfamily A member 4,3657,142,1.02 [0.82-1.27],0.83522653532399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB1,DnaJ homolog subfamily B member 1,4212,172,1.06 [0.90-1.24],0.490489805417388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB14,DnaJ homolog subfamily B member 14,3652,139,1.11 [0.87-1.41],0.396124590265498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB2,DnaJ homolog subfamily B member 2,3611,140,0.89 [0.66-1.20],0.4446729541871091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB6,DnaJ homolog subfamily B member 6,3577,138,0.93 [0.76-1.13],0.46601410315655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB8,DnaJ homolog subfamily B member 8,4152,167,1.09 [0.86-1.39],0.4749846430232226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJC21,DnaJ homolog subfamily C member 21,3657,142,0.73 [0.47-1.13],0.1581251882441807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,3579,143,1.07 [0.88-1.29],0.4938721280689336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJC9,DnaJ homolog subfamily C member 9,3652,139,1.05 [0.85-1.31],0.6282008920776911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,4220,169,0.58 [0.35-0.95],0.0322112477885967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNLZ,DNL-type zinc finger protein,3549,140,0.90 [0.72-1.12],0.3323664684013652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNM1,Dynamin-1,3652,139,0.94 [0.82-1.08],0.3984596238004905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNM3,Dynamin-3,3668,142,1.32 [1.02-1.72],0.0361430894012971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNMBP,Dynamin-binding protein,4194,169,1.25 [1.02-1.54],0.032913318621614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNPEP,Aspartyl aminopeptidase,3657,142,0.91 [0.70-1.19],0.495245318969281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,4240,170,0.95 [0.73-1.23],0.7015295780692423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOC2B,Double C2-like domain-containing protein beta,3584,138,0.56 [0.31-1.00],0.0482434362428884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOCK9,Dedicator of cytokinesis protein 9,3549,140,0.87 [0.74-1.03],0.11231374788684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOK1,Docking protein 1,3657,142,0.98 [0.87-1.10],0.6847503475756127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOK2,Docking protein 2,4233,173,0.98 [0.88-1.10],0.7844741911847615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPEP1,Dipeptidase 1,4185,168,0.87 [0.67-1.15],0.3299522632561203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPEP2,Dipeptidase 2,4212,172,1.49 [0.95-2.32],0.0807002029657483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP10,Inactive dipeptidyl peptidase 10,4226,172,1.32 [0.99-1.76],0.0626819570081658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP4,Dipeptidyl peptidase 4,4172,166,0.69 [0.45-1.05],0.0861412992808872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,4212,172,2.51 [1.81-3.47],2.7587731255101534e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP7,Dipeptidyl peptidase 2,4205,172,1.10 [0.89-1.37],0.3858662579583739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPT,Dermatopontin,4283,174,2.30 [1.33-3.97],0.0028242330828677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPY30,Protein dpy-30 homolog,4254,175,1.46 [1.21-1.77],0.0001048346073618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DRAXIN,Draxin,4194,169,2.04 [1.52-2.74],1.9577947714821577e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DRG2,Developmentally-regulated GTP-binding protein 2,4212,172,1.03 [0.81-1.31],0.7866883377252939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSC2,Desmocollin-2,4202,169,2.66 [2.20-3.22],1.0278376086193593e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSCAM,Down syndrome cell adhesion molecule,3668,142,1.65 [1.12-2.44],0.0119744121367117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG2,Desmoglein-2,4246,172,2.91 [1.94-4.35],2.114950631416475e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG3,Desmoglein-3,4254,175,1.24 [0.86-1.78],0.2493363241031473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG4,Desmoglein-4,4195,171,0.55 [0.42-0.73],2.2029799399185446e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTD1,D-aminoacyl-tRNA deacylase 1,3611,140,0.90 [0.75-1.09],0.2954143730462395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTNB,Dystrobrevin beta,3653,141,2.02 [1.52-2.67],9.788360540736175e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,3584,138,0.82 [0.59-1.13],0.2213177171604308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,4212,172,3.24 [2.06-5.10],3.783262981864189e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTYMK,Thymidylate kinase,3670,144,1.00 [0.79-1.26],0.9824402384155017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUOX2,Dual oxidase 2,4152,167,0.91 [0.74-1.13],0.4084129789963243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,3659,142,0.66 [0.45-0.98],0.0368999722015543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUSP29,Dual specificity phosphatase 29,3584,138,1.00 [0.77-1.29],0.983143151958439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUSP3,Dual specificity protein phosphatase 3,4101,164,0.89 [0.74-1.08],0.2355929972145867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",3652,139,0.99 [0.85-1.16],0.9289796995255346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DXO,Decapping and exoribonuclease protein,3657,142,0.96 [0.67-1.38],0.8339456407482237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,3659,142,1.06 [0.72-1.57],0.7516612385366372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNLT1,Dynein light chain Tctex-type 1,3584,138,0.91 [0.73-1.12],0.3638675060045503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNLT3,Dynein light chain Tctex-type 3,3659,142,0.54 [0.37-0.79],0.0017128214124956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,4194,169,1.03 [0.89-1.19],0.7162253464709698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EBI3_IL27,Interleukin-27,4259,175,3.18 [2.16-4.68],4.649557340963526e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECE1,Endothelin-converting enzyme 1,4101,164,0.97 [0.66-1.42],0.8676446815948017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",3670,144,1.02 [0.85-1.23],0.8171895943071446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",3579,143,0.99 [0.84-1.17],0.9282723670407188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECI2,Enoyl-CoA delta isomerase 2,3553,138,0.97 [0.74-1.26],0.8094705703848495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECM1,Extracellular matrix protein 1,3581,138,0.85 [0.55-1.31],0.4543158818273054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECSCR,Endothelial cell-specific chemotaxis regulator,3549,140,1.05 [0.76-1.45],0.7787119974442656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,4267,175,3.75 [3.08-4.58],6.995284690445946e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,4226,172,1.05 [0.90-1.22],0.5430244063318358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDDM3B,Epididymal secretory protein E3-beta,3659,142,1.02 [0.76-1.36],0.9155032578969003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,3553,138,1.41 [0.96-2.05],0.077144495572461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDF1,Endothelial differentiation-related factor 1,3668,142,1.02 [0.79-1.31],0.8813298004523527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,4152,167,1.61 [1.12-2.33],0.0110686800736507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDN1,Endothelin-1,3579,143,3.86 [2.47-6.02],2.8079371806555237e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDNRB,Endothelin receptor type B,3559,140,0.94 [0.61-1.44],0.7619055197340225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EEF1D,Elongation factor 1-delta,3670,144,1.07 [0.90-1.27],0.4681240340024635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,3652,139,3.56 [2.45-5.17],2.390067001888016e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFCAB2,Dynein regulatory complex protein 8,3618,140,0.85 [0.53-1.37],0.5063473279760572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,4242,171,4.05 [2.89-5.66],3.047350280804764e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFHD1,EF-hand domain-containing protein D1,3668,142,2.03 [1.45-2.85],4.25450788597138e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA1,Ephrin-A1,4242,172,5.15 [3.79-6.99],8.278772650889956e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA4,Ephrin-A4,4187,169,5.24 [4.05-6.79],4.223833924118033e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNB2,Ephrin-B2,3584,138,1.25 [1.00-1.57],0.0482654695248643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGF,Pro-epidermal growth factor,4220,169,1.02 [0.90-1.16],0.7740226651101489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFL7,Epidermal growth factor-like protein 7,4103,164,2.09 [1.53-2.84],2.9757263243141814e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFLAM,Pikachurin,3652,139,1.72 [1.11-2.66],0.0155740616833739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFR,Epidermal growth factor receptor,4283,174,1.27 [0.59-2.73],0.5408237627610386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGLN1,Egl nine homolog 1,4226,172,1.10 [0.88-1.37],0.3950143513431561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EHBP1,EH domain-binding protein 1,3670,144,1.00 [0.80-1.24],0.9998719823143356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EHD3,EH domain-containing protein 3,3579,143,0.95 [0.83-1.09],0.4921572268786481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",3657,142,0.84 [0.60-1.16],0.293954963018454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",3636,138,0.98 [0.84-1.14],0.752444399817641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,3553,138,0.81 [0.62-1.06],0.1208064976312682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,3579,143,0.67 [0.43-1.04],0.072388892850409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4B,Eukaryotic translation initiation factor 4B,4194,169,0.91 [0.71-1.16],0.4404642175749366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4E,Eukaryotic translation initiation factor 4E,3559,140,0.97 [0.80-1.17],0.7384830725686882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,4233,173,1.07 [0.87-1.31],0.5125890623182963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,4281,174,1.01 [0.88-1.17],0.8613874756126255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,3668,142,0.94 [0.74-1.20],0.615583554363479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF5,Eukaryotic translation initiation factor 5,3553,138,1.20 [0.88-1.63],0.2472764097853471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF5A,Eukaryotic translation initiation factor 5A-1,4131,169,1.01 [0.65-1.58],0.9626006225075924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,3668,142,0.96 [0.78-1.16],0.6552101974683512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELAVL4,ELAV-like protein 4,3549,140,1.12 [0.93-1.33],0.2240263969120017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELN,Elastin,3670,144,2.99 [2.02-4.43],4.352493198597511e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELOA,Elongin-A,4212,172,0.90 [0.69-1.16],0.4141884555205554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELOB,Elongin-B,3553,138,0.96 [0.62-1.49],0.8703330686874802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENAH,Protein enabled homolog,4131,169,1.23 [0.94-1.61],0.1338312364123064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENDOU,Poly(U)-specific endoribonuclease,3380,127,1.54 [1.16-2.04],0.0030293414546876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENG,Endoglin,4283,174,3.51 [1.74-7.11],0.0004722860531598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO1,Alpha-enolase,4233,170,0.98 [0.82-1.18],0.8615734747520932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO2,Gamma-enolase,4264,173,0.99 [0.80-1.22],0.9344412332943172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO3,Beta-enolase,3579,143,0.70 [0.54-0.92],0.0098728557108287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENOPH1,Enolase-phosphatase E1,3659,142,0.63 [0.48-0.83],0.0010448895748959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,3553,138,0.92 [0.52-1.63],0.7816347022982132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPEP,Glutamyl aminopeptidase,3553,138,1.08 [0.78-1.50],0.650300948840528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,4283,174,1.77 [1.16-2.72],0.0088046360303124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,4248,170,0.77 [0.60-0.99],0.0400146896706462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,3579,143,1.35 [0.87-2.10],0.182018073696577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,4088,166,1.12 [0.96-1.30],0.1468703481501794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENSA,Alpha-endosulfine,3659,142,0.80 [0.57-1.12],0.2010052801261269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,4103,164,1.16 [0.88-1.54],0.2931986647501218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,4152,167,0.69 [0.37-1.29],0.2481137553489661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,4152,167,2.82 [1.56-5.09],0.0005664779295274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTR1,Endosome-associated-trafficking regulator 1,3579,143,0.91 [0.72-1.17],0.4706857486932625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EP300,Histone acetyltransferase p300,3559,140,1.05 [0.64-1.72],0.8498871932910831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPB41L5,Band 4.1-like protein 5,3584,138,1.19 [0.95-1.48],0.1344084849904906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPCAM,Epithelial cell adhesion molecule,4225,168,0.95 [0.82-1.11],0.5539809674026213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPGN,Epigen,3659,142,1.01 [0.69-1.50],0.9410771144942546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA1,Ephrin type-A receptor 1,4240,170,2.51 [1.68-3.74],6.06168595644915e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA10,Ephrin type-A receptor 10,4101,164,1.06 [0.87-1.30],0.5350891477084663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA2,Ephrin type-A receptor 2,4074,166,3.95 [3.07-5.07],5.814250233249839e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA4,Ephrin type-A receptor 4,3611,140,2.26 [1.33-3.86],0.0027142207110965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB4,Ephrin type-B receptor 4,4283,174,5.22 [3.77-7.24],2.4054538377149445e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB6,Ephrin type-B receptor 6,4185,168,3.23 [2.30-4.55],1.7464003957923847e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHX2,Bifunctional epoxide hydrolase 2,4152,167,0.90 [0.71-1.14],0.3912969248590534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPN1,Epsin-1,3618,140,0.63 [0.39-1.04],0.0691991940218808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPO,Erythropoietin,4226,172,1.25 [1.08-1.45],0.0029689668094872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPPK1,Epiplakin,3579,143,1.08 [0.87-1.34],0.4922142497303725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,4262,175,1.61 [1.10-2.34],0.013308298328378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,4238,174,1.10 [0.67-1.81],0.6946927540722188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,4217,170,2.94 [1.57-5.49],0.0007168196259277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,4238,174,2.39 [1.59-3.59],2.79355537376044e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBIN,Erbin,4212,172,0.99 [0.87-1.13],0.929481958403292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERC2,ERC protein 2,3584,138,0.95 [0.74-1.22],0.6782659107877397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERCC1,DNA excision repair protein ERCC-1,3536,140,0.90 [0.52-1.55],0.6946232442669777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EREG,Proepiregulin,4185,168,1.08 [0.91-1.27],0.3837733718098182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERI1,3'-5' exoribonuclease 1,3618,140,0.89 [0.54-1.47],0.6556144409837257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERMAP,Erythroid membrane-associated protein,3559,140,2.03 [1.44-2.86],5.212071072079594e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,3659,142,1.08 [0.70-1.66],0.7378968604650801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERP29,Endoplasmic reticulum resident protein 29,3611,140,0.91 [0.79-1.05],0.1820355292142516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERP44,Endoplasmic reticulum resident protein 44,4208,172,1.06 [0.63-1.78],0.8226608968408304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,3553,138,1.12 [0.76-1.63],0.5737128413132373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESAM,Endothelial cell-selective adhesion molecule,4283,174,3.40 [2.45-4.71],2.819784064480663e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESM1,Endothelial cell-specific molecule 1,4226,170,1.41 [0.97-2.04],0.0680051223482526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESPL1,Separin,3536,140,1.03 [0.79-1.33],0.8438449763063478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESR1,Estrogen receptor,3559,140,0.86 [0.60-1.22],0.3949681994109997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESYT2,Extended synaptotagmin-2,3657,142,1.01 [0.83-1.23],0.9176477421588052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EVI2B,Protein EVI2B,3536,140,0.71 [0.42-1.22],0.2165374899280016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EVI5,Ecotropic viral integration site 5 protein homolog,3559,140,1.00 [0.83-1.20],0.9662885778421934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EVPL,Envoplakin,3618,140,1.20 [0.73-1.97],0.4723618835123938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EXOSC10,Exosome component 10,3553,138,0.90 [0.66-1.24],0.5223835922705633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EXTL1,Exostosin-like 1,3553,138,1.43 [1.12-1.82],0.0036633976011258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EZR,Ezrin,4264,173,1.02 [0.59-1.76],0.9416404986484784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F10,Coagulation factor X,3685,143,0.67 [0.40-1.12],0.1292265869145059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F11,Coagulation factor XI,3635,139,1.97 [1.15-3.37],0.0133186702681139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F11R,Junctional adhesion molecule A,4246,172,1.23 [0.97-1.56],0.089812251185232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F12,Coagulation factor XII,3684,142,1.04 [0.70-1.53],0.8601456622004626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F13B,Coagulation factor XIII B chain,3664,141,1.26 [0.69-2.32],0.4487764395710973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F2,Prothrombin,3684,142,0.60 [0.22-1.69],0.3339796460381743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F2R,Proteinase-activated receptor 1,4242,170,1.62 [1.28-2.06],6.13438712475938e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F3,Tissue factor,4240,175,2.49 [1.62-3.82],2.952610133171234e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F7,Coagulation factor VII,4240,171,0.88 [0.60-1.31],0.5426323934345162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F9,Coagulation factor IX,4245,171,1.23 [0.58-2.61],0.594411943342624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP1,"Fatty acid-binding protein, liver",4226,170,1.52 [1.34-1.72],3.673244707094856e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP2,"Fatty acid-binding protein, intestinal",4233,173,1.39 [1.20-1.60],8.226063384364901e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP3,"Fatty acid-binding protein, heart",3670,144,2.36 [1.91-2.91],8.573240605924789e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP4,"Fatty acid-binding protein, adipocyte",4283,174,2.12 [1.76-2.55],1.0533933458671973e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP5,Fatty acid-binding protein 5,4254,172,1.40 [1.15-1.70],0.0008531938788862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP6,Gastrotropin,4146,166,1.23 [0.99-1.53],0.0591236862415155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP9,Fatty acid-binding protein 9,4226,172,1.03 [0.81-1.30],0.828182499663254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FADD,FAS-associated death domain protein,4233,173,0.93 [0.77-1.11],0.4125796821406544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM13A,Protein FAM13A,3652,139,1.03 [0.81-1.32],0.7809154072405785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM171A2,Protein FAM171A2,3668,142,1.03 [0.94-1.14],0.5068778187588144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM171B,Protein FAM171B,3659,142,1.38 [0.80-2.41],0.2501489598257675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM172A,Cotranscriptional regulator FAM172A,3579,143,0.82 [0.62-1.07],0.1465188318518917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM20A,Pseudokinase FAM20A,3670,144,1.90 [1.09-3.29],0.0235006289748172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3B,Protein FAM3B,4212,172,3.32 [2.36-4.66],4.160445723492624e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3C,Protein FAM3C,4233,173,5.44 [3.93-7.54],1.946082953544946e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3D,Protein FAM3D,3652,139,1.53 [1.28-1.84],4.755289415899016e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAP,Prolyl endopeptidase FAP,4283,174,0.99 [0.64-1.53],0.9688381188882164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,3584,138,0.98 [0.77-1.24],0.8447113093764358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAS,Tumor necrosis factor receptor superfamily member 6,4273,174,1.84 [1.46-2.32],2.707517705277771e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FASLG,Tumor necrosis factor ligand superfamily member 6,4281,174,1.55 [1.08-2.21],0.0162399133950028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBLN2,Fibulin-2,3683,141,2.39 [1.59-3.60],3.188089454191457e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBN2,Fibrillin-2,3584,138,1.32 [1.00-1.75],0.0535802544445151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBP1,"Fructose-1,6-bisphosphatase 1",4233,173,0.92 [0.78-1.09],0.3608540455445017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,3670,144,1.22 [0.99-1.50],0.0630249155677855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCAR,Immunoglobulin alpha Fc receptor,4226,172,1.52 [1.20-1.92],0.0005519431649785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,3668,142,1.32 [0.72-2.40],0.3690884631558634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,4246,172,1.56 [1.28-1.91],1.3450332236932696e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,4225,169,1.31 [1.01-1.70],0.0429272195580004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,4103,164,0.95 [0.75-1.21],0.7032067606177901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,4237,171,1.20 [0.91-1.58],0.1983492422882766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCN1,Ficolin-1,3681,143,2.00 [1.44-2.79],4.231553065051634e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCN2,Ficolin-2,4216,170,0.85 [0.61-1.19],0.3441452540823265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL1,Fc receptor-like protein 1,4233,173,1.13 [0.85-1.51],0.3859980963497599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL2,Fc receptor-like protein 2,4261,172,1.38 [1.10-1.75],0.0064091636858126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL3,Fc receptor-like protein 3,4131,169,1.08 [0.86-1.37],0.5064126629020332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL5,Fc receptor-like protein 5,4246,172,1.20 [0.96-1.49],0.1100399117152731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL6,Fc receptor-like protein 6,4226,172,1.37 [1.12-1.67],0.0021714518557251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRLB,Fc receptor-like B,4103,164,1.41 [1.17-1.71],0.0003777170500453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FDX1,"Adrenodoxin, mitochondrial",3553,138,1.19 [0.95-1.50],0.1288346129653818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FDX2,"Ferredoxin-2, mitochondrial",3553,138,1.35 [1.03-1.77],0.0274584308842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FEN1,Flap endonuclease 1,4103,164,1.02 [0.84-1.23],0.8447710692637573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FES,Tyrosine-protein kinase Fes/Fps,4103,164,0.78 [0.58-1.06],0.1167032811172671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FETUB,Fetuin-B,4245,171,0.91 [0.64-1.28],0.5752818588174702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGA,Fibrinogen alpha chain,3589,138,1.57 [0.94-2.62],0.085945480096725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",3668,142,0.99 [0.81-1.21],0.9321578552630811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF12,Fibroblast growth factor 12,3559,140,0.83 [0.53-1.29],0.4047009331592157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF16,Fibroblast growth factor 16,3559,140,0.53 [0.36-0.79],0.0020211231961314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF19,Fibroblast growth factor 19,4248,170,1.04 [0.88-1.23],0.6698633576946686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF2,Fibroblast growth factor 2,4226,172,1.18 [0.98-1.42],0.0854336743830444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF20,Fibroblast growth factor 20,3559,140,1.00 [0.68-1.48],0.9849622570788208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF21,Fibroblast growth factor 21,4259,175,1.24 [1.12-1.37],3.474286538362427e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF23,Fibroblast growth factor 23,4256,175,1.64 [1.42-1.89],1.5993355583764977e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF3,Fibroblast growth factor 3,3559,140,1.09 [0.58-2.04],0.7912623758094938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF5,Fibroblast growth factor 5,4131,169,2.77 [2.14-3.59],1.2049867746250711e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF6,Fibroblast growth factor 6,3559,140,1.19 [0.87-1.63],0.2735445292108124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF7,Fibroblast growth factor 7,3536,140,0.91 [0.72-1.15],0.4283211259314533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF9,Fibroblast growth factor 9,3530,140,0.90 [0.60-1.35],0.6057882511589623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP1,Fibroblast growth factor-binding protein 1,4238,174,0.46 [0.34-0.63],1.2310016433869556e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP2,Fibroblast growth factor-binding protein 2,3683,141,0.55 [0.40-0.75],0.0001982354052823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP3,Fibroblast growth factor-binding protein 3,3657,142,0.92 [0.60-1.40],0.6885168072627245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFR2,Fibroblast growth factor receptor 2,4238,174,3.95 [2.69-5.80],2.147425187269592e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFR4,Fibroblast growth factor receptor 4,3611,140,0.95 [0.69-1.30],0.739619746324806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGL1,Fibrinogen-like protein 1,3685,143,1.68 [1.34-2.10],8.126127094799687e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGR,Tyrosine-protein kinase Fgr,4101,164,0.99 [0.80-1.23],0.926012159290392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FH,"Fumarate hydratase, mitochondrial",3549,140,1.07 [0.91-1.26],0.4176455335299326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,3553,138,0.72 [0.50-1.04],0.0789474255606715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FHIT,Bis(5'-adenosyl)-triphosphatase,4101,164,0.89 [0.74-1.08],0.2515709087083392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FIS1,Mitochondrial fission 1 protein,4230,170,0.98 [0.82-1.17],0.8033941865537801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,3668,142,0.95 [0.80-1.12],0.5418006964505588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,4245,172,1.03 [0.92-1.16],0.6081985766194359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,4194,169,1.40 [1.00-1.96],0.0523718878918236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,4194,169,1.04 [0.90-1.21],0.5934870325228461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,4092,163,1.07 [0.81-1.42],0.6166791242355498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBPL,FK506-binding protein-like,3652,139,1.10 [0.83-1.46],0.5175297288468375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLI1,Friend leukemia integration 1 transcription factor,4103,164,1.04 [0.92-1.18],0.5138896157046239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,4194,169,3.21 [2.21-4.67],1.0183305062680803e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT1,Vascular endothelial growth factor receptor 1,4207,172,1.91 [1.28-2.85],0.0014750185004635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,4103,164,0.88 [0.55-1.41],0.5877974466658288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,4281,174,1.76 [1.21-2.57],0.0032214146572088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT4,Vascular endothelial growth factor receptor 3,4238,174,0.86 [0.59-1.25],0.4375777431400275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FMNL1,Formin-like protein 1,4101,164,1.03 [0.86-1.24],0.7275385207818543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FMR1,Synaptic functional regulator FMR1,4103,164,1.03 [0.70-1.51],0.8929822611916961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FN1,Fibronectin,3684,142,0.62 [0.35-1.12],0.1139767671801236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FNDC1,Fibronectin type III domain-containing protein 1,3657,142,1.30 [0.94-1.80],0.1123749528414119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,3659,142,0.89 [0.53-1.48],0.6454549066399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLH1,Glutamate carboxypeptidase 2,3559,140,1.11 [0.96-1.28],0.1704126538768113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR1,Folate receptor alpha,4220,174,3.25 [2.27-4.66],1.3430720730003588e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR2,Folate receptor beta,4264,173,1.97 [1.28-3.04],0.0019928161768385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR3,Folate receptor gamma,4223,173,1.02 [0.95-1.09],0.5613004464153355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOS,Proto-oncogene c-Fos,3530,140,1.27 [0.79-2.03],0.3169311142743435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOSB,Protein fosB,4101,164,1.14 [0.81-1.59],0.4546917680940793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOXJ3,Forkhead box protein J3,3559,140,0.92 [0.64-1.32],0.6468851528389721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOXO1,Forkhead box protein O1,4226,172,1.04 [0.89-1.22],0.6003759252246215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOXO3,Forkhead box protein O3,4103,164,1.10 [0.95-1.26],0.2148463740268081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FRMD4B,FERM domain-containing protein 4B,3553,138,1.01 [0.80-1.28],0.9270773282964744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FRMD7,FERM domain-containing protein 7,3584,138,1.23 [0.77-1.97],0.3808678791906582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FRZB,Secreted frizzled-related protein 3,4181,169,1.34 [0.78-2.30],0.2906437878088321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSHB,Follitropin subunit beta,3579,143,1.36 [1.00-1.84],0.0482846391964086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FST,Follistatin,4242,170,1.38 [1.04-1.83],0.0254689690790372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL1,Follistatin-related protein 1,3579,143,4.55 [2.41-8.59],3.0122214093710506e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL3,Follistatin-related protein 3,4225,170,3.85 [2.91-5.10],6.165444284965464e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FTCD,Formimidoyltransferase-cyclodeaminase,3651,141,0.94 [0.80-1.10],0.4304694396671674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUCA1,Tissue alpha-L-fucosidase,4264,174,1.10 [0.93-1.29],0.2801910361801287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUOM,Fucose mutarotase,3611,140,0.93 [0.74-1.16],0.5248537247765273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FURIN,Furin,4238,174,0.71 [0.49-1.03],0.0742496371245026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUS,RNA-binding protein FUS,4092,164,1.11 [0.77-1.61],0.5666220565975769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",3610,140,0.92 [0.70-1.21],0.5509773793043393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,4264,173,1.79 [1.36-2.36],3.725219647462877e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT8,"Alpha-(1,6)-fucosyltransferase",4194,169,1.08 [0.86-1.36],0.5139150337229155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FXN,"Frataxin, mitochondrial",4267,175,1.02 [0.85-1.23],0.8376842650148706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FXYD5,FXYD domain-containing ion transport regulator 5,4131,169,1.05 [0.86-1.30],0.6114974381221616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FYB1,FYN-binding protein 1,4237,172,0.97 [0.84-1.12],0.677065477556837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FZD10,Frizzled-10,3584,138,0.84 [0.60-1.18],0.3070312613047247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FZD8,Frizzled-8,3549,140,1.25 [0.91-1.71],0.1686445496403776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,3659,142,1.20 [0.89-1.62],0.234551980325597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,3618,140,1.00 [0.79-1.27],0.993798778499172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,3549,140,1.14 [0.91-1.44],0.2432169461701785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAD1,Glutamate decarboxylase 1,3536,140,1.02 [0.54-1.93],0.9488544672417896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAD2,Glutamate decarboxylase 2,3559,140,0.87 [0.57-1.31],0.4981380729673499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,3618,140,0.98 [0.69-1.39],0.9130737891564612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,3579,143,0.85 [0.62-1.16],0.3138847153921041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAGE2A,G antigen 2A,3536,140,0.79 [0.59-1.06],0.119398792412522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAL,Galanin peptides,4248,170,1.01 [0.83-1.23],0.9233809857311012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,4212,172,2.35 [1.51-3.66],0.0001593854752562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,4267,175,0.65 [0.40-1.04],0.0745293257876262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,4131,169,1.70 [1.28-2.28],0.0003042188523763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,3670,144,1.51 [0.89-2.59],0.1289754362748122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT7,N-acetylgalactosaminyltransferase 7,4212,172,1.93 [1.03-3.62],0.0397074517916654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAMT,Guanidinoacetate N-methyltransferase,3553,138,0.99 [0.62-1.56],0.9544802600288912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,3520,134,1.16 [0.62-2.17],0.6395549039815085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GART,Trifunctional purine biosynthetic protein adenosine-3,3668,142,1.02 [0.54-1.93],0.9462460667226604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAS2,Growth arrest-specific protein 2,3618,140,0.74 [0.52-1.06],0.1005819230931299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAS6,Growth arrest-specific protein 6,4260,174,2.32 [1.39-3.86],0.0012105895651796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GASK1A,Golgi-associated kinase 1A,3553,138,0.83 [0.58-1.20],0.3277392530854456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAST,Gastrin,3657,142,1.17 [1.07-1.29],0.000626942849737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,3536,140,0.52 [0.28-0.98],0.0433982782493164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",3579,143,0.88 [0.71-1.09],0.2372550448063859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBA,Lysosomal acid glucosylceramidase,3584,138,1.14 [0.88-1.49],0.3247952281256072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP1,Guanylate-binding protein 1,3652,142,1.16 [0.91-1.48],0.217349677412192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP2,Guanylate-binding protein 2,4131,169,1.12 [0.91-1.39],0.2900308359800144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP4,Guanylate-binding protein 4,4101,164,1.02 [0.77-1.36],0.8756775074428818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP6,Guanylate-binding protein 6,3553,138,1.15 [0.84-1.59],0.3809012866350159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GC,Vitamin D-binding protein,3684,142,1.74 [0.96-3.17],0.0691167262150041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCC1,GRIP and coiled-coil domain-containing protein 1,3657,142,0.95 [0.81-1.10],0.4879258905065669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCG,Pro-glucagon,4103,164,1.25 [1.13-1.39],3.10583576175063e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,3514,136,1.42 [1.09-1.85],0.0097914140297943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCLM,Glutamate--cysteine ligase regulatory subunit,3553,138,1.01 [0.72-1.43],0.9476453101811622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",4212,172,2.27 [1.58-3.24],8.076192900747339e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF15,Growth/differentiation factor 15,4283,174,2.66 [2.27-3.12],4.954033740236371e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF2,Growth/differentiation factor 2,4233,173,1.26 [0.88-1.80],0.2125188086813906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDNF,Glial cell line-derived neurotrophic factor,4101,164,1.89 [1.40-2.54],2.747914447168167e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GET3,ATPase GET3,3670,144,1.10 [0.84-1.44],0.4985547011310458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFAP,Glial fibrillary acidic protein,4097,163,1.10 [0.83-1.48],0.5013736093299206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFER,FAD-linked sulfhydryl oxidase ALR,4103,164,1.16 [0.93-1.44],0.1787011050051036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,4103,164,1.09 [0.98-1.20],0.1040420273921371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA1,GDNF family receptor alpha-1,4259,175,6.02 [4.25-8.53],5.26088887016941e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA2,GDNF family receptor alpha-2,4212,172,1.53 [0.81-2.91],0.1882608811348364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA3,GDNF family receptor alpha-3,4184,168,2.87 [1.87-4.41],1.4846239719712969e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRAL,GDNF family receptor alpha-like,3546,141,0.89 [0.69-1.15],0.3793123468752958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGA1,ADP-ribosylation factor-binding protein GGA1,4101,164,0.93 [0.74-1.17],0.5272789146154142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGACT,Gamma-glutamylaminecyclotransferase,3670,144,1.01 [0.80-1.28],0.938766477661814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGCT,Gamma-glutamylcyclotransferase,3667,144,1.00 [0.70-1.41],0.990770267336102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGH,Gamma-glutamyl hydrolase,4163,167,0.83 [0.55-1.26],0.3893178376681018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT1,Glutathione hydrolase 1 proenzyme,4242,172,1.17 [0.94-1.48],0.1660223673321721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT5,Glutathione hydrolase 5 proenzyme,4194,169,6.07 [4.01-9.18],1.2343125974098359e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GH1,Somatotropin,4233,173,1.09 [1.01-1.18],0.0225668580463847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GH2,Growth hormone variant,4103,164,0.97 [0.89-1.06],0.5536123695864505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHR,Growth hormone receptor,3611,140,0.39 [0.23-0.66],0.0005507883521838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHRHR,Growth hormone-releasing hormone receptor,4101,164,1.14 [0.89-1.45],0.3112102328031007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHRL,Appetite-regulating hormone,4233,173,1.12 [0.96-1.32],0.1457080663488341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GID8,Glucose-induced degradation protein 8 homolog,3668,142,0.87 [0.51-1.50],0.6278285354344345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIGYF2,GRB10-interacting GYF protein 2,3668,142,1.15 [0.94-1.42],0.1799673552395773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIMAP7,GTPase IMAP family member 7,3611,140,0.85 [0.50-1.46],0.5561214051690553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIMAP8,GTPase IMAP family member 8,3536,140,0.82 [0.58-1.17],0.2791681528049556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIP,Gastric inhibitory polypeptide,3579,143,1.26 [0.95-1.67],0.1104093617820338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPC2,PDZ domain-containing protein GIPC2,3657,142,2.87 [1.90-4.33],5.32104775474519e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPC3,PDZ domain-containing protein GIPC3,3652,139,0.95 [0.81-1.13],0.57317164701521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPR,Gastric inhibitory polypeptide receptor,3559,140,0.96 [0.65-1.41],0.8185224250261728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIT1,ARF GTPase-activating protein GIT1,3559,140,0.95 [0.80-1.13],0.5908620774978945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GJA8,Gap junction alpha-8 protein,3536,140,0.97 [0.74-1.29],0.856418626465053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GKN1,Gastrokine-1,4025,159,1.40 [0.86-2.30],0.1779339856076585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLA,Alpha-galactosidase A,3606,139,1.49 [0.99-2.25],0.0552832865656224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLB1,Beta-galactosidase,4194,169,1.03 [0.75-1.42],0.8343921797166711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLI2,Zinc finger protein GLI2,3559,140,0.93 [0.53-1.63],0.8000389058456953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLO1,Lactoylglutathione lyase,4152,167,1.10 [0.86-1.39],0.4462434760133938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLOD4,Glyoxalase domain-containing protein 4,4224,170,1.03 [0.69-1.53],0.8987532003752285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLP1R,Glucagon-like peptide 1 receptor,3549,140,1.24 [0.84-1.84],0.2699404857462448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLRX,Glutaredoxin-1,4209,173,0.91 [0.72-1.15],0.4422339613097681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",3611,140,0.86 [0.71-1.04],0.1276034800265005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,4101,164,1.21 [0.95-1.55],0.1219074439897133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLYR1,Putative oxidoreductase GLYR1,3659,142,0.90 [0.66-1.23],0.49712086085786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GM2A,Ganglioside GM2 activator,3602,139,2.58 [1.97-3.38],4.6415601704344796e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GMFG,Glia maturation factor gamma,3670,144,0.98 [0.78-1.23],0.8472478350630582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GMPR,GMP reductase 1,4281,174,0.91 [0.69-1.19],0.4728761049693166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GMPR2,GMP reductase 2,3611,140,0.89 [0.70-1.15],0.3799259894853632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNAS,Neuroendocrine secretory protein 55,3668,142,0.99 [0.82-1.19],0.897498400263876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,4103,164,0.90 [0.73-1.12],0.3595506237257483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,3584,138,0.90 [0.64-1.26],0.5333593110064292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNLY,Granulysin,4246,172,1.09 [0.85-1.39],0.5018951262513113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,3579,143,1.06 [0.68-1.66],0.7970333835279686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,3611,140,0.57 [0.37-0.88],0.011349060842788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOLGA3,Golgin subfamily A member 3,3668,142,1.03 [0.83-1.27],0.7890757131553449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOLM2,Protein GOLM2,4264,173,2.12 [1.52-2.96],9.141629843843338e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,4226,172,0.99 [0.87-1.13],0.8968842248721417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GORASP2,Golgi reassembly-stacking protein 2,3652,139,0.99 [0.70-1.41],0.9542994460057536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOT1,"Aspartate aminotransferase, cytoplasmic",3683,141,0.74 [0.52-1.05],0.0947046970224994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP1BA,Platelet glycoprotein Ib alpha chain,4219,170,1.39 [0.95-2.04],0.0914725046242926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP1BB,Platelet glycoprotein Ib beta chain,3553,138,1.01 [0.79-1.28],0.9469456414289508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,4097,165,0.96 [0.82-1.12],0.5981014350814127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP5,Platelet glycoprotein V,3611,140,1.01 [0.63-1.61],0.9648730571363586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP6,Platelet glycoprotein VI,4237,172,1.05 [0.90-1.23],0.5437811485485455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPA33,Cell surface A33 antigen,4212,172,0.85 [0.77-0.94],0.0025754200878701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPC1,Glypican-1,4267,175,1.75 [1.15-2.68],0.0096766284199281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPC5,Glypican-5,4194,169,0.87 [0.68-1.10],0.2419503201563448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPD1,Glycerol-3-phosphate dehydrogenase,3659,142,0.94 [0.73-1.22],0.657245598555245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPHA2,Glycoprotein hormone alpha-2,3652,139,1.12 [0.80-1.56],0.4974466065862791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPI,Glucose-6-phosphate isomerase,3685,143,0.98 [0.70-1.37],0.8957681857467436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,3652,139,1.18 [0.93-1.49],0.1687990289516736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPKOW,G-patch domain and KOW motifs-containing protein,4101,164,1.27 [0.90-1.80],0.1779741843716461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPNMB,Transmembrane glycoprotein NMB,4131,168,2.63 [1.69-4.10],1.970084439091433e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR101,Probable G-protein coupled receptor 101,3549,140,1.10 [0.84-1.43],0.4904311375941347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR158,Probable G-protein coupled receptor 158,3668,142,1.39 [0.94-2.05],0.099579299669447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR15L,Protein GPR15L,3652,139,1.19 [0.93-1.52],0.1698707386057795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR37,Prosaposin receptor GPR37,4152,167,2.37 [1.96-2.87],6.381019060986228e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPRC5C,G-protein coupled receptor family C group 5 member C,3659,142,1.50 [1.22-1.85],0.000132152099863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRAP2,GRB2-related adapter protein 2,4233,173,0.98 [0.89-1.09],0.7597574629929817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,3670,144,1.04 [0.80-1.35],0.7573373630439864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",3668,142,0.85 [0.56-1.29],0.4439490768756216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",3549,140,1.05 [0.77-1.43],0.7720408669797336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRK5,G protein-coupled receptor kinase 5,4152,167,0.76 [0.56-1.04],0.0822241260531455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRN,Progranulin,4225,172,3.60 [2.19-5.91],4.0773655190102093e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRP,Gastrin-releasing peptide,3579,143,1.25 [0.95-1.63],0.1128191467977831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",4212,172,1.34 [1.11-1.63],0.0028690682323215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRSF1,G-rich sequence factor 1,3516,140,0.96 [0.78-1.17],0.6626485019797028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSAP,Gamma-secretase-activating protein,4103,164,0.93 [0.78-1.11],0.4215327291110697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSN,Gelsolin,3672,143,0.47 [0.24-0.93],0.0293059169952901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSR,"Glutathione reductase, mitochondrial",3668,142,0.78 [0.42-1.44],0.4208737544213101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTA1,Glutathione S-transferase A1,4226,173,0.83 [0.72-0.96],0.0125430212535271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTA3,Glutathione S-transferase A3,4103,164,0.85 [0.72-1.00],0.0460805919264832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTM4,Glutathione S-transferase Mu 4,3553,138,1.04 [0.85-1.29],0.6794576068809868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTP1,Glutathione S-transferase P,4076,164,0.89 [0.72-1.11],0.3071611477673208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTT2B,Glutathione S-transferase theta-2B,3657,142,0.99 [0.92-1.05],0.6955985992847391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,3618,140,0.93 [0.72-1.20],0.591053861546555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GTPBP2,GTP-binding protein 2,3584,138,0.92 [0.75-1.13],0.4513467509320004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCA2A,Guanylin,4226,172,2.79 [2.13-3.67],1.4768001776272669e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCY2C,Heat-stable enterotoxin receptor,3618,140,0.97 [0.79-1.20],0.8102993648044655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUK1,Guanylate kinase,3553,138,1.25 [0.82-1.91],0.2948932461892953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUSB,Beta-glucuronidase,4256,174,0.95 [0.78-1.14],0.5635123291833322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GYS1,"Glycogen [starch] synthase, muscle",4152,167,0.91 [0.78-1.07],0.2561615289915553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GZMA,Granzyme A,4281,174,1.51 [1.04-2.21],0.0321869823807525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GZMB,Granzyme B,4226,172,0.80 [0.64-1.01],0.0636021872822568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GZMH,Granzyme H,4152,167,1.06 [0.89-1.27],0.5272669956909057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,H2AP,Huntingtin-interacting protein M,3536,140,0.86 [0.59-1.27],0.4614196407682535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",3553,138,1.07 [0.85-1.34],0.5566229137557981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",4255,175,0.91 [0.75-1.09],0.2986110586215763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAO1,Hydroxyacid oxidase 1,4267,175,0.97 [0.87-1.07],0.4851962763963718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",4246,172,1.00 [0.83-1.19],0.9859129527278596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR1,Hepatitis A virus cellular receptor 1,4263,175,2.11 [1.85-2.40],4.802026284051896e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR2,Hepatitis A virus cellular receptor 2,4246,172,3.03 [2.23-4.10],1.135799242247847e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBEGF,Proheparin-binding EGF-like growth factor,4255,175,1.09 [0.91-1.30],0.346256225386253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBQ1,Hemoglobin subunit theta-1,4267,175,0.74 [0.59-0.92],0.0084966960300344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBZ,Hemoglobin subunit zeta,3670,144,0.83 [0.71-0.97],0.0205937130096787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HCG22,Protein PBMUCL2,3553,138,1.00 [0.76-1.31],0.989779214621267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HCLS1,Hematopoietic lineage cell-specific protein,4281,174,0.90 [0.70-1.15],0.391105647887915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDAC8,Histone deacetylase 8,3559,140,0.90 [0.64-1.25],0.528871182475855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDAC9,Histone deacetylase 9,3549,140,0.76 [0.55-1.06],0.1057645454558561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDDC2,5'-deoxynucleotidase HDDC2,3652,139,1.11 [0.77-1.60],0.5696934868421586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDGF,Hepatoma-derived growth factor,4259,175,1.01 [0.88-1.17],0.8638453508385924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,3657,142,1.09 [0.85-1.40],0.508936748465004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEBP1,Heme-binding protein 1,4152,167,0.91 [0.69-1.20],0.5070416646726568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEG1,Protein HEG homolog 1,3611,140,1.65 [0.96-2.82],0.068617816316884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEPACAM2,HEPACAM family member 2,3657,142,0.78 [0.55-1.12],0.180465439976618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEPH,Hephaestin,3670,144,5.35 [2.96-9.66],2.656726842809372e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEXIM1,Protein HEXIM1,4226,172,1.03 [0.87-1.23],0.6997168637384906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HGF,Hepatocyte growth factor,4281,174,1.45 [1.04-2.04],0.0308534114257326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HGFAC,Hepatocyte growth factor activator,3654,140,2.11 [1.15-3.88],0.0166044492900902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,4103,164,0.98 [0.82-1.18],0.8509128512486115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,3657,142,1.09 [0.88-1.36],0.4202696867570394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HIF1A,Hypoxia-inducible factor 1-alpha,3559,140,0.99 [0.76-1.29],0.9502496379003544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HIP1,Huntingtin-interacting protein 1,3553,138,1.02 [0.62-1.67],0.9491827047554025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HIP1R,Huntingtin-interacting protein 1-related protein,3653,142,1.29 [1.03-1.61],0.0239116909211478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HJV,Hemojuvelin,3668,142,1.54 [1.16-2.06],0.0031128432586208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HK2,Hexokinase-2,4152,167,0.89 [0.54-1.48],0.6631753137644802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",3668,142,2.43 [1.48-4.01],0.0004831586024373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",4212,169,1.45 [1.02-2.05],0.0358896519854629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",4226,172,3.11 [2.31-4.20],1.1940535202691984e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMBS,Porphobilinogen deaminase,4267,175,0.83 [0.61-1.13],0.2399494431370741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMCN2,Hemicentin-2,3604,139,1.16 [0.88-1.54],0.2909618884235389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",3579,143,0.90 [0.64-1.27],0.5465208222190663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",3553,138,0.88 [0.59-1.32],0.5430518384292682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMMR,Hyaluronan mediated motility receptor,3530,139,1.12 [0.83-1.51],0.4517545804693471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMOX1,Heme oxygenase 1,4202,172,0.78 [0.60-1.02],0.0723169530166036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMOX2,Heme oxygenase 2,4101,164,1.33 [1.03-1.72],0.0293411677555544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNF1A,Hepatocyte nuclear factor 1-alpha,3584,138,1.00 [0.80-1.24],0.970359044161756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNMT,Histamine N-methyltransferase,4175,168,1.39 [1.10-1.77],0.0062112695504559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,4142,167,0.93 [0.77-1.11],0.4166327795027184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,3668,142,1.30 [0.98-1.74],0.0731676401879016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HPCAL1,Hippocalcin-like protein 1,4281,174,0.98 [0.82-1.18],0.8280728147596335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HPGDS,Hematopoietic prostaglandin D synthase,4103,164,0.63 [0.43-0.92],0.018022202577944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HPSE,Heparanase,3644,139,1.05 [0.88-1.25],0.5722091687316289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRAS,GTPase Hras,3609,140,1.03 [0.88-1.20],0.7372133225487086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,3579,143,1.82 [1.36-2.44],5.995402844403024e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRG,Histidine-rich glycoprotein,3664,141,1.65 [1.01-2.70],0.0454990656250096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS1BP3,HCLS1-binding protein 3,3579,143,0.99 [0.82-1.19],0.9089476074674931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,4212,172,1.44 [1.03-2.01],0.0343524432571112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,4267,175,1.06 [0.74-1.50],0.7545045242354933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,3559,140,1.83 [1.28-2.61],0.0008725185659845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSBP1,Heat shock factor-binding protein 1,3579,143,0.98 [0.83-1.17],0.8412578258646621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,4226,172,1.08 [0.79-1.47],0.6282177199090291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,3657,142,1.06 [0.84-1.35],0.6136893738061493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,3553,138,0.96 [0.69-1.35],0.8253636966732003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,3579,143,1.14 [0.81-1.59],0.4507839466782405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSP90B1,Endoplasmin,4087,164,1.19 [1.00-1.41],0.0524532566843582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPA1A,Heat shock 70 kDa protein 1A,4240,170,0.97 [0.80-1.17],0.7342726959446414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPA2,Heat shock-related 70 kDa protein 2,3659,142,1.97 [1.48-2.61],2.7856551804093565e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB1,Heat shock protein beta-1,4169,171,0.97 [0.80-1.18],0.7552035449553542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB6,Heat shock protein beta-6,4267,175,3.03 [2.34-3.92],2.9983691772706924e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,4208,169,3.85 [2.85-5.20],1.3334231484162334e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HTR1A,5-hydroxytryptamine receptor 1A,3549,140,0.98 [0.81-1.20],0.8786647073857284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HTR1B,5-hydroxytryptamine receptor 1B,3549,140,0.86 [0.57-1.29],0.463235427667262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HTRA2,"Serine protease HTRA2, mitochondrial",4238,174,1.07 [0.86-1.34],0.5327566724294903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYAL1,Hyaluronidase-1,4199,167,3.63 [2.31-5.70],2.315611248083237e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYOU1,Hypoxia up-regulated protein 1,4283,174,4.86 [2.95-8.02],5.40381906499098e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICA1,Islet cell autoantigen 1,4131,169,0.97 [0.81-1.16],0.743732225648339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM1,Intercellular adhesion molecule 1,4218,170,1.91 [1.29-2.83],0.0011762671227472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM2,Intercellular adhesion molecule 2,4283,174,2.99 [1.98-4.52],1.9741462195323373e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM3,Intercellular adhesion molecule 3,4283,174,1.95 [1.24-3.06],0.0039770607387831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM4,Intercellular adhesion molecule 4,4226,172,0.91 [0.70-1.17],0.4516285663793432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM5,Intercellular adhesion molecule 5,4233,173,1.34 [1.00-1.80],0.0496755741879806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICOSLG,ICOS ligand,4212,172,2.52 [1.31-4.86],0.0057145529626217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ID4,DNA-binding protein inhibitor ID-4,3618,140,0.93 [0.63-1.39],0.724929035865291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,4101,164,1.43 [1.13-1.80],0.0027832543952468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDO1,"Indoleamine 2,3-dioxygenase 1",3579,143,0.97 [0.75-1.24],0.7904919836668874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDS,Iduronate 2-sulfatase,4281,174,0.73 [0.17-3.20],0.6805472228444258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDUA,Alpha-L-iduronidase,4267,175,1.61 [1.19-2.17],0.0017815129343238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,3556,131,1.83 [1.21-2.76],0.0041409081752239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,3618,140,0.92 [0.66-1.28],0.6173420814293523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,3618,140,0.84 [0.55-1.29],0.4298624929150529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNAR1,Interferon alpha/beta receptor 1,3652,139,1.88 [1.10-3.22],0.0218838752917441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNG,Interferon gamma,4131,169,1.05 [0.93-1.19],0.429645914835348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNGR1,Interferon gamma receptor 1,4248,170,5.57 [3.38-9.19],1.5969799909329084e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNGR2,Interferon gamma receptor 2,4194,169,1.25 [0.98-1.59],0.066700149529974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNL1,Interferon lambda-1,4101,164,1.44 [1.16-1.81],0.0012450775462141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNL2,Interferon lambda-2,3549,140,1.19 [0.95-1.50],0.1353546023573355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNLR1,Interferon lambda receptor 1,4226,172,1.21 [0.85-1.73],0.2856679666927704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNW1,Interferon omega-1,3553,138,0.88 [0.52-1.48],0.6235254840499537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFT20,Intraflagellar transport protein 20 homolog,3584,138,0.97 [0.66-1.44],0.8818656405811173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGBP1,Immunoglobulin-binding protein 1,3668,142,1.00 [0.77-1.30],0.9879592699676332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,3549,140,0.93 [0.65-1.34],0.707092706671592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,3683,141,1.14 [0.64-2.02],0.6539210572375633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF1R,Insulin-like growth factor 1 receptor,4212,172,6.49 [4.26-9.89],2.9750728404209813e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,3553,138,0.74 [0.47-1.14],0.170013738332733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF2R,Cation-independent mannose-6-phosphate receptor,4246,172,2.45 [1.42-4.23],0.0012988732773776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP1,Insulin-like growth factor-binding protein 1,4279,174,1.31 [1.18-1.46],6.611060928092401e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP2,Insulin-like growth factor-binding protein 2,4276,174,1.95 [1.63-2.34],2.688346592695402e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP3,Insulin-like growth factor-binding protein 3,4246,171,0.52 [0.39-0.70],8.836927318517066e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP4,Insulin-like growth factor-binding protein 4,4191,166,2.66 [2.21-3.21],4.8160089569927335e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP6,Insulin-like growth factor-binding protein 6,4223,170,2.76 [2.10-3.63],3.1784577880766134e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP7,Insulin-like growth factor-binding protein 7,4283,174,2.73 [2.13-3.51],3.0350459390125053e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,4233,173,2.39 [1.81-3.16],9.477193234668471e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFL4,Insulin growth factor-like family member 4,3559,140,0.87 [0.67-1.13],0.2934566991250615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGHMBP2,DNA-binding protein SMUBP-2,3553,138,1.09 [0.81-1.46],0.5755871897217356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGLC2,Immunoglobulin lambda constant 2,3674,142,1.79 [1.04-3.06],0.0341863992917131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGLON5,IgLON family member 5,3536,140,1.13 [0.97-1.32],0.124086407643779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF21,Immunoglobulin superfamily member 21,3579,143,0.98 [0.67-1.43],0.9013856119824556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF3,Immunoglobulin superfamily member 3,4212,172,1.58 [1.21-2.06],0.0007927491524371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF8,Immunoglobulin superfamily member 8,4233,173,2.17 [1.64-2.87],5.655148015905752e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF9,Protein turtle homolog A,3670,144,1.16 [0.99-1.36],0.0725125554750397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IKBKG,NF-kappa-B essential modulator,4226,172,0.99 [0.85-1.15],0.8528807566986729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IKZF2,Zinc finger protein Helios,4103,164,1.07 [0.93-1.23],0.3642316078903478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10,Interleukin-10,4131,169,1.26 [1.09-1.45],0.0014178827500199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10RA,Interleukin-10 receptor subunit alpha,4131,169,1.10 [0.88-1.37],0.4012231227279543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10RB,Interleukin-10 receptor subunit beta,4248,170,4.13 [2.87-5.96],3.075769565121867e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL11,Interleukin-11,4131,169,1.15 [0.95-1.40],0.1460944112714839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12A_IL12B,Interleukin-12,4212,172,1.36 [1.17-1.58],8.146535166118813e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12B,Interleukin-12 subunit beta,4281,174,1.55 [1.23-1.94],0.0001740973564224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12RB1,Interleukin-12 receptor subunit beta-1,4131,169,1.81 [1.28-2.55],0.0007725452861872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12RB2,Interleukin-12 receptor subunit beta-2,3559,140,1.05 [0.70-1.57],0.8119425868441067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL13,Interleukin-13,4131,169,0.86 [0.62-1.19],0.3574778230756059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,4174,170,1.55 [0.89-2.69],0.1232731285458806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,3549,140,0.95 [0.53-1.70],0.8664884182009311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL15,Interleukin-15,4226,172,2.15 [1.57-2.95],1.7871620588040672e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL15RA,Interleukin-15 receptor subunit alpha,4131,169,2.19 [1.55-3.09],9.46924444882016e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL16,Pro-interleukin-16,4281,174,1.31 [1.00-1.70],0.0500356398267077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17A,Interleukin-17A,4123,168,0.80 [0.57-1.12],0.1962472336089513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17C,Interleukin-17C,4131,169,1.39 [1.21-1.61],7.111843195644598e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17D,Interleukin-17D,4131,169,1.54 [1.21-1.97],0.0005067718371868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17F,Interleukin-17F,4131,169,1.02 [0.85-1.23],0.8091966764624215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17RA,Interleukin-17 receptor A,4246,172,1.17 [0.87-1.57],0.2969241503764556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17RB,Interleukin-17 receptor B,4179,171,1.25 [0.98-1.60],0.0697772784035088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18,Interleukin-18,4216,170,1.87 [1.42-2.48],9.2330889209339e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18BP,Interleukin-18-binding protein,4246,171,3.30 [2.37-4.60],1.3835801654335804e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18R1,Interleukin-18 receptor 1,4281,174,2.71 [1.94-3.79],4.915027510597008e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18RAP,Interleukin-18 receptor accessory protein,4162,166,0.97 [0.89-1.05],0.4204706317034187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL19,Interleukin-19,4137,167,1.28 [1.10-1.48],0.0013860408846893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1A,Interleukin-1 alpha,4131,169,1.10 [0.89-1.36],0.375838084408072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1B,Interleukin-1 beta,4111,169,0.91 [0.72-1.15],0.4325330159289445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1R1,Interleukin-1 receptor type 1,4242,172,6.80 [4.51-10.24],4.6165135317067815e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1R2,Interleukin-1 receptor type 2,4220,170,1.66 [0.90-3.07],0.1066431439858361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RAP,Interleukin-1 receptor accessory protein,4246,172,1.05 [0.79-1.39],0.7529907131506158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RL1,Interleukin-1 receptor-like 1,4273,174,1.95 [1.47-2.59],4.392994921509961e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RL2,Interleukin-1 receptor-like 2,4131,169,1.05 [0.74-1.50],0.7817131929010689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RN,Interleukin-1 receptor antagonist protein,4220,169,1.24 [1.02-1.52],0.0350157105724402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2,Interleukin-2,4131,169,1.62 [1.05-2.51],0.0299341572845083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20,Interleukin-20,4131,169,1.08 [0.85-1.38],0.5157063528868515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20RA,Interleukin-20 receptor subunit alpha,4131,169,1.20 [0.91-1.58],0.1866936769950339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20RB,Interleukin-20 receptor subunit beta,3559,140,1.06 [0.73-1.54],0.7629013692682571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL21R,Interleukin-21 receptor,3559,140,0.69 [0.46-1.03],0.0707573046463363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL22,Interleukin-22,3659,142,1.16 [0.93-1.45],0.178250394159301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,4131,169,1.26 [0.96-1.66],0.0955057168179771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL24,Interleukin-24,4131,169,1.14 [0.88-1.47],0.3165847160928708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL25,Interleukin-25,3525,140,0.99 [0.62-1.59],0.9664405139420008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RA,Interleukin-2 receptor subunit alpha,4208,171,2.46 [1.92-3.16],1.4540746513901973e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RB,Interleukin-2 receptor subunit beta,4131,169,1.23 [0.92-1.63],0.1588862721351317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RG,Cytokine receptor common subunit gamma,3659,142,1.44 [1.11-1.86],0.0064164774913475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL3,Interleukin-3,3536,140,0.81 [0.64-1.03],0.0806414772526125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL31,Interleukin-31,3559,140,0.92 [0.67-1.26],0.5973662228849687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL31RA,Interleukin-31 receptor subunit alpha,3545,140,1.25 [0.83-1.87],0.2893296340519211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL32,Interleukin-32,4226,172,1.05 [0.82-1.36],0.6976492895770707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL33,Interleukin-33,4131,169,1.42 [1.02-1.98],0.0378673311319795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL34,Interleukin-34,4095,164,1.22 [0.83-1.78],0.3093770597218774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL36A,Interleukin-36 alpha,3559,140,0.83 [0.60-1.16],0.2810002935385304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL36G,Interleukin-36 gamma,3552,140,0.98 [0.77-1.25],0.899698605516124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL3RA,Interleukin-3 receptor subunit alpha,4131,169,1.48 [0.99-2.21],0.058657309918645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL4,Interleukin-4,4131,169,1.03 [0.88-1.19],0.729046573484958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL4R,Interleukin-4 receptor subunit alpha,4226,172,2.53 [1.92-3.33],3.599145088373297e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL5,Interleukin-5,4131,169,0.96 [0.86-1.06],0.4014190450616223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL5RA,Interleukin-5 receptor subunit alpha,4226,172,1.29 [1.03-1.61],0.0266601004178742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6,Interleukin-6,4212,172,1.05 [0.89-1.23],0.5861680109368134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6R,Interleukin-6 receptor subunit alpha,4213,170,1.49 [1.02-2.19],0.0415216808861148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6ST,Interleukin-6 receptor subunit beta,4233,173,4.81 [2.39-9.67],1.0264825417847482e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL7,Interleukin-7,4226,172,0.87 [0.70-1.08],0.2208049792028029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL7R,Interleukin-7 receptor subunit alpha,4246,172,1.21 [0.94-1.57],0.1411542827122885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL9,Interleukin-9,3618,140,0.94 [0.70-1.27],0.7010309514053714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,4094,164,1.07 [0.85-1.35],0.5551980700636078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMMT,MICOS complex subunit MIC60,3659,142,1.56 [1.19-2.06],0.0015397778508559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMPA1,Inositol monophosphatase 1,4194,169,0.96 [0.77-1.21],0.7469686453052704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMPACT,Protein IMPACT,3657,142,0.97 [0.72-1.30],0.8472974666276957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,3549,140,0.87 [0.50-1.51],0.6126901135932181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ING1,Inhibitor of growth protein 1,4092,163,0.99 [0.76-1.31],0.9667204086230964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBB,Inhibin beta B chain,3611,140,2.48 [1.94-3.15],2.0494975866671402e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBC,Inhibin beta C chain,4246,172,1.58 [1.09-2.29],0.0146220346862447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP1,Inositol polyphosphate 1-phosphatase,4212,172,1.04 [0.81-1.33],0.7686673000428818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",3579,143,1.11 [0.83-1.46],0.4853804953453562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",3668,142,1.04 [0.70-1.56],0.8295413016876201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",4212,172,1.01 [0.88-1.16],0.8468105007953679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL3,Insulin-like 3,3657,142,0.92 [0.76-1.10],0.3529729697670661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL4,Early placenta insulin-like peptide,3659,142,1.76 [1.44-2.15],4.0645348725708034e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL5,Insulin-like peptide INSL5,3652,139,1.24 [1.07-1.45],0.0046609668897598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSR,Insulin receptor,3559,140,6.03 [2.71-13.40],1.0283977650306917e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,4187,169,1.01 [0.87-1.18],0.8769218814078316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,4212,172,1.13 [0.89-1.42],0.3137666339830905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",4152,167,1.08 [0.94-1.25],0.2910367177976303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IRAK1,Interleukin-1 receptor-associated kinase 1,4131,169,1.07 [0.88-1.30],0.505585365473426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IRAK4,Interleukin-1 receptor-associated kinase 4,4226,172,1.01 [0.88-1.15],0.8885224102527527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,4039,158,0.84 [0.58-1.22],0.3538610325458204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ISM1,Isthmin-1,4226,172,1.19 [0.87-1.64],0.2707394216589435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ISM2,Isthmin-2,3683,141,1.31 [0.99-1.73],0.063401777005508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IST1,IST1 homolog,3625,139,0.98 [0.83-1.17],0.8535900076876628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA11,Integrin alpha-11,4226,172,0.72 [0.50-1.04],0.0818814371628065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA2,Integrin alpha-2,3611,140,0.69 [0.44-1.09],0.1088520354715681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA5,Integrin alpha-5,4246,172,2.21 [1.41-3.47],0.0005901558163123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA6,Integrin alpha-6,4226,172,0.84 [0.64-1.10],0.2097521405062723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAL,Integrin alpha-L,3559,140,1.06 [0.73-1.54],0.7443926443568514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAM,Integrin alpha-M,4246,172,1.38 [0.94-2.03],0.1011737740408525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAV,Integrin alpha-V,4267,175,0.41 [0.20-0.84],0.0148301986100478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAX,Integrin alpha-X,3618,140,0.83 [0.58-1.18],0.2890572283356927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1,Integrin beta-1,4229,171,2.12 [1.23-3.67],0.007165114465893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1BP1,Integrin beta-1-binding protein 1,4103,164,1.32 [0.94-1.84],0.1045462129367763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1BP2,Integrin beta-1-binding protein 2,4152,167,0.98 [0.86-1.11],0.7151807951545367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB2,Integrin beta-2,4215,170,1.75 [1.16-2.65],0.0081393406482005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB5,Integrin beta-5,4238,174,1.02 [0.74-1.41],0.891964353157785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB6,Integrin beta-6,4131,169,2.48 [1.61-3.80],3.261806094208792e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB7,Integrin beta-7,4267,175,1.31 [1.01-1.70],0.0451441778217911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGBL1,Integrin beta-like protein 1,3683,141,1.82 [1.43-2.33],1.471661635715846e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,3684,142,1.19 [0.52-2.70],0.6780350201806405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,4246,171,2.64 [1.85-3.76],7.495744969993955e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,3684,142,1.72 [0.96-3.09],0.0694946782770383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,3659,142,1.12 [0.78-1.60],0.5437468298471975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITM2A,Integral membrane protein 2A,4226,172,1.19 [0.96-1.48],0.1066993912345916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITPA,Inosine triphosphate pyrophosphatase,3553,138,0.94 [0.73-1.20],0.5925237486791692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",3579,143,1.20 [0.98-1.48],0.080509577540878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",3549,140,0.98 [0.67-1.44],0.9190584806509036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",4101,164,0.82 [0.60-1.10],0.1895074655398949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IZUMO1,Izumo sperm-egg fusion protein 1,3536,140,1.15 [0.84-1.57],0.3761897346919239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM2,Junctional adhesion molecule B,4264,173,5.11 [3.68-7.09],2.296467932135694e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM3,Junctional adhesion molecule C,3611,140,1.39 [1.07-1.80],0.0122604941473197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JCHAIN,Immunoglobulin J chain,4131,169,1.20 [0.96-1.49],0.1121889195208777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,3536,140,0.85 [0.62-1.17],0.3184779411438838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JPT2,Jupiter microtubule associated homolog 2,3652,139,1.05 [0.87-1.28],0.6060698406246876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JUN,Transcription factor AP-1,4131,169,1.39 [1.16-1.66],0.0004413367789032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,4212,172,1.95 [1.45-2.63],8.927116100929903e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KAZN,Kazrin,3652,139,1.00 [0.86-1.17],0.9802648832291986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,3549,140,0.90 [0.65-1.25],0.52793346834797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,3584,138,0.83 [0.64-1.08],0.16229145992765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCNIP4,Kv channel-interacting protein 4,4101,164,0.91 [0.68-1.21],0.5033514520728307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCTD5,BTB/POZ domain-containing protein KCTD5,3593,139,1.25 [0.93-1.68],0.1472966210284891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KDM3A,Lysine-specific demethylase 3A,3559,140,1.09 [0.91-1.29],0.3457509768830553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KDR,Vascular endothelial growth factor receptor 2,4238,174,1.02 [0.61-1.70],0.950679947000702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KEL,Kell blood group glycoprotein,4101,164,0.97 [0.67-1.41],0.8826505054139703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KHDC3L,KH domain-containing protein 3,3536,140,1.12 [0.91-1.37],0.2804349743144647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KHK,Ketohexokinase,3579,143,0.90 [0.71-1.16],0.4197623772021734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA0319,Dyslexia-associated protein KIAA0319,3657,142,1.66 [1.04-2.63],0.0320750087858819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA1549,UPF0606 protein KIAA1549,3618,140,1.32 [1.06-1.64],0.0130758842990769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA1549L,UPF0606 protein KIAA1549L,3618,140,1.14 [0.64-2.02],0.6495438451911671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA2013,Uncharacterized protein KIAA2013,3659,142,0.83 [0.58-1.20],0.3214009500605199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF1C,Kinesin-like protein KIF1C,3553,138,1.93 [1.29-2.88],0.0012578223991714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF20B,Kinesin-like protein KIF20B,3549,140,1.14 [0.96-1.37],0.1369753904221161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF22,Kinesin-like protein KIF22,3553,138,0.89 [0.78-1.02],0.0918025901059866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIFBP,KIF-binding protein,4212,172,1.04 [0.88-1.22],0.6604943848304311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,3659,142,1.27 [1.07-1.50],0.0059610696606949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,4103,164,1.23 [1.05-1.45],0.011879404979349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,3652,139,0.99 [0.91-1.09],0.9085505941022318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,4103,164,0.97 [0.87-1.08],0.5427777514081431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,3536,140,0.98 [0.80-1.20],0.8363858423866966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIRREL1,Kin of IRRE-like protein 1,3549,140,1.02 [0.74-1.40],0.918541483563126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIRREL2,Kin of IRRE-like protein 2,4101,164,1.03 [0.73-1.45],0.8733235993064964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIT,Mast/stem cell growth factor receptor Kit,4245,171,0.84 [0.54-1.32],0.4540257368058543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KITLG,Kit ligand,4233,173,1.21 [0.88-1.68],0.240641038150828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLB,Beta-klotho,4101,164,1.20 [1.00-1.43],0.045538651630279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLF4,Krueppel-like factor 4,3549,140,1.23 [0.84-1.81],0.2781012180350409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLHL41,Kelch-like protein 41,3668,142,1.07 [0.78-1.45],0.689222681643711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK1,Kallikrein-1,4192,173,0.98 [0.88-1.09],0.749171727103182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK10,Kallikrein-10,4225,174,1.77 [1.31-2.38],0.0001739395862086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK11,Kallikrein-11,4192,173,3.51 [2.67-4.60],1.2373573387605265e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK12,Kallikrein-12,4103,164,1.02 [0.92-1.13],0.6584341743780096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK13,Kallikrein-13,4124,169,1.02 [0.78-1.32],0.9094808066677944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK14,Kallikrein-14,4267,175,1.49 [1.13-1.96],0.0047924962673947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK15,Kallikrein-15,3652,142,1.16 [0.85-1.59],0.3417430931992225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK3,Prostate-specific antigen,3683,141,0.90 [0.78-1.05],0.1901937923993673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK4,Kallikrein-4,4267,175,2.05 [1.78-2.37],1.1342088306166241e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK6,Kallikrein-6,4232,174,2.25 [1.54-3.30],3.097107356976763e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK7,Kallikrein-7,3513,136,0.57 [0.37-0.89],0.0128163350304192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK8,Kallikrein-8,4078,170,1.73 [1.25-2.40],0.0010060697937483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLKB1,Plasma kallikrein,3605,141,1.28 [0.67-2.45],0.4598403097625664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,4281,174,3.12 [2.35-4.14],3.225129490631056e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,3549,140,1.00 [0.76-1.33],0.9756688635593728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRD1,Natural killer cells antigen CD94,4281,174,1.70 [1.29-2.24],0.0001712425657453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,3559,140,1.44 [1.15-1.81],0.0017816136985221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRK1,NKG2-D type II integral membrane protein,3657,142,1.65 [1.17-2.33],0.0043992119124024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT14,"Keratin, type I cytoskeletal 14",3981,158,1.28 [0.83-1.99],0.2658707406775547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT17,"Keratin, type I cytoskeletal 17",3553,138,1.08 [0.73-1.61],0.6994244029408421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT18,"Keratin, type I cytoskeletal 18",4212,172,1.11 [0.98-1.26],0.0930672302419465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT19,"Keratin, type I cytoskeletal 19",4218,172,1.76 [1.51-2.06],1.0552648036491202e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT5,"Keratin, type II cytoskeletal 5",4101,164,1.03 [0.79-1.32],0.8463357241560661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT6C,"Keratin, type II cytoskeletal 6C",3553,138,1.05 [0.71-1.57],0.7994678006372926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT8,"Keratin, type II cytoskeletal 8",3549,140,1.11 [1.00-1.23],0.0465410579231235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,4229,173,0.88 [0.69-1.11],0.2846584280086109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KYNU,Kynureninase,4281,174,0.68 [0.52-0.88],0.0033888049568175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,L1CAM,Neural cell adhesion molecule L1,4238,174,1.37 [0.89-2.09],0.1502182933913695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,3670,144,0.96 [0.80-1.15],0.6364298877918084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LACRT,Extracellular glycoprotein lacritin,3643,141,1.08 [0.77-1.51],0.6485800280450885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LACTB2,Endoribonuclease LACTB2,4233,173,0.95 [0.77-1.17],0.5979219205219561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAG3,Lymphocyte activation gene 3 protein,4212,172,2.01 [1.64-2.47],2.2114144670463048e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,4226,170,2.57 [2.13-3.09],1.809242571787549e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,4194,169,1.14 [0.99-1.30],0.0676139657098699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMA1,Laminin subunit alpha-1,3553,138,0.73 [0.49-1.09],0.1275918390779639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMA4,Laminin subunit alpha-4,4248,170,1.96 [1.37-2.80],0.0002363689764791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMB1,Laminin subunit beta-1,3579,143,2.00 [1.22-3.28],0.0058253088381302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP1,Lysosome-associated membrane glycoprotein 1,3592,139,1.75 [1.04-2.95],0.0345634835785918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP2,Lysosome-associated membrane glycoprotein 2,4115,165,1.89 [0.96-3.74],0.0664240587141865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP3,Lysosome-associated membrane glycoprotein 3,4273,174,1.46 [1.14-1.87],0.0023999289978464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMTOR5,Ragulator complex protein LAMTOR5,3659,142,1.06 [0.71-1.58],0.7768485087895404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAP3,Cytosol aminopeptidase,4131,169,0.97 [0.72-1.29],0.8131577989573936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LARP1,La-related protein 1,3659,142,1.06 [0.82-1.36],0.670467019206087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAT,Linker for activation of T-cells family member 1,4281,174,1.07 [0.89-1.28],0.492891883759981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAT2,Linker for activation of T-cells family member 2,4212,172,1.03 [0.93-1.15],0.5693683798293683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LATS1,Serine/threonine-protein kinase LATS1,3559,140,0.97 [0.80-1.18],0.7515955158998185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAYN,Layilin,4185,168,3.92 [3.07-5.00],6.324302904536225e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LBP,Lipopolysaccharide-binding protein,4246,171,1.29 [1.02-1.63],0.0308957052029628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LBR,Delta(14)-sterol reductase LBR,4264,173,1.10 [0.92-1.31],0.2762684191898754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCAT,Phosphatidylcholine-sterol acyltransferase,3685,143,0.75 [0.37-1.53],0.4274207331956551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN15,Lipocalin-15,3668,142,1.51 [1.30-1.76],1.3684135716668004e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN2,Neutrophil gelatinase-associated lipocalin,4106,166,2.20 [1.73-2.78],6.516425302602424e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCP1,Plastin-2,3683,141,0.81 [0.57-1.15],0.2379921171551701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LDLR,Low-density lipoprotein receptor,4241,172,0.92 [0.71-1.18],0.4966112679272982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,3668,142,0.97 [0.82-1.14],0.6753222248818791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LECT2,Leukocyte cell-derived chemotaxin-2,3670,144,1.37 [1.12-1.69],0.0023049789745172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEFTY2,Left-right determination factor 2,4259,175,1.41 [1.10-1.80],0.00617722411731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEG1,Protein LEG1 homolog,3480,132,1.20 [0.95-1.50],0.1232003456243147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LELP1,Late cornified envelope-like proline-rich protein 1,3549,140,0.90 [0.70-1.15],0.3957051009987894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEO1,RNA polymerase-associated protein LEO1,3668,142,1.26 [0.83-1.90],0.2822606454227508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEP,Leptin,4233,173,1.02 [0.83-1.26],0.8299669251106657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEPR,Leptin receptor,4233,173,1.69 [1.14-2.51],0.0086076643221011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LETM1,Mitochondrial proton/calcium exchanger protein,3668,142,1.28 [0.97-1.68],0.0769469083715936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS1,Galectin-1,4233,173,1.87 [1.32-2.63],0.000365348595214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS3,Galectin-3,4233,171,2.64 [1.76-3.97],2.9801780782703875e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS3BP,Galectin-3-binding protein,3684,142,1.58 [1.02-2.44],0.0388411304504077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS4,Galectin-4,4226,170,2.32 [1.92-2.81],2.408778742611657e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS7_LGALS7B,Galectin-7,4224,172,1.58 [1.20-2.08],0.0010313460126863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS8,Galectin-8,4264,173,1.04 [0.83-1.30],0.7262893479338338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS9,Galectin-9,4232,170,3.76 [2.59-5.45],3.6068516120608538e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGMN,Legumain,4248,170,1.53 [1.07-2.20],0.0190073721364759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LHB,Lutropin subunit beta,4103,164,1.09 [0.94-1.26],0.2361624339518502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,4230,169,0.82 [0.66-1.03],0.0827386697643405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIF,Leukemia inhibitory factor,4101,164,1.15 [0.91-1.46],0.2442656329559159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIFR,Leukemia inhibitory factor receptor,4226,172,6.19 [4.32-8.86],2.4400399008829362e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,4246,172,1.34 [0.92-1.94],0.1252092155075708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,3683,141,0.98 [0.88-1.10],0.7527466357818416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,3553,138,1.08 [0.78-1.50],0.6223409540284495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,4233,173,1.86 [1.23-2.82],0.0032238963232599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,3670,144,0.96 [0.78-1.18],0.704940361351356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,4283,174,1.59 [0.99-2.55],0.052744276749404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,4266,174,1.30 [0.89-1.91],0.1731099987187696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,4131,169,2.34 [1.79-3.06],5.759705343273983e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,4283,174,1.06 [0.87-1.29],0.554258775716022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIPF,Gastric triacylglycerol lipase,3579,143,1.00 [0.80-1.26],0.987087517777091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMNB1,Lamin-B1,3645,139,1.02 [0.80-1.30],0.8823829934296998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMNB2,Lamin-B2,3657,142,2.33 [1.51-3.61],0.0001431861893603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD1,Leiomodin-1,3668,142,2.68 [2.06-3.48],2.1587334257286605e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD2,Leiomodin-2,3549,140,0.87 [0.65-1.17],0.3532421734261406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LONP1,"Lon protease homolog, mitochondrial",3579,143,1.00 [0.83-1.20],0.9774339440351948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPA,Apolipoprotein(a),3589,139,0.92 [0.85-1.01],0.0707405395317141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,4212,172,1.13 [0.89-1.43],0.333850518418273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPL,Lipoprotein lipase,4233,173,0.96 [0.73-1.27],0.7971471250819192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPO,Lactoperoxidase,4091,167,1.55 [1.28-1.88],1.019691189869224e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPP,Lipoma-preferred partner,3553,138,0.97 [0.75-1.25],0.8309543094776133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,3553,138,1.04 [0.81-1.33],0.7516166037721661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,3584,138,1.17 [0.84-1.63],0.347323239283566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRG1,Leucine-rich alpha-2-glycoprotein,3684,142,3.04 [1.71-5.39],0.0001428117273007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,4255,175,2.59 [1.89-3.53],2.040870941910073e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,3549,140,1.34 [0.82-2.19],0.2487695671270265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,4212,172,1.83 [1.16-2.88],0.0091960373515539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP11,Low-density lipoprotein receptor-related protein 11,4233,173,2.37 [1.73-3.24],8.228266747359239e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP2,Low-density lipoprotein receptor-related protein 2,3584,138,1.03 [0.65-1.64],0.8846476985351743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP2BP,LRP2-binding protein,3584,138,0.94 [0.76-1.17],0.5645104934055676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,4264,173,1.16 [0.94-1.44],0.1561289987001532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC25,Leucine-rich repeat-containing protein 25,4212,172,1.37 [1.04-1.80],0.0244087312398271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,3652,139,1.36 [0.94-1.97],0.1017800220426512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC38,Leucine-rich repeat-containing protein 38,3584,138,1.38 [1.01-1.87],0.0422041856763764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC59,Leucine-rich repeat-containing protein 59,3670,144,1.03 [0.75-1.43],0.8470799069879834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,3659,142,1.02 [0.74-1.41],0.8862481092852598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRN1,Leucine-rich repeat neuronal protein 1,4131,169,0.62 [0.45-0.87],0.0053201477827936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,3584,138,1.11 [0.74-1.67],0.6057990749887197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,3668,142,0.78 [0.41-1.46],0.4337298924746638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,4103,164,1.07 [0.84-1.38],0.5842293595899088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,3618,140,0.98 [0.81-1.19],0.8677868821112285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LSP1,Lymphocyte-specific protein 1,4226,172,1.20 [0.85-1.68],0.2934120735762064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTA,Lymphotoxin-alpha,4226,172,1.20 [0.86-1.68],0.2798686676550048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTA4H,Leukotriene A-4 hydrolase,4267,175,0.85 [0.68-1.07],0.1648433896865083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTB,Lymphotoxin-beta,3659,142,1.08 [0.70-1.67],0.7183895449953767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,4283,174,3.69 [2.74-4.95],5.2322499596482456e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,4103,164,1.44 [1.23-1.70],1.0690241365655357e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBR,Tumor necrosis factor receptor superfamily member 3,4208,170,3.81 [2.85-5.09],1.1322275909299442e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTO1,Protein LTO1 homolog,4131,169,0.93 [0.64-1.34],0.6925363629294528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LUZP2,Leucine zipper protein 2,3659,142,1.30 [0.98-1.71],0.0658951722508407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LXN,Latexin,4168,169,0.96 [0.78-1.17],0.6767747852976546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY6D,Lymphocyte antigen 6D,4203,168,2.08 [1.63-2.67],4.868142483944897e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY75,Lymphocyte antigen 75,4226,172,1.44 [1.02-2.02],0.0370572824996967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY9,T-lymphocyte surface antigen Ly-9,4180,169,2.43 [1.62-3.63],1.7067619528586914e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY96,Lymphocyte antigen 96,4194,169,1.91 [1.40-2.62],5.382450794134611e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYAR,Cell growth-regulating nucleolar protein,4103,164,0.98 [0.74-1.30],0.9003297333870702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYN,Tyrosine-protein kinase Lyn,4212,172,1.02 [0.87-1.20],0.8075044299382268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD1,Ly6/PLAUR domain-containing protein 1,4101,164,0.88 [0.68-1.14],0.3301575222541036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD3,Ly6/PLAUR domain-containing protein 3,4193,171,1.82 [1.26-2.61],0.0013220114458638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD8,Ly6/PLAUR domain-containing protein 8,4103,164,1.27 [1.04-1.54],0.0164982382344055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPLA2,Acyl-protein thioesterase 2,3549,140,0.85 [0.71-1.02],0.0746948806563002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,3584,138,0.94 [0.80-1.11],0.4630390494342985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,3684,142,2.60 [1.19-5.67],0.0161181898107075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYZL2,Lysozyme-like protein 2,3536,140,1.11 [0.71-1.75],0.6430566760813008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LZTFL1,Leucine zipper transcription factor-like protein 1,3611,140,0.85 [0.67-1.08],0.1810058737763676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,M6PR,Cation-dependent mannose-6-phosphate receptor,3579,143,0.82 [0.53-1.27],0.3807368694120197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,4174,168,1.32 [1.09-1.60],0.0043685635573436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAEA,E3 ubiquitin-protein transferase MAEA,4103,164,0.84 [0.58-1.22],0.3632620480614745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAG,Myelin-associated glycoprotein,3584,138,0.63 [0.45-0.89],0.009162739288968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAGEA3,Melanoma-associated antigen 3,3618,140,1.04 [0.86-1.27],0.6636562044147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAGED1,Melanoma-associated antigen D1,4103,164,1.17 [0.90-1.53],0.2397972100072092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAMDC2,MAM domain-containing protein 2,3670,144,2.94 [2.12-4.08],1.0945302252698014e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAMDC4,Apical endosomal glycoprotein,3659,142,1.21 [0.92-1.57],0.1671408538628546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",3579,143,2.09 [1.11-3.93],0.0221303839489954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAN2B2,Epididymis-specific alpha-mannosidase,3670,144,1.01 [0.78-1.31],0.9296014811286516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",3536,140,1.37 [1.02-1.83],0.0353085358866782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,4248,170,1.01 [0.90-1.14],0.8169544175127404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANSC1,MANSC domain-containing protein 1,4238,174,4.00 [2.67-6.01],2.1674993993063427e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANSC4,MANSC domain-containing protein 4,3553,138,0.83 [0.65-1.06],0.1417674737914394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,3549,140,0.83 [0.49-1.41],0.4904724857417233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,3553,138,0.97 [0.74-1.26],0.8066114318347305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2,Microtubule-associated protein 2,3657,142,1.56 [1.17-2.09],0.0027033153580677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,3652,139,1.19 [0.92-1.55],0.1872452534957988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,4226,172,0.97 [0.85-1.12],0.6941259857848407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,4103,164,1.02 [0.89-1.18],0.7674423294479548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,4185,168,0.99 [0.88-1.12],0.8865394425594607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPK13,Mitogen-activated protein kinase 13,3536,140,1.04 [0.74-1.46],0.829979801886327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPK9,Mitogen-activated protein kinase 9,4226,172,1.31 [0.97-1.78],0.08322592830867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPKAPK2,MAP kinase-activated protein kinase 2,3618,140,0.95 [0.76-1.19],0.6558847465476476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,3536,140,0.98 [0.87-1.10],0.7193765219390961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPT,Microtubule-associated protein tau,4101,164,1.19 [0.91-1.56],0.211838603569856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MARCO,Macrophage receptor MARCO,4233,173,1.07 [0.65-1.75],0.792271222933038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",3606,139,0.95 [0.78-1.16],0.6294780867728982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MASP1,Mannan-binding lectin serine protease 1,4185,168,1.37 [0.77-2.41],0.2821651227032692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MATN2,Matrilin-2,4235,170,1.95 [1.28-2.97],0.0019195567837668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MATN3,Matrilin-3,4187,169,0.70 [0.47-1.04],0.0757809106082581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAVS,Mitochondrial antiviral-signaling protein,4103,164,1.06 [0.91-1.24],0.4519375010894708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAX,Protein max,4101,164,1.03 [0.90-1.17],0.7022962521222105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MB,Myoglobin,4283,174,1.66 [1.36-2.01],4.1044983070860674e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MBL2,Mannose-binding protein C,3628,139,0.97 [0.84-1.12],0.7171622174481539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCAM,Cell surface glycoprotein MUC18,4246,171,2.19 [1.56-3.06],5.264971868759871e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",3668,142,0.71 [0.46-1.10],0.1281507689127475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCEMP1,Mast cell-expressed membrane protein 1,3559,140,0.90 [0.74-1.10],0.3010235008640587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCFD2,Multiple coagulation factor deficiency protein 2,4210,171,1.34 [1.00-1.80],0.0512653832283476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCTS1,Malignant T-cell-amplified sequence 1,3652,139,1.48 [0.89-2.44],0.1276866133763033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,4194,169,1.41 [1.17-1.69],0.0003269617736731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDH1,"Malate dehydrogenase, cytoplasmic",3664,142,0.81 [0.53-1.23],0.3215581356877619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDK,Midkine,4225,173,1.97 [1.65-2.36],1.740714636287444e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDM1,Nuclear protein MDM1,3584,138,0.87 [0.51-1.49],0.611160238455785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",3579,143,0.96 [0.80-1.14],0.618773844481149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MED18,Mediator of RNA polymerase II transcription subunit 18,4103,164,1.01 [0.84-1.22],0.8884135811451709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MED21,Mediator of RNA polymerase II transcription subunit 21,3553,138,0.95 [0.66-1.36],0.7738064938880622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,4226,170,1.37 [0.98-1.91],0.0629072365993796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,3553,138,1.15 [0.68-1.94],0.6135843030165644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,4273,174,2.01 [1.07-3.77],0.0302043123538516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MELTF,Melanotransferrin,3670,144,2.34 [1.44-3.82],0.0006352021295138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MENT,Protein MENT,3611,140,0.36 [0.19-0.67],0.0012237416159248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEP1A,Meprin A subunit alpha,3652,139,0.86 [0.69-1.07],0.1706868209124545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEP1B,Meprin A subunit beta,4233,173,0.85 [0.76-0.95],0.002870291061083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEPE,Matrix extracellular phosphoglycoprotein,4226,170,0.77 [0.47-1.25],0.2927130593494548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MERTK,Tyrosine-protein kinase Mer,4281,174,2.94 [1.87-4.61],2.714298250959544e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MESD,LRP chaperone MESD,4246,172,1.00 [0.90-1.12],0.9785925288238736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MET,Hepatocyte growth factor receptor,4243,169,1.97 [1.04-3.72],0.037091243015116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,METAP1,Methionine aminopeptidase 1,4101,164,0.85 [0.52-1.38],0.509055545296199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",4226,172,1.01 [0.85-1.20],0.9054140060103362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,METAP2,Methionine aminopeptidase 2,4259,175,0.99 [0.77-1.28],0.9528757540799716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP3,Microfibril-associated glycoprotein 3,4152,167,1.07 [0.82-1.40],0.6106206440442777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP3L,Microfibrillar-associated protein 3-like,3584,138,0.86 [0.65-1.14],0.2911986504499211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP4,Microfibril-associated glycoprotein 4,3611,140,3.23 [2.08-5.02],1.730826019626846e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP5,Microfibrillar-associated protein 5,4283,174,1.85 [1.37-2.51],6.842351128266759e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFGE8,Lactadherin,4246,172,1.53 [1.19-1.96],0.0008447381040885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MGLL,Monoglyceride lipase,4242,170,0.96 [0.83-1.13],0.6506345691614459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,4226,172,1.01 [0.90-1.13],0.890226003568058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MIA,Melanoma-derived growth regulatory protein,4238,174,1.38 [0.99-1.92],0.0560192858490436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MICALL2,MICAL-like protein 2,3584,138,1.10 [0.88-1.39],0.4039293961281317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,4226,172,1.08 [0.98-1.19],0.1374929288934457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MIF,Macrophage migration inhibitory factor,4239,172,1.02 [0.83-1.26],0.8164290623240539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MILR1,Allergin-1,4131,169,1.57 [1.23-2.01],0.0002977260372293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,3659,142,0.93 [0.80-1.08],0.3293540718992571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MINK1,Misshapen-like kinase 1,3657,142,0.95 [0.80-1.14],0.6015282861184015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MITD1,MIT domain-containing protein 1,4194,169,0.99 [0.86-1.14],0.8970449534955591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MKI67,Proliferation marker protein Ki-67,3559,140,0.87 [0.56-1.35],0.5272212913015895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MLLT1,Protein ENL,3536,140,0.99 [0.78-1.27],0.9545106068360434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MLN,Promotilin,4226,172,1.23 [1.06-1.44],0.0082912985516745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MME,Neprilysin,4212,172,1.19 [1.03-1.39],0.0226741539507445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP1,Interstitial collagenase,4091,161,1.33 [1.14-1.57],0.0004369715229292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP10,Stromelysin-2,4222,170,1.79 [1.45-2.20],4.301569893113485e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP12,Macrophage metalloelastase,4237,175,1.64 [1.33-2.03],4.548199685006963e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP13,Collagenase 3,4101,164,1.66 [1.09-2.54],0.0177976006371982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP15,Matrix metalloproteinase-15,3670,144,1.17 [0.89-1.53],0.2554229596008334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP3,Stromelysin-1,4246,172,1.42 [1.12-1.80],0.0042103607765234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP7,Matrilysin,4147,167,2.45 [1.85-3.24],2.9856343772542136e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP8,Neutrophil collagenase,4258,173,1.13 [0.95-1.35],0.1550375653115216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP9,Matrix metalloproteinase-9,4242,172,1.14 [0.92-1.42],0.2420274080390811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",3553,138,0.94 [0.67-1.33],0.7314041123089143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MN1,Transcriptional activator MN1,3584,138,1.07 [0.82-1.40],0.6194226687986459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MNAT1,CDK-activating kinase assembly factor MAT1,3618,140,0.80 [0.53-1.21],0.285675008786464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MNDA,Myeloid cell nuclear differentiation antigen,4226,173,0.95 [0.83-1.09],0.4740693165350752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MOCS2,Molybdopterin synthase catalytic subunit,3611,140,1.01 [0.79-1.29],0.9472927800811732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MOG,Myelin-oligodendrocyte glycoprotein,4267,175,2.11 [1.51-2.94],1.0086433014954178e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORC3,MORC family CW-type zinc finger protein 3,3657,142,0.78 [0.42-1.46],0.4394042866032656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORF4L1,Mortality factor 4-like protein 1,3618,140,0.90 [0.59-1.36],0.6075928923588186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORF4L2,Mortality factor 4-like protein 2,3536,140,0.98 [0.63-1.53],0.94365609791194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORN4,MORN repeat-containing protein 4,3536,140,0.94 [0.76-1.16],0.559994010817667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPHOSPH8,M-phase phosphoprotein 8,4152,167,0.95 [0.79-1.14],0.5783634905130548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPI,Mannose-6-phosphate isomerase,4212,172,1.12 [0.96-1.32],0.1520729333148363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,4242,170,1.02 [0.85-1.22],0.8233358077581523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPO,Myeloperoxidase,4246,172,1.17 [0.89-1.53],0.2588813986763976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPRIP,Myosin phosphatase Rho-interacting protein,3651,142,0.91 [0.63-1.31],0.6099584640749509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRC1,Macrophage mannose receptor 1,3685,143,2.37 [1.42-3.95],0.0008926060831418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRI1,Methylthioribose-1-phosphate isomerase,3584,138,1.10 [0.87-1.40],0.4371977607419431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL24,"39S ribosomal protein L24, mitochondrial",3553,138,1.31 [0.95-1.82],0.0960805035581941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL28,"39S ribosomal protein L28, mitochondrial",3668,142,0.94 [0.61-1.45],0.7624161788296814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL46,"39S ribosomal protein L46, mitochondrial",4101,164,0.81 [0.48-1.35],0.4103790939766506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL52,"39S ribosomal protein L52, mitochondrial",3530,139,0.96 [0.52-1.79],0.9059780144317702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",3668,142,1.02 [0.83-1.26],0.8189303883852024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPS16,"28S ribosomal protein S16, mitochondrial",3559,140,0.62 [0.31-1.23],0.1723277381992286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSLN,Mesothelin,4200,171,1.37 [1.12-1.68],0.0026207267921799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSLNL,Mesothelin-like protein,3584,138,0.90 [0.56-1.45],0.6598195069095746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSMB,Beta-microseminoprotein,4234,174,1.44 [1.20-1.72],6.646191881757823e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSR1,Macrophage scavenger receptor types I and II,4264,173,1.71 [1.31-2.24],0.0001015764683718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,4238,174,0.97 [0.81-1.18],0.7880830710944917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MST1,Hepatocyte growth factor-like protein,3625,140,1.14 [0.85-1.52],0.3875966575627114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSTN,Growth/differentiation factor 8,4152,167,0.75 [0.58-0.96],0.0206539668529589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTDH,Protein LYRIC,3559,140,1.05 [0.88-1.24],0.5835840062196361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",3657,142,0.97 [0.52-1.82],0.9367247725024144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,3618,140,0.97 [0.84-1.12],0.6826654451596479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",3652,139,0.93 [0.77-1.12],0.4346791165425223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTPN,Myotrophin,4152,167,0.64 [0.39-1.06],0.0807829350772868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTR,Methionine synthase,3553,138,0.99 [0.78-1.27],0.9536095419880296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTSS1,Protein MTSS 1,3652,139,1.09 [0.94-1.26],0.237559644346049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTSS2,Protein MTSS 2,3659,142,1.01 [0.86-1.19],0.8591474591436947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTUS1,Microtubule-associated tumor suppressor 1,3618,140,0.83 [0.62-1.11],0.2038845716580553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC13,Mucin-13,4101,164,1.96 [1.63-2.35],9.375669756121545e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC16,Mucin-16,4212,172,1.01 [0.94-1.09],0.8159158145285276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC2,Mucin-2,3683,141,1.04 [0.88-1.24],0.6500763298365262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUCL3,Mucin-like protein 3,3536,140,0.92 [0.62-1.37],0.6870637210458415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MVK,Mevalonate kinase,4131,169,1.06 [0.91-1.23],0.4740896396118954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MXRA8,Matrix remodeling-associated protein 8,3611,140,0.63 [0.38-1.06],0.0814624717895614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYBPC1,"Myosin-binding protein C, slow-type",3670,144,1.37 [1.14-1.65],0.0007980343837682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYBPC2,"Myosin-binding protein C, fast-type",3579,143,1.20 [1.03-1.40],0.0223863787780984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,3668,142,0.91 [0.71-1.18],0.485959508113579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYDGF,Myeloid-derived growth factor,3670,144,1.04 [0.88-1.24],0.6065187555950706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYH4,Myosin-4,3553,138,1.16 [0.84-1.60],0.3795476560333348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYH7B,Myosin-7B,3536,140,0.89 [0.59-1.35],0.5844297921620869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYH9,Myosin-9,3683,141,0.98 [0.85-1.13],0.7847360547188154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",3553,138,1.21 [0.90-1.63],0.2005008967251042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL3,Myosin light chain 3,3579,143,1.15 [0.93-1.41],0.1963400598351004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL4,Myosin light chain 4,3579,143,1.22 [0.92-1.61],0.1634983520680831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL6B,Myosin light chain 6B,3584,138,0.99 [0.82-1.19],0.9129251184869124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",3584,138,1.61 [1.31-1.96],4.058673909225135e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYO6,Unconventional myosin-VI,3668,142,1.04 [0.66-1.64],0.8552359194650185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYO9B,Unconventional myosin-IXb,4131,169,1.01 [0.83-1.25],0.8875929593524741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOC,Myocilin,4246,172,0.87 [0.65-1.15],0.3263172078402114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM1,Myomesin-1,3549,140,1.04 [0.74-1.46],0.8073453902777072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM2,Myomesin-2,3553,138,1.26 [0.98-1.63],0.0687092660781902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM3,Myomesin-3,3611,140,1.09 [0.92-1.29],0.3168328743414254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MZB1,Marginal zone B- and B1-cell-specific protein,4241,170,1.24 [0.97-1.60],0.089016257650986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MZT1,Mitotic-spindle organizing protein 1,4103,164,1.02 [0.78-1.33],0.8910164757642763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAA10,N-alpha-acetyltransferase 10,3553,138,0.90 [0.65-1.24],0.5115334888550399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAA80,N-alpha-acetyltransferase 80,3584,138,0.96 [0.84-1.10],0.5730459192314632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,4175,168,1.09 [0.86-1.38],0.4591519647438965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NACC1,Nucleus accumbens-associated protein 1,3659,142,0.88 [0.65-1.18],0.3833442511114037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NADK,NAD kinase,4233,173,0.94 [0.74-1.20],0.6259338150227963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGA,Alpha-N-acetylgalactosaminidase,3549,140,1.12 [0.84-1.49],0.4461569583087257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGK,N-acetyl-D-glucosamine kinase,3571,143,0.67 [0.50-0.89],0.0058556802291178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,3611,140,2.39 [1.21-4.73],0.0123756263682823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAMPT,Nicotinamide phosphoribosyltransferase,4103,164,0.95 [0.74-1.23],0.709468697130075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAP1L4,Nucleosome assembly protein 1-like 4,3646,138,0.91 [0.60-1.36],0.6440023809048303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAPRT,Nicotinate phosphoribosyltransferase,3657,142,0.63 [0.38-1.06],0.084794067603826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",3668,142,0.96 [0.68-1.35],0.7967793565934287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,4238,174,5.20 [3.55-7.62],2.187521782799337e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBN,Nibrin,4131,169,1.01 [0.78-1.31],0.9310675151809096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAM1,Neural cell adhesion molecule 1,4246,171,1.03 [0.69-1.54],0.8758673091458173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAM2,Neural cell adhesion molecule 2,4246,172,1.33 [0.82-2.16],0.247739719199664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAN,Neurocan core protein,4264,173,0.63 [0.46-0.86],0.0038944785066957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCF2,Neutrophil cytosol factor 2,4219,172,0.96 [0.82-1.12],0.5894612609386367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCK2,Cytoplasmic protein NCK2,4248,170,1.00 [0.88-1.14],0.9589272763718908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCLN,Nicalin,4131,169,1.11 [0.88-1.41],0.3756180093291097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR1,Natural cytotoxicity triggering receptor 1,4223,172,3.32 [2.49-4.42],2.3046698266961227e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,3652,139,4.14 [2.86-5.99],4.5741972260202514e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCS1,Neuronal calcium sensor 1,4267,175,4.44 [2.96-6.64],4.2908605423167313e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDRG1,Protein NDRG1,4101,164,1.02 [0.83-1.25],0.8535174593442095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,3659,142,1.20 [0.98-1.49],0.0828131817175198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,3553,140,0.97 [0.61-1.55],0.9012643690831844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,3652,139,0.95 [0.79-1.15],0.6065921630823687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",4103,164,1.19 [1.02-1.39],0.0295912922219676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEB,Nebulin,3553,138,1.39 [0.95-2.04],0.0874179287752655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECAP2,Adaptin ear-binding coat-associated protein 2,3553,138,0.94 [0.72-1.22],0.6375043324954228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN1,Nectin-1,3559,140,1.32 [0.84-2.08],0.2283370748656577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN2,Nectin-2,4233,173,3.74 [2.75-5.09],3.4134060021626075e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN4,Nectin-4,4238,174,2.61 [2.09-3.25],1.090194785066787e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,3559,140,0.72 [0.52-0.98],0.0347578135566132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEDD9,Enhancer of filamentation 1,3559,140,1.43 [0.95-2.15],0.0835924197326728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEFL,Neurofilament light polypeptide,4088,163,2.98 [2.50-3.55],3.325776505153205e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEK7,Serine/threonine-protein kinase Nek7,3618,140,0.78 [0.60-1.01],0.0603587741975889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL1,Protein kinase C-binding protein NELL1,4238,174,0.37 [0.30-0.47],7.884336194477506e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL2,Protein kinase C-binding protein NELL2,4248,170,1.17 [0.76-1.81],0.48075995419288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NENF,Neudesin,3659,142,1.11 [0.98-1.25],0.1145832834732666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEO1,Neogenin,3668,142,1.55 [0.89-2.70],0.1200770320833727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEXN,Nexilin,3685,143,0.91 [0.72-1.14],0.4010512446772848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFASC,Neurofascin,4281,174,4.22 [2.93-6.08],9.633326468178884e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFAT5,Nuclear factor of activated T-cells 5,3559,140,1.01 [0.84-1.23],0.8875890337158894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",4226,172,1.00 [0.87-1.15],0.9773763316243276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",4131,169,0.99 [0.80-1.22],0.8937795209248137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFE2,Transcription factor NF-E2 45 kDa subunit,3579,143,0.99 [0.80-1.24],0.9582028885677992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFIC,Nuclear factor 1 C-type,3668,142,1.14 [0.81-1.60],0.4516484202567778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,3553,138,1.00 [0.80-1.27],0.9690028225354492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,3618,140,0.95 [0.68-1.32],0.7530622058698385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFKBIE,NF-kappa-B inhibitor epsilon,4103,164,1.15 [0.87-1.52],0.3324568394223136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",3652,139,0.97 [0.83-1.14],0.7500511649397736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFX1,Transcriptional repressor NF-X1,3553,138,1.03 [0.83-1.29],0.7792305079613029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFYA,Nuclear transcription factor Y subunit alpha,3553,138,1.34 [0.96-1.86],0.0837351071376477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGF,Beta-nerve growth factor,4194,169,4.74 [1.94-11.60],0.0006584798475162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGFR,Tumor necrosis factor receptor superfamily member 16,3670,144,1.65 [1.22-2.22],0.0012221893469139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGRN,Neugrin,3657,142,1.77 [0.88-3.52],0.1067590528258416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NHLRC3,NHL repeat-containing protein 3,3519,135,2.42 [1.43-4.10],0.0009686371153438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NID1,Nidogen-1,4240,170,1.60 [1.13-2.26],0.008571156895762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NID2,Nidogen-2,4246,172,1.08 [0.90-1.29],0.4033032565039312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NINJ1,Ninjurin-1,4103,164,1.27 [1.04-1.55],0.017192484427599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NIT1,Deaminated glutathione amidase,3579,143,0.82 [0.57-1.18],0.2818573834728216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NIT2,Omega-amidase NIT2,3650,144,0.94 [0.75-1.18],0.592171687508531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NLGN1,Neuroligin-1,3584,138,0.99 [0.77-1.27],0.9065089137605848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NLGN2,Neuroligin-2,3549,140,0.86 [0.57-1.29],0.4674781675819311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NME1,Nucleoside diphosphate kinase A,3559,140,0.69 [0.31-1.53],0.3657383789402578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NME3,Nucleoside diphosphate kinase 3,4235,170,1.26 [0.72-2.18],0.4167992882912043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMI,N-myc-interactor,3644,142,0.96 [0.76-1.21],0.7156866055289925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,4194,169,1.02 [0.87-1.21],0.7830041885834871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMRK2,Nicotinamide riboside kinase 2,3536,140,1.02 [0.67-1.55],0.9294339676714588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,3668,142,0.80 [0.60-1.07],0.1297647619274648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOMO1,Nodal modulator 1,4246,172,2.12 [1.29-3.49],0.0029947146693209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOP56,Nucleolar protein 56,3553,138,1.07 [0.93-1.23],0.3685278420679616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS1,"Nitric oxide synthase, brain",4101,164,1.73 [1.42-2.11],6.004792069725396e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS2,"Nitric oxide synthase, inducible",3553,138,0.91 [0.59-1.41],0.6764138621879123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS3,"Nitric oxide synthase, endothelial",4101,164,1.36 [1.10-1.69],0.0043080920726216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH1,Neurogenic locus notch homolog protein 1,4283,174,10.07 [4.74-21.40],1.958024682602244e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH2,Neurogenic locus notch homolog protein 2,3683,141,3.52 [1.98-6.28],1.98637070516078e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH3,Neurogenic locus notch homolog protein 3,4283,174,1.77 [1.25-2.51],0.0013111219251416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPC2,NPC intracellular cholesterol transporter 2,3632,140,4.43 [3.01-6.51],3.4353065858947123e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPDC1,Neural proliferation differentiation and control protein 1,4233,173,2.95 [2.30-3.78],1.822225484142692e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPHS1,Nephrin,3559,140,0.90 [0.56-1.46],0.6742853256710057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPHS2,Podocin,3559,140,0.96 [0.82-1.14],0.6583486217745277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPL,N-acetylneuraminate lyase,3670,144,1.21 [0.88-1.65],0.2434612315800885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPPB,Natriuretic peptides B,4152,167,1.27 [1.16-1.39],3.8534490510066673e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPPC,C-type natriuretic peptide,4226,172,1.21 [0.98-1.49],0.0794243704030948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPR1,Atrial natriuretic peptide receptor 1,3553,138,0.86 [0.54-1.36],0.5250596524048914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTN,Neuroplastin,4103,164,1.11 [0.95-1.31],0.1972017876478359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTX1,Neuronal pentraxin-1,4246,172,1.08 [0.80-1.47],0.6107798694856277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTX2,Neuronal pentraxin-2,3683,141,1.63 [1.04-2.55],0.034029629599891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTXR,Neuronal pentraxin receptor,4233,173,1.01 [0.71-1.43],0.9676349932416743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPY,Pro-neuropeptide Y,4267,175,1.96 [1.58-2.44],9.98180354528999e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRCAM,Neuronal cell adhesion molecule,4233,173,2.16 [1.47-3.18],9.065962294355422e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRGN,Neurogranin,3685,143,0.94 [0.79-1.12],0.4688988742482965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRN1,Neuritin,3668,142,0.67 [0.38-1.18],0.1606702503250119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRP1,Neuropilin-1,4249,171,3.16 [2.02-4.94],4.886589703598548e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRP2,Neuropilin-2,4246,172,1.72 [1.11-2.67],0.0147962854900411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRTN,Neurturin,4131,169,1.00 [0.76-1.31],0.9819520209623196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRXN3,Neurexin-3,3584,138,0.86 [0.52-1.44],0.5715843495706129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NSFL1C,NSFL1 cofactor p47,4264,173,0.97 [0.79-1.19],0.7680712447859982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",3670,144,1.03 [0.82-1.29],0.7834610890182796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,3657,142,2.03 [1.49-2.78],7.488956251758484e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,4221,172,0.91 [0.78-1.06],0.2403636564301694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5E,5'-nucleotidase,4238,174,1.12 [0.88-1.42],0.3474822942863561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTF3,Neurotrophin-3,4226,172,1.56 [1.16-2.10],0.0030030990258055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTF4,Neurotrophin-4,4103,164,1.11 [0.77-1.58],0.578864262325261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTRK2,BDNF/NT-3 growth factors receptor,4233,173,1.50 [0.91-2.45],0.1099006633309862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTRK3,NT-3 growth factor receptor,4264,173,1.40 [0.78-2.52],0.2536729530789414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,4233,173,1.33 [1.22-1.46],7.236428363498021e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUB1,NEDD8 ultimate buster 1,4226,172,0.98 [0.83-1.16],0.8559862154765998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,3659,142,0.97 [0.82-1.16],0.762184622079332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUCB2,Nucleobindin-2,4262,175,2.21 [1.59-3.06],2.176050762112181e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDC,Nuclear migration protein nudC,4281,174,1.01 [0.81-1.25],0.9436581776381308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,3579,143,0.84 [0.41-1.72],0.6337978287332241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,3553,138,0.84 [0.59-1.21],0.3548512897219176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT16,U8 snoRNA-decapping enzyme,3646,138,1.04 [0.86-1.26],0.7124230415641417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],4212,172,0.87 [0.68-1.12],0.2894387057241358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT5,ADP-sugar pyrophosphatase,4246,172,1.14 [0.87-1.49],0.3493239889541616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUMB,Protein numb homolog,3559,140,0.97 [0.79-1.18],0.7569873291018483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUP50,Nuclear pore complex protein Nup50,3553,138,1.51 [1.10-2.07],0.0101903847508377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPE4,NXPE family member 4,3553,138,1.08 [0.68-1.71],0.7497348838176745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPH1,Neurexophilin-1,4101,164,1.29 [0.92-1.81],0.1335952388092154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPH3,Neurexophilin-3,3559,140,1.73 [1.01-2.97],0.0454089192047913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OBP2B,Odorant-binding protein 2b,4183,169,1.28 [1.02-1.61],0.0309544473882331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OCLN,Occludin,3668,142,1.98 [1.47-2.69],9.398970813328966e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ODAM,Odontogenic ameloblast-associated protein,4095,164,1.15 [0.91-1.44],0.2378768099393085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OFD1,Oral-facial-digital syndrome 1 protein,3618,140,1.18 [0.95-1.45],0.1291421306675639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGA,Protein O-GlcNAcase,3652,139,1.09 [0.87-1.38],0.4577887641511471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGFR,Opioid growth factor receptor,4212,172,1.36 [0.90-2.06],0.1417946555236175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGN,Mimecan,4246,172,2.74 [2.16-3.49],1.7818599517419656e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,3618,140,0.73 [0.52-1.02],0.0636113228770786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OLFM4,Olfactomedin-4,3473,134,1.14 [1.00-1.30],0.0496834556596691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OLR1,Oxidized low-density lipoprotein receptor 1,4201,172,1.17 [0.95-1.44],0.135609599204337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OMD,Osteomodulin,4248,170,0.80 [0.61-1.06],0.1231679702823428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OMG,Oligodendrocyte-myelin glycoprotein,4212,172,0.83 [0.68-1.00],0.0496720810785376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OMP,Olfactory marker protein,3549,140,1.11 [0.81-1.54],0.5123067825781895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPHN1,Oligophrenin-1,3657,142,0.97 [0.84-1.13],0.6942193068674873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPLAH,5-oxoprolinase,3579,143,1.14 [0.90-1.44],0.2641311481715793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPTC,Opticin,4212,172,1.42 [1.11-1.81],0.0055026291230235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ORM1,Alpha-1-acid glycoprotein 1,3673,140,2.33 [1.11-4.90],0.0255342328806264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSBPL2,Oxysterol-binding protein-related protein 2,3657,142,1.07 [0.71-1.59],0.7530636503211704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,4235,170,2.75 [1.87-4.03],2.566521978440448e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSM,Oncostatin-M,4209,172,1.06 [0.88-1.27],0.5636513021472553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSMR,Oncostatin-M-specific receptor subunit beta,4249,171,1.64 [0.87-3.08],0.1261324747339932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSTN,Osteocrin,3584,138,0.96 [0.63-1.44],0.8312968661683104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OTOA,Otoancorin,3549,140,1.05 [0.80-1.38],0.7329710187976493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OTUD6B,Deubiquitinase OTUD6B,3652,139,0.97 [0.73-1.29],0.8417534656254682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OTUD7B,OTU domain-containing protein 7B,3668,142,1.09 [0.84-1.41],0.5246986323501645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",3579,143,0.83 [0.67-1.05],0.1191608530352322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OXT,Oxytocin-neurophysin 1,4264,173,1.04 [0.95-1.15],0.3951281653497885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,P4HB,Protein disulfide-isomerase,4202,173,1.59 [1.12-2.25],0.009318983024518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PACS2,Phosphofurin acidic cluster sorting protein 2,3553,138,0.93 [0.70-1.22],0.581039898143479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PADI2,Protein-arginine deiminase type-2,4131,169,1.18 [0.97-1.44],0.1044659413176041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PADI4,Protein-arginine deiminase type-4,4095,164,0.93 [0.77-1.11],0.4009312746396578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAEP,Glycodelin,4194,169,1.05 [0.93-1.19],0.4003126127687612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,3668,142,1.00 [0.86-1.15],0.9657152966210222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",3618,140,0.79 [0.56-1.13],0.2027394721243768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,4152,167,1.31 [1.03-1.65],0.0245845065627292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,3579,143,1.12 [0.78-1.61],0.5271146128040789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,3530,140,0.98 [0.72-1.32],0.877542307047668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAK4,Serine/threonine-protein kinase PAK 4,4101,164,0.98 [0.78-1.22],0.8398705007324277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALLD,Palladin,3559,140,1.03 [0.68-1.54],0.9000042804584333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM,Paralemmin-1,3634,138,2.68 [1.81-3.96],9.0736312268554e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM2,Paralemmin-2,3657,142,2.67 [1.97-3.61],1.9216134697477972e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM3,Paralemmin-3,3553,138,1.01 [0.80-1.27],0.9450144144433046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,4265,173,1.32 [0.83-2.11],0.2428452508642602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAMR1,Inactive serine protease PAMR1,4246,172,1.09 [0.68-1.77],0.7135703812199994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAPPA,Pappalysin-1,4131,169,0.80 [0.60-1.07],0.1372308125740518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PARD3,Partitioning defective 3 homolog,3618,140,1.01 [0.81-1.26],0.9252866006092264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PARK7,Parkinson disease protein 7,4246,172,1.00 [0.76-1.30],0.972321619542458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PARP1,Poly [ADP-ribose] polymerase 1,4226,172,1.05 [0.83-1.32],0.7003062228011901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAXX,Protein PAXX,3611,140,1.07 [0.76-1.53],0.6881270574130751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,3536,140,0.78 [0.46-1.32],0.360505770553875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBLD,Phenazine biosynthesis-like domain-containing protein,4101,164,0.73 [0.56-0.95],0.0173744027286991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,3652,139,1.59 [0.97-2.59],0.0647316364775002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCARE,Photoreceptor cilium actin regulator,3549,140,0.98 [0.80-1.19],0.810648962669758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,3604,139,0.93 [0.70-1.23],0.6236552636561379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCBP2,Poly(rC)-binding protein 2,3668,142,1.00 [0.80-1.26],0.9725165481445556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH1,Protocadherin-1,4261,174,2.86 [1.80-4.56],8.821809270985139e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH12,Protocadherin-12,3668,142,1.66 [0.93-2.95],0.0851954606586981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH17,Protocadherin-17,4233,173,1.71 [1.27-2.30],0.0004130759716271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH7,Protocadherin-7,3652,139,2.01 [1.48-2.72],6.714052959272786e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH9,Protocadherin-9,3652,139,1.32 [0.85-2.06],0.2216456421920941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDHB15,Protocadherin beta-15,3659,142,1.82 [1.34-2.48],0.0001230833960001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCNA,Proliferating cell nuclear antigen,3536,140,1.01 [0.79-1.29],0.9240041858659512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,3659,142,1.03 [0.76-1.40],0.8485659549384063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,4283,174,1.69 [1.21-2.34],0.0018124314579145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,3652,139,0.96 [0.76-1.20],0.6976054071679894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,3670,144,1.01 [0.85-1.20],0.9146471843548184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1,Programmed cell death protein 1,4262,174,1.82 [1.43-2.32],1.3001118530198665e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1LG2,Programmed cell death 1 ligand 2,4212,172,3.74 [2.74-5.11],1.2029375319575596e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD5,Programmed cell death protein 5,4264,173,1.19 [0.94-1.51],0.144315134968209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD6,Programmed cell death protein 6,4233,173,1.18 [0.94-1.46],0.1465630289433679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCL2,Phosducin-like protein 2,3536,140,0.63 [0.43-0.94],0.0223973872468289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",3536,140,0.93 [0.67-1.30],0.6857281896608037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",3553,138,0.97 [0.72-1.30],0.8156026911229022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",3611,140,0.95 [0.82-1.11],0.55421192828733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFA,Platelet-derived growth factor subunit A,4283,174,1.04 [0.87-1.25],0.6376161650584085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFB,Platelet-derived growth factor subunit B,4248,170,1.06 [0.91-1.24],0.4533444629396742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFC,Platelet-derived growth factor C,4103,164,1.20 [0.77-1.86],0.430190685167553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFRA,Platelet-derived growth factor receptor alpha,4233,173,3.19 [2.16-4.70],4.617338878191939e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFRB,Platelet-derived growth factor receptor beta,4283,174,1.22 [0.83-1.78],0.3131266809577256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA2,Protein disulfide-isomerase A2,3536,140,0.69 [0.43-1.11],0.1266951066533708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA3,Protein disulfide-isomerase A3,3611,140,1.63 [0.90-2.95],0.1097094242751562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA4,Protein disulfide-isomerase A4,3683,141,1.00 [0.77-1.31],0.988006400965148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA5,Protein disulfide-isomerase A5,3536,140,0.90 [0.68-1.19],0.4690748293985861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDLIM5,PDZ and LIM domain protein 5,3668,142,0.94 [0.82-1.08],0.3786421734399797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDLIM7,PDZ and LIM domain protein 7,4248,170,1.05 [0.94-1.16],0.4213099323419382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",4103,164,1.04 [0.79-1.36],0.7863644580357677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDRG1,p53 and DNA damage-regulated protein 1,3584,138,0.86 [0.61-1.21],0.3890070764823342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,3536,140,0.68 [0.44-1.05],0.0834685245405158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDZD2,PDZ domain-containing protein 2,3553,138,0.97 [0.73-1.27],0.8102899453048922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,3559,140,1.41 [1.08-1.84],0.0115616744028371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEAR1,Platelet endothelial aggregation receptor 1,4283,174,2.95 [1.66-5.25],0.0002394325471942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEBP1,Phosphatidylethanolamine-binding protein 1,4246,172,1.07 [0.84-1.35],0.6016631320799497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PECAM1,Platelet endothelial cell adhesion molecule,4246,172,1.19 [0.78-1.83],0.4193871679749151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,3579,143,0.81 [0.43-1.52],0.5037553169884474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PENK,Proenkephalin-A,3611,140,2.15 [1.45-3.20],0.000153666988685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEPD,Xaa-Pro dipeptidase,3685,143,0.66 [0.37-1.17],0.1560087221013615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PER3,Period circadian protein homolog 3,3559,140,0.94 [0.82-1.08],0.3709304635687069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PF4,Platelet factor 4,3660,142,1.06 [0.89-1.26],0.5118596234234728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFDN2,Prefoldin subunit 2,4101,164,1.31 [1.03-1.68],0.029382533944636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFDN4,Prefoldin subunit 4,3536,140,1.04 [0.76-1.42],0.792246136198381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFDN6,Prefoldin subunit 6,3584,138,1.02 [0.78-1.32],0.9068914715527886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",4208,172,0.95 [0.80-1.14],0.601019720031604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGA4,Pepsin A-4,3685,143,1.35 [1.13-1.62],0.0007985554250889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",3670,144,1.13 [0.85-1.52],0.4025626652843602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGF,Placenta growth factor,4281,174,4.57 [3.28-6.37],3.167588189796169e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP1,Peptidoglycan recognition protein 1,4266,174,1.75 [1.35-2.28],2.39579367481859e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,3640,139,1.08 [0.62-1.88],0.7869486587859634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP4,Peptidoglycan recognition protein 4,3553,138,1.14 [0.87-1.51],0.3377658203718022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGM2,Phosphoglucomutase-2,3584,138,0.79 [0.56-1.11],0.1690721922334619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGR,Progesterone receptor,3559,140,1.11 [0.96-1.28],0.1511013739591859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHACTR2,Phosphatase and actin regulator 2,3668,142,0.96 [0.83-1.10],0.5519446450533818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHLDB1,Pleckstrin homology-like domain family B member 1,3652,139,1.95 [1.46-2.59],4.633427014067515e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHLDB2,Pleckstrin homology-like domain family B member 2,3536,140,0.90 [0.74-1.09],0.284120683446823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,4194,169,3.15 [2.07-4.81],9.58649573196128e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,3611,140,0.94 [0.65-1.35],0.7338250104124759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI16,Peptidase inhibitor 16,3685,143,2.18 [1.16-4.10],0.0158292980430817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI3,Elafin,4179,171,1.63 [1.38-1.93],1.0665540403649342e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",3668,142,0.90 [0.73-1.12],0.3473833849800072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIGR,Polymeric immunoglobulin receptor,4190,170,2.52 [1.93-3.28],6.436336737052237e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,4226,172,0.85 [0.68-1.07],0.1608133656504735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,4246,172,5.10 [3.82-6.82],3.553914954664088e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,3559,140,1.02 [0.76-1.38],0.8938015718918926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,4246,172,2.93 [2.14-4.01],1.671632958961874e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,4233,173,2.05 [1.58-2.64],4.1667880453886815e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,3611,140,0.97 [0.77-1.23],0.8127324742413788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PITHD1,PITH domain-containing protein 1,3530,140,1.05 [0.88-1.25],0.5857801216357806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKD1,Polycystin-1,3670,144,4.46 [2.62-7.61],3.9770843186150186e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKD2,Polycystin-2,3553,138,1.16 [0.88-1.53],0.2819350433780774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKLR,Pyruvate kinase PKLR,4234,170,0.87 [0.70-1.07],0.1739919613753745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKN3,Serine/threonine-protein kinase N3,3618,140,0.99 [0.79-1.23],0.9168638458813958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G10,Group 10 secretory phospholipase A2,4194,169,1.50 [1.19-1.89],0.0005349187553795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G15,Phospholipase A2 group XV,4238,174,2.01 [1.29-3.12],0.0019138622932641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G1B,Phospholipase A2,4278,174,0.98 [0.76-1.27],0.8742289995406747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G2A,"Phospholipase A2, membrane associated",4220,171,1.17 [0.95-1.44],0.1413296955794637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G4A,Cytosolic phospholipase A2,4248,170,1.00 [0.86-1.17],0.9738925472170836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G7,Platelet-activating factor acetylhydrolase,4246,172,0.46 [0.33-0.65],8.64773694894892e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAT,Tissue-type plasminogen activator,4273,174,0.91 [0.71-1.16],0.4437159694550422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAU,Urokinase-type plasminogen activator,4246,172,0.98 [0.64-1.51],0.9235586394486393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAUR,Urokinase plasminogen activator surface receptor,4207,170,4.96 [3.41-7.20],3.906234995989406e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLB1,"Phospholipase B1, membrane-associated",3657,142,0.55 [0.42-0.72],1.3440650066545978e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",3559,140,1.00 [0.67-1.50],0.9828834424778358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",3657,142,0.97 [0.82-1.14],0.6912170113261789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,3657,142,1.03 [0.82-1.29],0.8128820530277683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLG,Plasminogen,3587,138,2.53 [1.25-5.09],0.0096015008490742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLIN1,Perilipin-1,4101,164,1.36 [0.98-1.89],0.0696390119547982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLIN3,Perilipin-3,4233,173,1.24 [0.92-1.68],0.1594005809696131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLPBP,Pyridoxal phosphate homeostasis protein,4233,173,0.91 [0.74-1.11],0.3488347457711036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLSCR3,Phospholipid scramblase 3,3649,141,1.24 [0.93-1.66],0.1457804160092616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLTP,Phospholipid transfer protein,4267,173,0.86 [0.61-1.19],0.3583798436702804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXDC1,Plexin domain-containing protein 1,4103,164,1.34 [0.92-1.95],0.1253951631440072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXDC2,Plexin domain-containing protein 2,3657,142,1.71 [1.07-2.74],0.025241841043901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNA4,Plexin-A4,4226,172,1.02 [0.87-1.21],0.7830302778606544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB2,Plexin-B2,4262,172,5.46 [3.79-7.86],6.9922157458614e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB3,Plexin-B3,4218,172,0.98 [0.73-1.31],0.8835101985605307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,4221,173,0.99 [0.93-1.06],0.8488635893722011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMCH,Pro-MCH,3553,138,1.17 [0.99-1.39],0.0699633603986323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMM2,Phosphomannomutase 2,3553,138,0.94 [0.71-1.26],0.6953220244470364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMS1,PMS1 protein homolog 1,3584,138,1.13 [0.83-1.52],0.4406123705718354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMVK,Phosphomevalonate kinase,4097,164,0.97 [0.86-1.10],0.651387253931405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNLIP,Pancreatic triacylglycerol lipase,3685,143,0.91 [0.74-1.12],0.3872441669507006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,3657,142,1.06 [0.89-1.26],0.5298613625688413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNLIPRP2,Pancreatic lipase-related protein 2,4226,170,1.02 [0.97-1.07],0.4491530607780526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNMA1,Paraneoplastic antigen Ma1,3579,143,0.90 [0.67-1.19],0.4531037558421487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNMA2,Paraneoplastic antigen Ma2,3549,140,0.99 [0.69-1.43],0.976503381542606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",4131,169,1.02 [0.91-1.15],0.7098293256909891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PODXL,Podocalyxin,4212,172,1.27 [0.54-2.98],0.581936960329502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PODXL2,Podocalyxin-like protein 2,4238,174,2.47 [1.64-3.73],1.6251713373806964e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POF1B,Protein POF1B,3559,140,1.79 [1.38-2.31],8.289632661777638e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,3559,140,0.90 [0.50-1.61],0.7117652911916152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",4212,172,1.67 [1.29-2.16],9.785557534598155e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POMC,Pro-opiomelanocortin,3579,143,0.96 [0.77-1.19],0.692025532240111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON1,Serum paraoxonase/arylesterase 1,3685,143,0.58 [0.35-0.96],0.0351046303675486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON2,Serum paraoxonase/arylesterase 2,4152,167,0.84 [0.58-1.22],0.3696939352623287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON3,Serum paraoxonase/lactonase 3,4248,170,0.62 [0.42-0.89],0.0108633249931878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POSTN,Periostin,3683,141,1.23 [0.81-1.86],0.3280973348680852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPBP,Platelet basic protein,3654,141,1.13 [0.93-1.37],0.2267195743581559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,4264,173,0.88 [0.66-1.18],0.3889469848752517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,4235,172,1.02 [0.88-1.17],0.8191066413172019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,3618,140,1.19 [0.95-1.49],0.1280519961231682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",3683,141,0.80 [0.60-1.06],0.1179172039316463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPL,Periplakin,3559,140,1.35 [0.86-2.12],0.1914068994865782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPM1A,Protein phosphatase 1A,4103,164,0.84 [0.53-1.33],0.4546875718356239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPM1B,Protein phosphatase 1B,3559,140,0.90 [0.65-1.24],0.5078640624764386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPM1F,Protein phosphatase 1F,3670,144,0.96 [0.70-1.30],0.7857162391870787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPME1,Protein phosphatase methylesterase 1,4212,172,0.94 [0.75-1.17],0.5662615383657861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,3659,142,0.87 [0.71-1.07],0.1772734251155269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,4238,174,0.97 [0.85-1.12],0.7127095968457797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,3618,140,1.03 [0.83-1.29],0.7673953649823251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,3668,142,0.90 [0.73-1.11],0.3364124696020838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,3668,142,1.81 [1.35-2.41],5.946825556935255e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R2,Protein phosphatase inhibitor 2,4233,173,0.98 [0.83-1.17],0.8369347336821289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R9B,Neurabin-2,4281,174,1.05 [0.92-1.21],0.4570125747001798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,3652,139,0.96 [0.84-1.10],0.571909540162443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP3R1,Calcineurin subunit B type 1,4194,169,1.42 [1.03-1.95],0.0324085295902809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPT1,Palmitoyl-protein thioesterase 1,3584,138,1.11 [0.91-1.34],0.3050465330240131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPY,Pancreatic prohormone,4221,173,1.20 [1.06-1.35],0.0028806196447808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PQBP1,Polyglutamine-binding protein 1,4103,164,1.08 [0.86-1.36],0.5199750828786853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAME,Melanoma antigen preferentially expressed in tumors,3536,140,0.79 [0.41-1.51],0.4698425792533798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAP1,Proline-rich acidic protein 1,3683,141,4.98 [3.22-7.72],6.116051208307159e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRC1,Protein regulator of cytokinesis 1,3659,142,0.77 [0.50-1.20],0.2547570718561062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRCP,Lysosomal Pro-X carboxypeptidase,4261,174,2.02 [1.44-2.84],5.198636119195455e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX1,Peroxiredoxin-1,4096,165,0.96 [0.82-1.12],0.6269638947655358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX2,Peroxiredoxin-2,3622,142,0.89 [0.68-1.15],0.3675728942058492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",4131,169,1.19 [0.99-1.43],0.0642400885243037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX5,"Peroxiredoxin-5, mitochondrial",4281,174,0.91 [0.74-1.12],0.3766016698115098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX6,Peroxiredoxin-6,4267,175,0.96 [0.77-1.19],0.6892024323149987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PREB,Prolactin regulatory element-binding protein,4131,169,2.09 [1.50-2.92],1.4858812249201146e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRELP,Prolargin,4226,170,4.89 [3.14-7.61],2.1427116692716293e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRG2,Bone marrow proteoglycan,3683,141,1.87 [1.42-2.46],9.116927510829934e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRG3,Proteoglycan 3,3683,141,1.34 [0.98-1.83],0.0714106658155529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,4131,169,1.24 [0.98-1.57],0.0750368753483383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,3584,138,0.90 [0.54-1.48],0.666159662763909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,4233,173,0.93 [0.79-1.09],0.3687804481227903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,3653,142,1.05 [0.85-1.31],0.6387178323974925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKCQ,Protein kinase C theta type,4131,169,1.09 [0.81-1.48],0.5711375129858578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKD2,Serine/threonine-protein kinase D2,3553,138,1.08 [0.73-1.60],0.706589844796676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKG1,cGMP-dependent protein kinase 1,3611,140,0.90 [0.79-1.03],0.1165449395713466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,4103,164,1.12 [0.91-1.37],0.2756850025103809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRL,Prolactin,4264,173,1.25 [1.08-1.46],0.0036395999555678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRND,Prion-like protein doppel,3657,142,1.34 [1.01-1.77],0.0412461193421045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROC,Vitamin K-dependent protein C,4245,171,0.87 [0.52-1.45],0.5869435872613066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROCR,Endothelial protein C receptor,3553,138,1.18 [0.72-1.91],0.5122388981642354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROK1,Prokineticin-1,4226,172,1.05 [0.83-1.32],0.7084269980997002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROS1,Vitamin K-dependent protein S,3684,142,0.68 [0.38-1.23],0.2066100131595696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRR4,Proline-rich protein 4,3579,139,1.20 [0.97-1.49],0.0982446740820304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRR5,Proline-rich protein 5,3559,140,0.88 [0.62-1.25],0.4607898058718697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRRT3,Proline-rich transmembrane protein 3,3579,143,1.94 [1.41-2.67],5.053663879358992e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS2,Trypsin-2,4246,171,1.28 [1.06-1.53],0.0087747734283898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS22,Brain-specific serine protease 4,3559,140,1.73 [1.25-2.39],0.0009234016287971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS27,Serine protease 27,4224,173,2.08 [1.52-2.86],5.8132008165478585e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS53,Serine protease 53,3657,142,0.71 [0.47-1.06],0.0972140826066847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS8,Prostasin,4216,169,3.19 [2.39-4.25],2.468634283977944e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,4101,164,0.95 [0.84-1.07],0.4002270130500498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTG,Protogenin,4267,175,3.14 [1.94-5.09],3.2230792806929466e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTN3,Myeloblastin,4132,170,1.28 [1.00-1.63],0.0518241011463582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRUNE2,Protein prune homolog 2,3618,140,0.67 [0.37-1.20],0.1788670905743245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSAP,Prosaposin,3658,141,4.71 [2.84-7.81],1.962510927032447e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSAPL1,Proactivator polypeptide-like 1,3652,139,1.16 [0.86-1.56],0.334622972823693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSCA,Prostate stem cell antigen,3652,139,1.06 [0.99-1.13],0.0890877236192375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,4194,169,1.47 [1.29-1.68],1.0942552683164946e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSIP1,PC4 and SFRS1-interacting protein,4226,172,0.99 [0.80-1.22],0.919536372540746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMA1,Proteasome subunit alpha type-1,4103,164,1.11 [0.82-1.49],0.5088521446379293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMC3,26S proteasome regulatory subunit 6A,3536,140,0.68 [0.40-1.17],0.1656704802059637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,3668,142,1.12 [0.83-1.52],0.4619780821651552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,3584,138,1.25 [0.97-1.61],0.0905179538671539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,4212,172,0.86 [0.68-1.09],0.219578901494072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSME1,Proteasome activator complex subunit 1,4191,169,1.09 [0.75-1.58],0.6509362665220022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSME2,Proteasome activator complex subunit 2,4168,163,1.14 [0.77-1.67],0.520259166150346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMG3,Proteasome assembly chaperone 3,4226,172,0.91 [0.70-1.19],0.5096862751568828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMG4,Proteasome assembly chaperone 4,3559,140,1.03 [0.78-1.36],0.844180702441335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSPN,Persephin,4226,172,1.05 [0.92-1.21],0.4466966130117402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSRC1,Proline/serine-rich coiled-coil protein 1,4103,164,1.18 [0.95-1.45],0.1341360049794984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,3499,134,0.92 [0.79-1.08],0.3037525966191217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",4101,164,1.05 [0.67-1.64],0.8385941750415866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGDS,Prostaglandin-H2 D-isomerase,4203,170,3.04 [2.35-3.94],4.482546159856148e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGES2,Prostaglandin E synthase 2,3534,139,0.90 [0.66-1.23],0.5191743101122739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGR1,Prostaglandin reductase 1,3670,144,0.88 [0.74-1.04],0.129378494112425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTH,Parathyroid hormone,3584,138,1.05 [0.88-1.27],0.5657865087828211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,4226,172,1.51 [1.19-1.90],0.000557956497623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTK7,Inactive tyrosine-protein kinase 7,4101,164,2.37 [1.70-3.31],3.539219995268723e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTN,Pleiotrophin,4152,167,1.24 [0.96-1.61],0.1055085481433319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,3559,140,1.21 [0.89-1.64],0.2148668062505768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,4194,169,1.08 [0.91-1.28],0.3974505318890221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,4242,170,0.99 [0.85-1.15],0.8687523312057781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,3556,140,1.39 [0.99-1.96],0.0592198632385617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,3670,144,1.28 [0.77-2.12],0.3471159816954903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,3683,141,2.89 [1.48-5.63],0.0018238206365205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,4283,174,2.05 [1.33-3.17],0.0011390661034596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,3652,139,1.64 [1.26-2.13],0.0002250238584982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,3652,139,1.75 [0.97-3.17],0.0638458319126351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,4217,171,1.26 [0.75-2.13],0.3792832506882297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,4180,168,2.57 [1.94-3.40],3.6076415626391106e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,3657,142,1.30 [0.89-1.92],0.1761305827933261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,4283,174,1.74 [1.07-2.84],0.0253768212651726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,3670,144,1.14 [0.69-1.86],0.6126105333879217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,3611,140,0.83 [0.62-1.10],0.1897896107302693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,4083,162,0.95 [0.77-1.17],0.6278655275510591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTTG1,Securin,3618,140,0.65 [0.42-1.01],0.0537865485201582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTX3,Pentraxin-related protein PTX3,4226,172,1.85 [1.33-2.57],0.0002859923955153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PVALB,Parvalbumin alpha,4248,175,1.11 [0.98-1.25],0.1060704703913638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PVR,Poliovirus receptor,4264,173,2.02 [1.52-2.68],1.257937902199545e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PXDNL,Peroxidasin-like protein,3659,142,1.19 [0.93-1.51],0.1689789240736584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PXN,Paxillin,4101,164,1.31 [1.03-1.66],0.0267417318559477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PYDC1,Pyrin domain-containing protein 1,3579,143,1.06 [0.72-1.56],0.7790580985471797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PYY,Peptide YY,3553,138,1.38 [1.21-1.57],1.1841588314090384e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PZP,Pregnancy zone protein,3684,142,0.81 [0.56-1.15],0.2350705689900116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QDPR,Dihydropteridine reductase,4217,173,0.85 [0.61-1.18],0.3284469975438708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QPCT,Glutaminyl-peptide cyclotransferase,4242,174,4.36 [2.75-6.91],3.5902849449360377e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QSOX1,Sulfhydryl oxidase 1,3603,138,1.49 [1.09-2.02],0.0112251727511962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB10,Ras-related protein Rab-10,3670,144,0.85 [0.62-1.15],0.2900710761451939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB11FIP3,Rab11 family-interacting protein 3,3670,144,0.99 [0.86-1.15],0.9388544058325684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB27B,Ras-related protein Rab-27B,3670,144,0.96 [0.79-1.17],0.6778605385068379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB2B,Ras-related protein Rab-2B,3659,142,0.87 [0.66-1.14],0.3105112768023206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB33A,Ras-related protein Rab-33A,3553,138,0.81 [0.63-1.05],0.1096869298086858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB37,Ras-related protein Rab-37,4131,169,1.03 [0.87-1.21],0.7529770709781941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB39B,Ras-related protein Rab-39B,3553,138,0.94 [0.77-1.13],0.5073634122417906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,3549,140,1.16 [0.89-1.50],0.266538331723228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB44,Ras-related protein Rab-44,3659,142,1.01 [0.74-1.39],0.9320846888353034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB6A,Ras-related protein Rab-6A,4226,172,0.57 [0.43-0.74],3.675501410776628e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB6B,Ras-related protein Rab-6B,4101,164,1.07 [0.81-1.42],0.6245035309004051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RABEP1,Rab GTPase-binding effector protein 1,3611,140,0.92 [0.74-1.14],0.4512926497744817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RABEPK,Rab9 effector protein with kelch motifs,4103,164,1.00 [0.78-1.27],0.9698955031050664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RABGAP1L,Rab GTPase-activating protein 1-like,4131,169,0.97 [0.77-1.22],0.8041811006698752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAC3,Ras-related C3 botulinum toxin substrate 3,3584,138,1.10 [0.87-1.39],0.4279849906859708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAD23B,UV excision repair protein RAD23 homolog B,4103,164,1.22 [0.92-1.61],0.16182154948881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAD51,DNA repair protein RAD51 homolog 1,3618,140,0.98 [0.69-1.40],0.9274439344755758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RALB,Ras-related protein Ral-B,3559,140,0.93 [0.53-1.62],0.798840391664847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RALY,RNA-binding protein Raly,3659,142,1.09 [0.79-1.49],0.6079085858109108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RANBP1,Ran-specific GTPase-activating protein,3579,143,0.90 [0.66-1.23],0.5287241857317574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RANBP2,E3 SUMO-protein ligase RanBP2,3549,140,0.87 [0.51-1.46],0.5966974912950701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RANGAP1,Ran GTPase-activating protein 1,4103,164,1.11 [0.85-1.45],0.4481533800072831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAP1A,Ras-related protein Rap-1A,3559,140,0.95 [0.74-1.23],0.7044173557341866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,3618,140,0.96 [0.70-1.31],0.7852103697448036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RARRES1,Retinoic acid receptor responder protein 1,4103,164,1.50 [1.04-2.16],0.0289816168507796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RARRES2,Retinoic acid receptor responder protein 2,4249,171,1.85 [1.47-2.32],1.05467823980182e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RASA1,Ras GTPase-activating protein 1,4101,164,1.04 [0.68-1.57],0.8696931893367414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,3536,140,0.73 [0.49-1.06],0.1009774302872544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RASSF2,Ras association domain-containing protein 2,4103,164,1.22 [1.02-1.47],0.0324769882730714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBFOX3,RNA binding protein fox-1 homolog 3,3668,142,2.26 [1.84-2.77],6.5626859542390625e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBKS,Ribokinase,4130,166,0.73 [0.58-0.93],0.0105730616439876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBM17,Splicing factor 45,3668,142,1.04 [0.84-1.29],0.7463660597541069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBM19,Probable RNA-binding protein 19,3553,138,1.25 [0.88-1.78],0.2071713863996462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBM25,RNA-binding protein 25,3536,140,0.88 [0.61-1.28],0.5062551431542291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP1,Retinol-binding protein 1,3584,138,1.11 [0.90-1.37],0.340295271259657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP2,Retinol-binding protein 2,4212,172,1.59 [1.37-1.84],1.6424889146023331e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP5,Retinol-binding protein 5,4212,172,1.33 [1.09-1.62],0.0048997546883763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP7,Retinoid-binding protein 7,3652,139,1.44 [1.18-1.76],0.0004268837801901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBPMS,RNA-binding protein with multiple splicing,3559,140,0.91 [0.68-1.23],0.5448913884422936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBPMS2,RNA-binding protein with multiple splicing 2,3579,143,1.01 [0.86-1.18],0.9417778536059672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RCC1,Regulator of chromosome condensation,3659,142,1.13 [0.85-1.51],0.4062844254742705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RCOR1,REST corepressor 1,4152,167,1.05 [0.78-1.42],0.751546255240028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,3579,143,2.13 [1.01-4.53],0.0481974777818886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REEP4,Receptor expression-enhancing protein 4,3668,142,1.07 [0.84-1.37],0.5881518343221948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1A,Lithostathine-1-alpha,4210,170,2.36 [1.97-2.84],4.187577307287875e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1B,Lithostathine-1-beta,4283,174,1.76 [1.47-2.11],7.87133452850422e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG3A,Regenerating islet-derived protein 3-alpha,4283,174,1.69 [1.42-2.01],3.3546479711283443e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG3G,Regenerating islet-derived protein 3-gamma,3659,142,0.91 [0.61-1.37],0.6675138621094605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG4,Regenerating islet-derived protein 4,4235,170,2.78 [2.27-3.40],3.135641717648654e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELB,Transcription factor RelB,3559,140,1.09 [0.79-1.53],0.5921501516846825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELT,Tumor necrosis factor receptor superfamily member 19L,4246,172,3.59 [2.54-5.08],5.793111189654367e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REN,Renin,4233,173,1.76 [1.57-1.98],1.2576486599258472e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REPS1,RalBP1-associated Eps domain-containing protein 1,3559,140,0.77 [0.48-1.23],0.2784837142451576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REST,RE1-silencing transcription factor,3536,140,0.93 [0.58-1.47],0.7498497898358547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,4212,172,1.10 [0.79-1.54],0.5629202735730989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RETN,Resistin,4231,173,1.81 [1.41-2.34],4.867069661045807e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REXO2,"Oligoribonuclease, mitochondrial",3553,138,1.03 [0.72-1.48],0.8739407966621464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RFC4,Replication factor C subunit 4,3659,142,0.98 [0.48-2.00],0.9473469571104116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGCC,Regulator of cell cycle RGCC,3668,142,0.90 [0.73-1.11],0.3361188313465907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,3618,140,1.00 [0.77-1.30],0.9875882250771348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGMA,Repulsive guidance molecule A,4264,173,1.61 [1.08-2.38],0.0186712045096835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGMB,RGM domain family member B,4264,173,2.85 [1.91-4.24],2.585353961027708e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGS10,Regulator of G-protein signaling 10,3668,142,0.91 [0.69-1.20],0.4977206363433087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGS8,Regulator of G-protein signaling 8,4131,169,1.12 [0.93-1.35],0.2496613011493789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RHOC,Rho-related GTP-binding protein RhoC,4174,168,1.04 [0.92-1.17],0.5434624182019471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RICTOR,Rapamycin-insensitive companion of mTOR,3559,140,0.72 [0.47-1.11],0.1356650203475495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,3611,140,1.29 [0.99-1.68],0.0601058664511434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RILP,Rab-interacting lysosomal protein,4255,175,0.91 [0.73-1.14],0.4024760750110046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RILPL2,RILP-like protein 2,3670,144,0.96 [0.81-1.13],0.6230029644533113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,3553,138,1.16 [0.94-1.43],0.1640893231117157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RLN1,Prorelaxin H1,3668,142,1.14 [0.87-1.49],0.3512814608445878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RLN2,Prorelaxin H2,3601,140,1.04 [0.83-1.29],0.7536745870328252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE1,Ribonuclease pancreatic,3685,143,4.48 [2.98-6.73],6.261471502218906e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE10,Inactive ribonuclease-like protein 10,3579,143,1.83 [1.43-2.34],1.3829673301119767e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE3,Eosinophil cationic protein,4217,173,1.00 [0.89-1.13],0.974135769568954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE4,Ribonuclease 4,3550,136,4.28 [2.80-6.55],2.230739795151694e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE6,Ribonuclease K6,3654,141,2.07 [1.63-2.62],1.7229441986520111e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASEH2A,Ribonuclease H2 subunit A,3668,142,0.92 [0.64-1.32],0.6587556311614025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASET2,Ribonuclease T2,4269,174,3.51 [2.75-4.47],5.9461398874331915e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF149,E3 ubiquitin-protein ligase RNF149,3579,143,4.13 [2.84-6.01],1.34004598499697e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF168,E3 ubiquitin-protein ligase RNF168,3559,140,0.77 [0.49-1.23],0.2820602584577485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF31,E3 ubiquitin-protein ligase RNF31,3559,140,1.01 [0.68-1.51],0.949277189322288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF4,E3 ubiquitin-protein ligase RNF4,3618,140,0.91 [0.69-1.20],0.5141916584859554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF41,E3 ubiquitin-protein ligase NRDP1,4103,164,1.01 [0.82-1.25],0.8970482837216704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF43,E3 ubiquitin-protein ligase RNF43,3618,140,1.07 [0.82-1.41],0.6141608875368936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF5,E3 ubiquitin-protein ligase RNF5,3579,143,0.81 [0.65-1.02],0.0680812298047274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROBO1,Roundabout homolog 1,4235,170,1.65 [1.06-2.58],0.0276779572058176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROBO2,Roundabout homolog 2,4264,173,1.49 [0.88-2.52],0.1408159968339573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROBO4,Roundabout homolog 4,3579,143,2.82 [1.16-6.85],0.0218798858018701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,4233,173,2.01 [1.39-2.92],0.0002349619200586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RP2,Protein XRP2,4212,172,1.07 [0.80-1.43],0.6642702369758753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPA2,Replication protein A 32 kDa subunit,3559,140,0.73 [0.41-1.28],0.2688228333056965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPE,Ribulose-phosphate 3-epimerase,3618,140,0.95 [0.75-1.20],0.6619146923015069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,3584,138,0.74 [0.48-1.13],0.1623422054995411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPL14,60S ribosomal protein L14,3579,143,0.91 [0.59-1.40],0.6691204741279793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPS10,40S ribosomal protein S10,3553,138,1.12 [0.75-1.67],0.5861822239248331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRAS,Ras-related protein R-Ras,3584,138,1.00 [0.88-1.13],0.9796432851177752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,4103,164,1.07 [0.83-1.39],0.5907550906684651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,4103,164,1.06 [0.86-1.30],0.5943134442168917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRP15,RRP15-like protein,3549,140,1.00 [0.83-1.20],0.9862286583871298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO1,R-spondin-1,4194,169,2.45 [1.68-3.58],3.5115790177411737e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO3,R-spondin-3,4267,175,3.01 [2.13-4.26],5.373538417455935e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTBDN,Retbindin,4212,172,1.95 [1.46-2.60],5.102202027341456e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTKN2,Rhotekin-2,3553,138,1.16 [0.88-1.52],0.2929169905107019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",3668,142,0.94 [0.78-1.12],0.4592911423093362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTN4R,Reticulon-4 receptor,4267,175,3.61 [2.58-5.06],8.28178833462527e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RUVBL1,RuvB-like 1,4103,164,1.10 [0.97-1.25],0.1193245377905069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RWDD1,RWD domain-containing protein 1,4264,173,1.00 [0.80-1.24],0.9945848120838924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RYR1,Ryanodine receptor 1,3553,138,1.15 [0.78-1.71],0.4826910318644266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A11,Protein S100-A11,4192,170,0.94 [0.71-1.26],0.6865291967748826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A12,Protein S100-A12,4170,170,1.04 [0.87-1.26],0.6460018538585743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A13,Protein S100-A13,3559,140,1.22 [0.79-1.87],0.3664792630090686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A14,Protein S100-A14,3668,142,0.60 [0.43-0.85],0.0040401514702517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A16,Protein S100-A16,4095,164,0.91 [0.72-1.14],0.4050405001876398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A3,Protein S100-A3,3659,142,1.23 [0.97-1.55],0.0900261844097078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A4,Protein S100-A4,4238,174,0.79 [0.63-0.99],0.0446718664296315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100G,Protein S100-G,3668,142,1.12 [0.82-1.51],0.478543693342919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100P,Protein S100-P,4152,167,1.43 [1.21-1.70],3.338261376109526e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAA4,Serum amyloid A-4 protein,3684,142,0.53 [0.23-1.22],0.1358963337048457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAFB2,Scaffold attachment factor B2,3668,142,0.95 [0.51-1.79],0.8783910576569749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAG,S-arrestin,3549,140,1.29 [0.96-1.72],0.0915604317794716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,4226,172,1.06 [0.88-1.28],0.5496034658068262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAP18,Histone deacetylase complex subunit SAP18,3618,140,1.05 [0.85-1.29],0.6767870331088157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SARG,Specifically androgen-regulated gene protein,3661,144,1.06 [0.92-1.22],0.4432087654316493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,3553,138,1.34 [0.94-1.91],0.105389954464545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAT1,Diamine acetyltransferase 1,3553,138,0.87 [0.59-1.27],0.4626392299453222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAT2,Thialysine N-epsilon-acetyltransferase,3618,140,0.96 [0.76-1.21],0.7335509336422246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SATB1,DNA-binding protein SATB1,3668,142,1.12 [0.65-1.93],0.6780148085449231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SBSN,Suprabasin,3675,141,1.22 [0.81-1.85],0.3431111533327019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCAMP3,Secretory carrier-associated membrane protein 3,4212,172,1.09 [0.93-1.28],0.2964484912520183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARA5,Scavenger receptor class A member 5,4264,173,4.81 [3.45-6.70],1.798338742011497e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB1,Scavenger receptor class B member 1,4101,164,1.34 [1.12-1.60],0.0016441846916456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB2,Lysosome membrane protein 2,4107,167,3.84 [3.01-4.91],3.0046822457996976e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF1,Scavenger receptor class F member 1,4283,174,1.79 [1.33-2.41],0.000111113400991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF2,Scavenger receptor class F member 2,4264,173,4.61 [3.46-6.15],1.8446932368010624e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG2,Secretogranin-2,4250,175,4.66 [3.39-6.40],2.539502127240861e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG3,Secretogranin-3,4235,170,1.81 [1.24-2.66],0.0023354940208692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB1A1,Uteroglobin,4235,170,1.92 [1.49-2.47],4.073639216339978e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB2A2,Mammaglobin-A,3553,138,0.74 [0.40-1.39],0.3518767073220963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB3A1,Secretoglobin family 3A member 1,3611,140,1.73 [0.94-3.19],0.0809249293375077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB3A2,Secretoglobin family 3A member 2,4242,170,1.16 [1.02-1.32],0.0233613117454755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGN,Secretagogin,4131,169,2.44 [1.93-3.08],9.035593187884205e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCIN,Adseverin,3549,140,0.84 [0.66-1.07],0.1597533161729961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCLY,Selenocysteine lyase,4255,175,0.87 [0.67-1.12],0.2676731453093063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN2A,Sodium channel protein type 2 subunit alpha,3549,140,1.18 [0.87-1.60],0.2958598820480277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN2B,Sodium channel subunit beta-2,3584,138,0.93 [0.51-1.70],0.8244796946789877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN3A,Sodium channel protein type 3 subunit alpha,3584,138,0.69 [0.41-1.16],0.1641512463999689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN3B,Sodium channel subunit beta-3,3549,140,1.03 [0.72-1.48],0.8617229782549811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN4B,Sodium channel subunit beta-4,3579,143,1.66 [1.23-2.23],0.0008295252144824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCP2,Non-specific lipid-transfer protein,4103,164,1.03 [0.85-1.24],0.7937601615630806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,3569,143,1.09 [0.79-1.50],0.6200927522401121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRG1,Scrapie-responsive protein 1,3670,144,2.36 [1.47-3.77],0.0003427765689258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRIB,Protein scribble homolog,3579,143,1.04 [0.87-1.24],0.6728708687047916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRN1,Secernin-1,4226,172,1.02 [0.80-1.31],0.8595003156764898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCT,Secretin,3584,138,1.37 [1.01-1.86],0.0463170462037825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDC1,Syndecan-1,4233,173,1.40 [1.05-1.86],0.0205909090176228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDC4,Syndecan-4,4233,173,0.66 [0.51-0.86],0.0022032949602603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDCCAG8,Serologically defined colon cancer antigen 8,3659,142,1.02 [0.88-1.17],0.8006414509196549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDHB,Succinate dehydrogenase,3652,139,0.98 [0.75-1.28],0.8900623909102099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDK2,Protein sidekick-2,3611,140,1.51 [1.06-2.14],0.0214048202058213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEC31A,Protein transport protein Sec31A,3579,143,0.90 [0.73-1.11],0.3233366008492801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEL1L,Protein sel-1 homolog 1,3579,143,1.92 [1.40-2.64],4.91857189678541e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELE,E-selectin,4283,174,1.39 [1.09-1.76],0.0069093670214949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELENOP,Selenoprotein P,3684,142,0.71 [0.36-1.39],0.3215937208822594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELL,L-selectin,3684,142,0.87 [0.43-1.74],0.6941550340771356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELP,P-selectin,4246,171,1.17 [0.93-1.48],0.1858191120644563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELPLG,P-selectin glycoprotein ligand 1,4226,172,1.12 [0.71-1.76],0.6319845559003712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA3F,Semaphorin-3F,4233,173,2.29 [1.46-3.59],0.0003139986022595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA3G,Semaphorin-3G,3611,140,1.24 [0.90-1.71],0.182409949417738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA4C,Semaphorin-4C,4212,172,1.38 [1.06-1.81],0.0182942938184564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA4D,Semaphorin-4D,4264,173,1.12 [0.71-1.77],0.6273998987161018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA6C,Semaphorin-6C,3559,140,1.14 [0.64-2.02],0.6510193243957731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA7A,Semaphorin-7A,4273,174,2.47 [1.74-3.51],4.630012357467557e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN3,Neuronal-specific septin-3,3668,142,0.91 [0.74-1.12],0.3705098528029211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN7,Septin-7,3618,140,1.24 [0.99-1.55],0.059718547363576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN8,Septin-8,3648,141,2.53 [1.86-3.44],2.626527380659795e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN9,Septin-9,4212,172,0.99 [0.63-1.57],0.9812163865883364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA1,Alpha-1-antitrypsin,3618,141,10.88 [1.63-72.66],0.0137262109864384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA11,Serpin A11,4283,174,1.38 [1.01-1.89],0.0464350079340791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA12,Serpin A12,4137,171,0.86 [0.76-0.99],0.035408049874136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA3,Alpha-1-antichymotrypsin,3670,142,2.99 [1.14-7.84],0.0256133475538767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA4,Kallistatin,3602,139,1.97 [1.02-3.83],0.0450572406740388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA5,Plasma serine protease inhibitor,3625,140,1.55 [0.94-2.54],0.0831993066536293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA6,Corticosteroid-binding globulin,3684,142,4.59 [1.85-11.38],0.0009860338642028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA7,Thyroxine-binding globulin,3684,142,1.17 [0.50-2.77],0.7176110765661201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA9,Serpin A9,4192,171,1.00 [0.83-1.20],0.9959331736237652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB1,Leukocyte elastase inhibitor,4235,172,1.01 [0.87-1.17],0.9347297520061072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB5,Serpin B5,4152,167,0.99 [0.75-1.31],0.9336119231972498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB6,Serpin B6,4251,173,1.15 [0.91-1.45],0.2325372921788105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB8,Serpin B8,4281,174,1.16 [0.97-1.40],0.1091015054142645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB9,Serpin B9,4194,169,1.25 [0.81-1.93],0.3074617577287354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINC1,Antithrombin-III,3674,141,3.95 [1.47-10.61],0.0064350745924637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPIND1,Heparin cofactor 2,3674,141,2.02 [1.16-3.50],0.0124718263217666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINE1,Plasminogen activator inhibitor 1,4283,174,1.04 [0.85-1.27],0.7030121583557412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINE2,Glia-derived nexin,3670,144,0.94 [0.73-1.20],0.6009755391248286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINF1,Pigment epithelium-derived factor,3621,140,3.73 [2.13-6.52],4.112557738467928e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINF2,Alpha-2-antiplasmin,3603,140,1.74 [0.56-5.35],0.3366335130401536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPING1,Plasma protease C1 inhibitor,3674,141,4.57 [2.03-10.28],0.000245650512544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINH1,Serpin H1,3618,140,1.03 [0.91-1.17],0.6501942007054798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINI1,Neuroserpin,3606,139,0.80 [0.47-1.38],0.4247188082762935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINI2,Serpin I2,3652,139,1.02 [0.78-1.35],0.8724240283508862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,4101,164,1.06 [0.86-1.30],0.6111214368558368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,4180,169,0.74 [0.47-1.18],0.2092533855804155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6,Seizure protein 6 homolog,3584,138,1.10 [0.67-1.80],0.7082697142774452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6L,Seizure 6-like protein,4238,174,2.73 [1.83-4.08],9.03593568634782e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6L2,Seizure 6-like protein 2,4212,172,2.25 [1.42-3.57],0.0005793357729846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SF3B4,Splicing factor 3B subunit 4,4212,172,1.03 [0.86-1.24],0.7571192084097935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFRP1,Secreted frizzled-related protein 1,4182,169,2.02 [1.59-2.58],1.1364336317040436e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFRP4,Secreted frizzled-related protein 4,3611,140,0.91 [0.62-1.33],0.6182440471879693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFTPA1,Pulmonary surfactant-associated protein A1,4103,164,1.26 [1.02-1.56],0.0333926960273478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFTPA2,Pulmonary surfactant-associated protein A2,4103,164,1.19 [0.93-1.54],0.1701152995803261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFTPD,Pulmonary surfactant-associated protein D,4233,173,1.20 [0.98-1.46],0.0715694175190558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SGSH,N-sulphoglucosamine sulphohydrolase,3616,143,1.35 [1.04-1.75],0.0237091936414325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH2B3,SH2B adapter protein 3,4103,164,1.03 [0.90-1.19],0.6652673630039614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH2D1A,SH2 domain-containing protein 1A,4226,172,1.08 [0.85-1.36],0.5367592007711777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,3549,140,0.98 [0.74-1.30],0.9103483746009776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3BP1,SH3 domain-binding protein 1,3652,139,0.88 [0.62-1.24],0.4637422733090166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3GL3,Endophilin-A3,3595,140,1.18 [0.97-1.43],0.0995732192264956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3GLB2,Endophilin-B2,3657,142,1.07 [0.85-1.36],0.5592227600883924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHBG,Sex hormone-binding globulin,3685,143,0.98 [0.74-1.31],0.907991453988289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHC1,SHC-transforming protein 1,3536,140,1.03 [0.89-1.19],0.710348651666812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHD,SH2 domain-containing adapter protein D,3543,138,1.13 [0.97-1.31],0.1214009096342046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHH,Sonic hedgehog protein,3559,140,0.95 [0.65-1.39],0.7839974050523145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHISA5,Protein shisa-5,3683,141,3.50 [2.51-4.88],1.5178290995470982e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",4242,170,0.93 [0.79-1.09],0.3475059536802036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHPK,Sedoheptulokinase,3618,140,0.87 [0.57-1.34],0.5355129985332514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIAE,Sialate O-acetylesterase,4234,174,1.41 [1.06-1.86],0.0181170359127144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC1,Sialoadhesin,4248,170,2.38 [1.79-3.16],2.3790850231209484e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,4226,172,2.60 [1.93-3.50],3.1494028767205723e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,4101,164,1.15 [0.99-1.34],0.0687734379394486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,4246,172,1.14 [1.01-1.30],0.0413343227104106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,4267,175,3.41 [2.40-4.85],7.344720139886067e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,4233,173,2.11 [1.35-3.32],0.0011409722314437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,3579,143,1.53 [1.12-2.09],0.0069313550143893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,4263,175,1.29 [0.83-1.99],0.2559594850057588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIL1,Nucleotide exchange factor SIL1,3579,143,1.47 [1.01-2.14],0.0432174935669811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,4235,171,1.36 [1.05-1.76],0.0180966482809932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRPB1,Signal-regulatory protein beta-1,4218,170,2.29 [1.78-2.96],2.1810877385359566e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,3559,140,1.12 [0.94-1.34],0.1886235963333427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,4212,172,1.03 [0.87-1.20],0.7583836244780406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",4101,164,1.06 [0.83-1.34],0.6384012704074561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,4131,169,1.46 [1.15-1.85],0.0019782046806046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SKAP1,Src kinase-associated phosphoprotein 1,4185,168,1.07 [0.88-1.29],0.4958715127351335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SKAP2,Src kinase-associated phosphoprotein 2,4248,170,0.98 [0.86-1.12],0.7925893294623259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SKIV2L,Helicase SKI2W,3553,138,1.01 [0.66-1.53],0.9778419352193236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLA2,Src-like-adapter 2,3668,142,0.98 [0.84-1.14],0.7836591267887982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF1,Signaling lymphocytic activation molecule,4131,169,1.58 [1.27-1.96],3.886682351477141e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF6,SLAM family member 6,4103,164,1.66 [1.22-2.26],0.0011134067578082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF7,SLAM family member 7,4226,172,1.50 [1.21-1.86],0.000253088721382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF8,SLAM family member 8,4103,164,1.57 [1.22-2.01],0.0004012001429765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC12A2,Solute carrier family 12 member 2,3553,138,1.46 [0.82-2.58],0.1951876993565633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC13A1,Solute carrier family 13 member 1,3659,142,1.09 [0.85-1.41],0.4920762915245475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC16A1,Monocarboxylate transporter 1,4101,164,1.21 [0.96-1.52],0.1077737227168818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC1A4,Neutral amino acid transporter A,3584,138,0.83 [0.56-1.21],0.3288842246372276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC27A4,Long-chain fatty acid transport protein 4,4101,164,1.04 [0.85-1.28],0.6979908272615185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC28A1,Sodium/nucleoside cotransporter 1,3536,140,1.07 [0.82-1.40],0.629020136486073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,3536,140,0.88 [0.59-1.30],0.5186290868359538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC39A14,Zinc transporter ZIP14,4101,164,1.76 [1.37-2.27],1.0804787830212457e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC39A5,Zinc transporter ZIP5,4226,172,1.49 [1.25-1.79],1.0339175394413432e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC44A4,Choline transporter-like protein 4,3584,138,1.03 [0.81-1.30],0.833165830611385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC4A1,Band 3 anion transport protein,3683,141,0.85 [0.60-1.21],0.373887169916544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC51B,Organic solute transporter subunit beta,3553,138,0.97 [0.77-1.23],0.7988528468429718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,3611,140,0.92 [0.75-1.12],0.4005253210872367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,3652,139,1.07 [0.80-1.43],0.6546388134286922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",3536,140,0.98 [0.73-1.31],0.8800994400998033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLIT2,Slit homolog 2 protein,4101,164,1.24 [0.97-1.57],0.0862869198677593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK1,SLIT and NTRK-like protein 1,3559,140,0.83 [0.51-1.36],0.4644115187659564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK2,SLIT and NTRK-like protein 2,4267,175,2.27 [1.65-3.14],5.662896695949668e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK6,SLIT and NTRK-like protein 6,4152,167,2.12 [1.51-2.97],1.4853765820473798e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLK,STE20-like serine/threonine-protein kinase,3618,140,1.00 [0.80-1.24],0.9902662062778428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLMAP,Sarcolemmal membrane-associated protein,3652,139,1.11 [0.92-1.34],0.2566314329694402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,3652,141,1.59 [1.10-2.30],0.0129463266480539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD1,Mothers against decapentaplegic homolog 1,4103,164,1.02 [0.87-1.20],0.7907856281979979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD2,Mothers against decapentaplegic homolog 2,3659,142,0.98 [0.78-1.23],0.8664190576222266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD3,Mothers against decapentaplegic homolog 3,3659,142,0.98 [0.71-1.33],0.8743846108477304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD5,Mothers against decapentaplegic homolog 5,4212,172,0.62 [0.32-1.21],0.1608110507970387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMARCA2,Probable global transcription activator SNF2L2,4101,164,1.05 [0.87-1.27],0.6066356191075537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMC3,Structural maintenance of chromosomes protein 3,3536,140,0.96 [0.69-1.33],0.7999616045998581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,3652,139,1.00 [0.77-1.29],0.9803322094720068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC1,SPARC-related modular calcium-binding protein 1,4267,175,3.04 [2.14-4.30],3.9033403272447356e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC2,SPARC-related modular calcium-binding protein 2,4248,170,2.61 [1.99-3.44],5.91165572250775e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPD1,Sphingomyelin phosphodiesterase,4243,172,1.38 [1.08-1.77],0.0108267754993853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPD3,Sphingomyelin phosphodiesterase 3,3559,140,1.09 [0.83-1.44],0.5440976222138303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,4240,170,0.99 [0.81-1.21],0.9232564090949372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,3659,142,0.77 [0.58-1.01],0.0554919859638548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMS,Spermine synthase,3549,140,0.88 [0.67-1.16],0.3757471450639251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMTN,Smoothelin,3650,142,1.16 [0.99-1.36],0.0721031832621034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAP23,Synaptosomal-associated protein 23,4233,173,0.95 [0.82-1.11],0.5073342948624159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAP25,Synaptosomal-associated protein 25,3549,140,0.91 [0.66-1.26],0.5741704711757394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAP29,Synaptosomal-associated protein 29,4238,174,1.01 [0.87-1.16],0.9396696653666384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAPIN,SNARE-associated protein Snapin,3668,142,0.88 [0.66-1.15],0.3441127812408527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCA,Alpha-synuclein,3611,140,0.96 [0.83-1.10],0.5300968076046035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCG,Gamma-synuclein,4194,169,1.95 [1.60-2.37],2.8353164768326555e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",3579,143,1.46 [0.95-2.25],0.0853667008308285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',3657,142,1.20 [0.92-1.57],0.1769515847472571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNU13,NHP2-like protein 1,3553,138,1.05 [0.80-1.37],0.7445194231243721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX15,Sorting nexin-15,3611,140,0.92 [0.69-1.24],0.6021600669200367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX18,Sorting nexin-18,3652,139,1.00 [0.68-1.48],0.9901836092229604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX2,Sorting nexin-2,3659,142,1.06 [0.88-1.27],0.5612761628906774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX5,Sorting nexin-5,3579,143,0.85 [0.49-1.50],0.5828536405933277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX9,Sorting nexin-9,4233,173,1.04 [0.86-1.27],0.6607756682958961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOD1,Superoxide dismutase [Cu-Zn],4147,164,1.01 [0.76-1.34],0.9647826133301378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",4246,172,0.73 [0.53-1.00],0.0502446554146958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOD3,Extracellular superoxide dismutase,3685,143,0.84 [0.62-1.13],0.2494900808601924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORBS1,Sorbin and SH3 domain-containing protein 1,3668,142,1.35 [1.03-1.78],0.0294425933602196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORCS2,VPS10 domain-containing receptor SorCS2,4103,164,2.70 [2.02-3.60],1.3578595795250804e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORD,Sorbitol dehydrogenase,4246,174,0.84 [0.70-1.00],0.0555286018572376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORT1,Sortilin,4233,173,1.39 [1.00-1.94],0.0515976223213003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOST,Sclerostin,4233,173,1.48 [1.07-2.06],0.0184586027803726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,3584,138,0.59 [0.38-0.93],0.0235144871956048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOX2,Transcription factor SOX-2,3662,141,1.01 [0.52-1.96],0.966494301474842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOX9,Transcription factor SOX-9,3584,138,1.73 [0.94-3.18],0.0775160333499331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,3668,142,1.57 [1.06-2.32],0.0240068965948968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPAG1,Sperm-associated antigen 1,3668,142,0.86 [0.63-1.17],0.3347368090548281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPARC,SPARC,4238,174,1.04 [0.86-1.26],0.6638841573811955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPARCL1,SPARC-like protein 1,4221,169,1.97 [1.24-3.14],0.0043114075736007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPART,Spartin,3611,140,0.98 [0.79-1.21],0.833259775820978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPESP1,Sperm equatorial segment protein 1,3670,144,1.94 [1.27-2.96],0.0021418675522636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK1,Serine protease inhibitor Kazal-type 1,4246,172,2.52 [2.07-3.06],1.7288279816147934e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK2,Serine protease inhibitor Kazal-type 2,3611,140,1.58 [1.07-2.32],0.0214205153187097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK4,Serine protease inhibitor Kazal-type 4,4226,172,2.39 [2.05-2.78],9.01228761947017e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK5,Serine protease inhibitor Kazal-type 5,4246,172,1.73 [1.20-2.49],0.0035458092009844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK6,Serine protease inhibitor Kazal-type 6,4267,175,1.13 [0.88-1.46],0.3355988919840256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK8,Serine protease inhibitor Kazal-type 8,3553,138,0.85 [0.51-1.42],0.5293200080581777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT1,Kunitz-type protease inhibitor 1,4235,172,2.20 [1.46-3.30],0.0001568534104939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT2,Kunitz-type protease inhibitor 2,4248,170,2.42 [1.80-3.24],3.966273115217784e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT3,Kunitz-type protease inhibitor 3,3652,139,0.99 [0.89-1.10],0.8599601482905423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPOCK1,Testican-1,4194,169,0.60 [0.37-0.97],0.0355232728080775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON1,Spondin-1,4235,170,3.15 [2.34-4.25],4.72752106106404e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON2,Spondin-2,4218,172,3.13 [2.26-4.32],4.856375615237986e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPP1,Osteopontin,4276,174,1.54 [1.19-2.00],0.0009150927780107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",3559,140,0.97 [0.65-1.44],0.8777328983546682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRING1,SREBP regulating gene protein,3536,140,1.13 [0.87-1.46],0.3625398391665161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRR1B,Cornifin-B,3618,140,1.00 [0.83-1.21],0.972032948568887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRR3,Small proline-rich protein 3,3657,142,1.37 [1.12-1.69],0.0027038011075577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRY2,Protein sprouty homolog 2,4131,169,0.95 [0.82-1.10],0.4970268128123088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",3549,140,1.13 [0.70-1.82],0.6215245045524914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPTLC1,Serine palmitoyltransferase 1,3657,142,0.81 [0.51-1.31],0.395426337030244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRC,Proto-oncogene tyrosine-protein kinase Src,4229,173,1.00 [0.89-1.12],0.991366840733144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRP14,Signal recognition particle 14 kDa protein,4212,172,1.13 [0.90-1.41],0.2983006976608875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRPK2,SRSF protein kinase 2,4226,172,1.01 [0.86-1.18],0.907256098975832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRPX,Sushi repeat-containing protein SRPX,3670,144,2.64 [1.78-3.92],1.3907591054751157e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSB,Lupus La protein,4101,164,1.01 [0.80-1.27],0.9519627352558095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",3559,140,0.74 [0.44-1.22],0.2355986585143079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,4233,173,0.88 [0.79-0.97],0.0124562192082873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4246,171,1.14 [0.84-1.56],0.4044846261220074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSH3,Protein phosphatase Slingshot homolog 3,3536,140,0.63 [0.34-1.18],0.1481498921912189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,3652,139,1.06 [0.78-1.44],0.7223465201230914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST13,Hsc70-interacting protein,3611,140,0.80 [0.60-1.08],0.1468067918648508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4212,172,1.79 [1.43-2.23],2.650412590280727e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",4283,174,2.54 [1.67-3.86],1.2600040619062082e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",3559,140,1.13 [0.85-1.52],0.4015127080845916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAB2,Stabilin-2,3683,141,1.66 [0.93-2.98],0.0878386376237242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAM,Signal transducing adapter molecule 1,3659,142,1.22 [0.80-1.85],0.3510326080968744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAMBP,STAM-binding protein,4185,168,1.06 [0.85-1.32],0.6085280477616681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAT2,Signal transducer and activator of transcription 2,3559,140,1.00 [0.81-1.23],0.9777756138341436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAT5B,Signal transducer and activator of transcription 5B,4212,172,0.98 [0.88-1.08],0.6312386511243717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,3536,140,1.13 [0.91-1.42],0.2730306456177153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC1,Stanniocalcin-1,4264,173,2.13 [1.66-2.73],2.909150726944069e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC2,Stanniocalcin-2,4237,169,2.88 [1.67-4.94],0.000129469606161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STEAP4,Metalloreductase STEAP4,3549,140,0.96 [0.76-1.22],0.7658914790719109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STIP1,Stress-induced-phosphoprotein 1,4239,172,0.94 [0.76-1.15],0.5330002918945224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STK11,Serine/threonine-protein kinase STK11,4152,167,1.02 [0.84-1.23],0.8394694389989685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STK24,Serine/threonine-protein kinase 24,4101,164,0.97 [0.77-1.22],0.8029419979558428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STK4,Serine/threonine-protein kinase 4,4233,173,0.87 [0.74-1.01],0.073490721393605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STOML2,"Stomatin-like protein 2, mitochondrial",3536,140,0.93 [0.78-1.12],0.450756738801702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX16,Syntaxin-16,4103,164,1.06 [0.84-1.35],0.6084951291090963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX1B,Syntaxin-1B,3584,138,1.30 [0.94-1.79],0.1145754684286988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX3,Syntaxin-3,3657,142,0.68 [0.40-1.14],0.1444541989251543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX4,Syntaxin-4,4212,172,1.17 [0.95-1.43],0.1332556801621756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX5,Syntaxin-5,3559,140,1.19 [0.89-1.60],0.2371371207321808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX6,Syntaxin-6,4103,164,1.09 [0.89-1.34],0.3933186779721012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX7,Syntaxin-7,3559,140,1.24 [0.88-1.73],0.21922310492734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX8,Syntaxin-8,4226,172,1.20 [0.92-1.58],0.1795770118627839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STXBP1,Syntaxin-binding protein 1,3668,142,0.88 [0.71-1.08],0.222789508605758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STXBP3,Syntaxin-binding protein 3,4103,164,0.95 [0.68-1.32],0.749343878492557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUGP1,SURP and G-patch domain-containing protein 1,3652,139,0.84 [0.55-1.27],0.3999386304547343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUGT1,Protein SGT1 homolog,4103,164,1.04 [0.87-1.24],0.6622639874364638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SULT1A1,Sulfotransferase 1A1,4264,173,0.95 [0.85-1.05],0.2898248281734978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SULT2A1,Bile salt sulfotransferase,4226,172,1.10 [0.92-1.31],0.2946464193161526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUMF1,Formylglycine-generating enzyme,3559,140,0.88 [0.66-1.18],0.4028319094349667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,4264,173,1.28 [0.97-1.68],0.0780486469704439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUOX,"Sulfite oxidase, mitochondrial",3668,142,1.05 [0.84-1.31],0.667517104691685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD1,Sushi domain-containing protein 1,4152,167,0.95 [0.71-1.26],0.7009433585521581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD2,Sushi domain-containing protein 2,4246,172,2.27 [1.48-3.49],0.0001681727004311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD4,Sushi domain-containing protein 4,3659,142,1.28 [0.93-1.75],0.1265937108835215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD5,Sushi domain-containing protein 5,3595,139,2.11 [1.37-3.25],0.0007304994479515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SV2A,Synaptic vesicle glycoprotein 2A,3584,138,1.01 [0.78-1.30],0.9397795588986628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SWAP70,Switch-associated protein 70,3652,139,1.04 [0.67-1.63],0.8581592555073163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYAP1,Synapse-associated protein 1,3611,140,0.89 [0.67-1.18],0.4238513893255421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,3549,140,0.75 [0.54-1.05],0.0975114328664655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYT1,Synaptotagmin-1,3657,142,1.21 [0.82-1.78],0.3372588538434056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYTL4,Synaptotagmin-like protein 4,3670,144,0.95 [0.76-1.18],0.6416058199822865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,3618,140,0.97 [0.83-1.14],0.7254424113652861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TACC3,Transforming acidic coiled-coil-containing protein 3,4212,172,1.00 [0.89-1.13],0.9727711287018038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TACSTD2,Tumor-associated calcium signal transducer 2,3746,154,3.52 [2.38-5.20],3.205326545435639e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TADA3,Transcriptional adapter 3,3659,142,1.04 [0.69-1.56],0.8627180093977835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAFA5,Chemokine-like protein TAFA-5,4212,172,2.96 [2.31-3.80],8.542245539478136e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAGLN3,Transgelin-3,3536,140,1.15 [0.91-1.45],0.2390072081367908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TALDO1,Transaldolase,3676,141,1.18 [0.82-1.69],0.3674049292941844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TANK,TRAF family member-associated NF-kappa-B activator,4131,169,1.09 [0.90-1.33],0.378866077894857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAP1,Antigen peptide transporter 1,3618,140,0.89 [0.66-1.20],0.4631847970627422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TARBP2,RISC-loading complex subunit TARBP2,4101,164,1.14 [0.96-1.37],0.1372480010835749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",3584,138,1.20 [0.99-1.45],0.0584165393560848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",3659,142,0.80 [0.51-1.26],0.3349041560369697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAX1BP1,Tax1-binding protein 1,3657,142,1.14 [0.89-1.46],0.288270908261933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBC1D17,TBC1 domain family member 17,4101,164,1.04 [0.77-1.40],0.7969554496877224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBC1D23,TBC1 domain family member 23,4212,172,0.99 [0.85-1.14],0.8522606753654218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBC1D5,TBC1 domain family member 5,4226,172,1.02 [0.86-1.21],0.7838491433931953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBCA,Tubulin-specific chaperone A,3611,140,0.95 [0.78-1.16],0.6482309014105854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBCB,Tubulin-folding cofactor B,4194,169,1.01 [0.88-1.16],0.8702230339448578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBCC,Tubulin-specific chaperone C,4194,169,1.05 [0.88-1.25],0.5892977747695565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,4103,164,1.04 [0.88-1.22],0.6640517507800161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBR1,T-box brain protein 1,3584,138,0.83 [0.57-1.20],0.3226261481049416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCL1A,T-cell leukemia/lymphoma protein 1A,4191,168,0.85 [0.75-0.97],0.0157528520945316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCL1B,T-cell leukemia/lymphoma protein 1B,4152,167,0.88 [0.72-1.08],0.2149077758455561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCN1,Transcobalamin-1,3594,139,0.98 [0.61-1.58],0.937732617492909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCN2,Transcobalamin-2,4276,174,2.39 [1.74-3.29],7.346693261078e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCOF1,Treacle protein,3670,144,1.81 [1.21-2.71],0.0039010998874236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCP11,T-complex protein 11 homolog,3618,140,0.80 [0.56-1.14],0.2133895045856451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCTN3,Tectonic-3,3670,144,1.44 [0.88-2.36],0.1430174375823331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDGF1,Teratocarcinoma-derived growth factor 1,4101,164,1.02 [0.93-1.12],0.6090825105945649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDO2,"Tryptophan 2,3-dioxygenase",3584,138,0.69 [0.43-1.11],0.1302140630908876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,3659,142,1.03 [0.83-1.28],0.7857270448531266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDRKH,Tudor and KH domain-containing protein,4101,164,1.05 [0.89-1.24],0.5808742258574111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEF,Thyrotroph embryonic factor,3553,138,0.94 [0.64-1.39],0.7667928642325428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEK,Angiopoietin-1 receptor,4238,174,2.38 [1.37-4.12],0.002026894226443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TERF1,Telomeric repeat-binding factor 1,3559,140,0.90 [0.51-1.59],0.714481892525865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TET2,Methylcytosine dioxygenase TET2,3609,140,0.98 [0.83-1.15],0.8164622244005881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEX101,Testis-expressed protein 101,3584,138,1.30 [0.99-1.71],0.0571334515710423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEX33,Testis-expressed protein 33,3618,140,0.86 [0.54-1.36],0.5135849999172072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TF,Serotransferrin,3684,142,3.69 [1.81-7.51],0.0003310424594271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFAP2A,Transcription factor AP-2-alpha,3549,140,0.81 [0.60-1.11],0.1946373289885041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF1,Trefoil factor 1,4226,172,1.65 [1.46-1.86],1.1269407595349361e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF2,Trefoil factor 2,4242,170,2.20 [1.87-2.60],2.6654033431612427e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF3,Trefoil factor 3,4207,169,2.14 [1.83-2.51],2.8544361515249506e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFPI,Tissue factor pathway inhibitor,4230,170,1.25 [0.87-1.81],0.2320073332975898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFPI2,Tissue factor pathway inhibitor 2,4230,174,1.52 [1.22-1.89],0.0001749272448676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFRC,Transferrin receptor protein 1,4244,170,1.36 [0.99-1.89],0.0612091244432509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TG,Thyroglobulin,3659,142,1.15 [1.00-1.31],0.0438174597316583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFA,Protransforming growth factor alpha,4226,172,1.84 [1.44-2.34],7.656930695397495e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFB1,Transforming growth factor beta-1 proprotein,4273,174,1.88 [1.42-2.50],1.1112684182502218e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFB2,Transforming growth factor beta-2 proprotein,3659,142,1.06 [0.78-1.43],0.7117368710361788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,4213,170,0.63 [0.39-1.00],0.0512843237466832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR1,TGF-beta receptor type-1,3559,140,1.89 [0.97-3.68],0.0611362784932434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR2,TGF-beta receptor type-2,4238,174,2.96 [2.39-3.66],2.4556269568291625e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR3,Transforming growth factor beta receptor type 3,4283,174,2.62 [1.81-3.79],3.241958035260943e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,4222,172,0.93 [0.78-1.11],0.43725664701076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGOLN2,Trans-Golgi network integral membrane protein 2,3685,143,3.69 [2.32-5.86],3.470860611959762e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,3530,140,0.92 [0.75-1.12],0.3862929828838221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBD,Thrombomodulin,4233,173,2.44 [1.74-3.42],1.987954007613233e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBS2,Thrombospondin-2,4246,172,1.69 [1.35-2.12],5.951457815815437e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBS4,Thrombospondin-4,4240,170,1.22 [0.93-1.60],0.1502362387198173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THOP1,Thimet oligopeptidase,4220,173,0.53 [0.36-0.77],0.0008905823321292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THPO,Thrombopoietin,4152,167,1.08 [0.78-1.51],0.6440474119894503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THRAP3,Thyroid hormone receptor-associated protein 3,3553,138,1.04 [0.89-1.20],0.638080392979615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THSD1,Thrombospondin type-1 domain-containing protein 1,3534,138,0.81 [0.50-1.34],0.4140740551576179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THTPA,Thiamine-triphosphatase,3652,142,0.98 [0.81-1.18],0.7956373617464423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THY1,Thy-1 membrane glycoprotein,4264,173,3.59 [2.48-5.21],1.3355550853081792e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIA1,Nucleolysin TIA-1 isoform p40,4104,164,1.02 [0.91-1.14],0.7646400464005849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIE1,Tyrosine-protein kinase receptor Tie-1,4283,174,1.25 [0.88-1.77],0.217902932071875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",4092,163,1.08 [0.80-1.45],0.6275360250548421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,3618,140,1.31 [1.01-1.70],0.043634919992442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,4246,171,1.07 [0.80-1.43],0.6265383116374053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,3670,144,1.07 [0.72-1.59],0.7464068022410675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,3657,142,0.97 [0.80-1.18],0.7682999074219362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP1,Metalloproteinase inhibitor 1,4176,168,3.28 [2.31-4.64],2.1853087245335245e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP2,Metalloproteinase inhibitor 2,3670,144,1.70 [1.19-2.42],0.0034806136377098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP3,Metalloproteinase inhibitor 3,4248,170,1.05 [0.95-1.15],0.3785283164364393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP4,Metalloproteinase inhibitor 4,4246,172,1.75 [1.30-2.35],0.0001917152248737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TINAGL1,Tubulointerstitial nephritis antigen-like,4227,173,2.86 [1.64-4.99],0.0002094588046523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TJAP1,Tight junction-associated protein 1,4238,174,1.01 [0.86-1.19],0.8946141495398097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TJP3,Tight junction protein ZO-3,3549,140,1.10 [0.77-1.57],0.595316048129449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TK1,"Thymidine kinase, cytosolic",3618,140,1.19 [0.86-1.65],0.2885734505362321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR1,Toll-like receptor 1,3559,140,1.98 [1.16-3.38],0.0116952049697189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR2,Toll-like receptor 2,3618,140,1.62 [0.81-3.27],0.1754404677610099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR3,Toll-like receptor 3,4281,174,1.03 [0.84-1.27],0.7629697646765715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR4,Toll-like receptor 4,3559,140,1.19 [0.67-2.11],0.5558535730579022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,3584,138,0.93 [0.67-1.29],0.672791248125366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED1,Transmembrane emp24 domain-containing protein 1,3618,140,1.22 [0.93-1.61],0.1533083864947001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED10,Transmembrane emp24 domain-containing protein 10,3553,138,0.94 [0.62-1.43],0.7851229811263623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED4,Transmembrane emp24 domain-containing protein 4,3553,138,0.94 [0.69-1.29],0.6977529388920336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED8,Protein TMED8,3652,139,0.97 [0.83-1.13],0.6912134179697924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM106A,Transmembrane protein 106A,3659,142,0.88 [0.69-1.12],0.2934844025943152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM132A,Transmembrane protein 132A,3579,143,0.70 [0.54-0.91],0.0068974919836346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM25,Transmembrane protein 25,3668,142,1.55 [1.15-2.08],0.0039070153985923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMOD4,Tropomodulin-4,3536,140,0.95 [0.63-1.42],0.7958817044819373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS11B,Transmembrane protease serine 11B,3549,140,1.05 [0.85-1.29],0.6389872362531881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS11D,Transmembrane protease serine 11D,3648,141,1.66 [1.18-2.35],0.0036625223571513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS15,Enteropeptidase,4212,172,1.32 [1.14-1.53],0.0002480493455724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS5,Transmembrane protease serine 5,4176,168,1.94 [1.35-2.77],0.0003243482053264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMSB10,Thymosin beta-10,4246,172,1.26 [1.05-1.51],0.0125875038921554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNC,Tenascin,4246,171,1.40 [1.08-1.81],0.0100688600268915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNF,Tumor necrosis factor,4148,166,1.56 [1.22-1.98],0.0003093138981164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,3652,139,1.07 [0.79-1.44],0.675334442493573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,4131,169,0.99 [0.68-1.44],0.9691926266955364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,3611,140,0.76 [0.58-1.00],0.0525898680562112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,4194,169,2.83 [2.32-3.46],3.001927160399257e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,4194,169,1.63 [1.47-1.81],2.902720967504046e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,4247,173,1.38 [1.03-1.84],0.0289909353776308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,4281,174,2.98 [2.39-3.72],4.786994824061768e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,4226,170,2.72 [1.90-3.89],3.7647942065068994e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,4238,174,4.03 [3.09-5.25],5.35670373305044e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,4235,170,2.09 [1.57-2.77],3.732100888496899e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,4131,169,1.23 [0.90-1.67],0.1892668643527869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,4235,170,3.78 [2.92-4.88],4.336090987745375e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,3611,140,1.46 [1.00-2.14],0.0503028209044907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,4267,175,2.81 [2.24-3.54],1.2936606802061962e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,4246,172,4.75 [3.52-6.40],1.327292784705738e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,4246,172,1.74 [1.50-2.03],3.9686860356136893e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,4264,173,3.78 [2.54-5.62],5.330964493041778e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,4273,174,3.26 [2.54-4.19],2.203692651498838e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,4194,169,1.61 [1.32-1.97],3.811753843538797e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,4264,173,1.75 [1.36-2.24],1.1568147096924004e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,4194,169,2.29 [1.88-2.78],8.916398224111205e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,4281,174,0.86 [0.52-1.41],0.5519492352410702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,4226,172,0.86 [0.68-1.07],0.1755675030380506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,4281,174,0.91 [0.58-1.43],0.6804404994383471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,4248,170,5.26 [3.49-7.93],2.297412823320652e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,4279,174,1.76 [1.16-2.67],0.0075634280760397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,4194,169,1.07 [0.84-1.36],0.5935866571113068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,3683,141,1.83 [1.25-2.68],0.0019458388460968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNIP1,TNFAIP3-interacting protein 1,3657,142,1.00 [0.84-1.21],0.961066463036338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNN,Tenascin-N,3683,141,1.73 [1.20-2.48],0.0031445178361529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNNI3,"Troponin I, cardiac muscle",4152,167,1.09 [0.92-1.29],0.3363511855221522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNPO1,Transportin-1,3618,140,0.82 [0.51-1.31],0.4087887737004806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNR,Tenascin-R,4194,169,1.61 [1.19-2.19],0.0022614263316906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNXB,Tenascin-X,4246,172,0.55 [0.34-0.88],0.0127382598174305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,3670,144,1.02 [0.82-1.26],0.8696959759151034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOP1,DNA topoisomerase 1,3652,139,1.00 [0.87-1.14],0.949429544614786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOP1MT,"DNA topoisomerase I, mitochondrial",3536,140,0.76 [0.51-1.12],0.1670049428419993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOP2B,DNA topoisomerase 2-beta,3559,140,1.00 [0.81-1.23],0.9935059348661196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOR1AIP1,Torsin-1A-interacting protein 1,3579,143,1.08 [0.81-1.44],0.6026233989225178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53,Cellular tumor antigen p53,4103,164,1.05 [0.76-1.43],0.7821825678485526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53BP1,TP53-binding protein 1,3559,140,1.06 [0.87-1.28],0.5678318845936877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53I3,Quinone oxidoreductase PIG3,3520,135,0.99 [0.73-1.35],0.958677431341702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,4152,167,0.71 [0.41-1.24],0.2284055065126782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP73,Tumor protein p73,3584,138,0.73 [0.45-1.19],0.2079046459251262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPBGL,Trophoblast glycoprotein-like,3584,138,0.74 [0.46-1.17],0.191347583023788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPD52L2,Tumor protein D54,3611,140,0.91 [0.78-1.06],0.2356722004426349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPK1,Thiamin pyrophosphokinase 1,3670,144,0.49 [0.28-0.86],0.0132570316187696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPM3,Tropomyosin alpha-3 chain,3553,138,1.34 [1.00-1.78],0.0472848565728849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPMT,Thiopurine S-methyltransferase,4103,164,0.77 [0.63-0.95],0.0129023997628176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPP1,Tripeptidyl-peptidase 1,4200,170,1.35 [1.03-1.76],0.0287609394488888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPPP2,Tubulin polymerization-promoting protein family member 2,3618,140,1.08 [0.87-1.33],0.4913785966187578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPPP3,Tubulin polymerization-promoting protein family member 3,4101,164,1.34 [0.98-1.82],0.063038217269024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPR,Nucleoprotein TPR,3553,138,1.08 [0.81-1.45],0.5857796346968478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPRKB,EKC/KEOPS complex subunit TPRKB,3536,140,1.13 [0.91-1.41],0.2613131468002035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSAB1,Tryptase alpha/beta-1,4273,174,1.43 [1.09-1.88],0.0105552939070321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSD1,Tryptase delta,3668,142,1.56 [1.07-2.27],0.0194518260063748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSG1,Tryptase gamma,3559,140,0.76 [0.40-1.44],0.4001467938078432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPT1,Translationally-controlled tumor protein,4131,169,0.95 [0.75-1.20],0.6614982850107876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRAF2,TNF receptor-associated factor 2,4226,172,1.08 [0.89-1.31],0.4289058033001265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",3559,140,0.95 [0.62-1.46],0.8134742433519879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,3553,138,0.99 [0.71-1.39],0.9718055283987648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,3618,140,0.98 [0.81-1.18],0.7992470880886784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREH,Trehalase,3683,141,1.21 [0.97-1.50],0.0908964915644606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREM2,Triggering receptor expressed on myeloid cells 2,4226,170,1.25 [1.01-1.56],0.0444437105588211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREML1,Trem-like transcript 1 protein,3685,143,1.00 [0.74-1.36],0.995075136841242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREML2,Trem-like transcript 2 protein,4246,172,1.65 [1.14-2.40],0.0080922058393804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,4267,175,1.27 [1.02-1.58],0.030694547256031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,4226,172,0.91 [0.77-1.09],0.2977947501872212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM24,Transcription intermediary factor 1-alpha,3610,140,0.91 [0.70-1.18],0.4828862659274395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,3652,139,1.01 [0.87-1.18],0.8971542153506912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM26,Tripartite motif-containing protein 26,3536,140,1.05 [0.82-1.35],0.7154688993679076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM40,E3 ubiquitin ligase TRIM40,3584,138,0.80 [0.64-1.00],0.0500075242505406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM5,Tripartite motif-containing protein 5,4226,172,0.98 [0.84-1.15],0.8047642147657343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,3659,142,0.93 [0.78-1.12],0.4361545457129766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,3553,138,0.84 [0.60-1.19],0.336737768912104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSC1,Hamartin,3559,140,0.97 [0.77-1.23],0.8189662298310406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSC22D1,TSC22 domain family protein 1,3668,142,1.09 [0.86-1.39],0.4698596233425338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSHB,Thyrotropin subunit beta,4233,173,0.84 [0.71-1.00],0.0567318629792603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSLP,Thymic stromal lymphopoietin,4152,167,1.16 [0.95-1.40],0.14756733120328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSNAX,Translin-associated protein X,3553,138,0.80 [0.52-1.24],0.3241222608005607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN1,Tetraspanin-1,4152,167,0.79 [0.63-0.99],0.0372239607115654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN15,Tetraspanin-15,3553,138,1.14 [0.86-1.51],0.3723801982246078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN7,Tetraspanin-7,3549,140,0.86 [0.69-1.06],0.1506149072582324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN8,Tetraspanin-8,3652,139,1.05 [0.90-1.22],0.5526729638594075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPYL1,Testis-specific Y-encoded-like protein 1,3559,140,1.03 [0.68-1.55],0.8918050556540108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TST,Thiosulfate sulfurtransferase,4098,163,0.95 [0.78-1.15],0.5897832163525425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TTF2,Transcription termination factor 2,3584,138,0.99 [0.71-1.38],0.960846544986696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TTN,Titin,3553,138,1.12 [0.89-1.41],0.3214261888962742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TTR,Transthyretin,3647,140,1.11 [0.61-2.01],0.7403446719851555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TUBB3,Tubulin beta-3 chain,3549,140,1.19 [0.64-2.18],0.5854539505319141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TWF2,Twinfilin-2,3683,141,0.97 [0.80-1.17],0.7200972040353302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXK,Tyrosine-protein kinase TXK,3618,140,0.98 [0.79-1.21],0.8416847091186574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXLNA,Alpha-taxilin,4194,169,1.07 [0.91-1.25],0.4294283741217181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXN,Thioredoxin,3619,139,0.98 [0.66-1.45],0.9080645393362872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC15,Thioredoxin domain-containing protein 15,4238,174,1.78 [1.13-2.79],0.012278954366697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC5,Thioredoxin domain-containing protein 5,4264,173,1.30 [1.07-1.58],0.0074453607357938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC9,Thioredoxin domain-containing protein 9,3657,142,0.93 [0.68-1.26],0.6372212151184855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNL1,Thioredoxin-like protein 1,3545,140,0.94 [0.78-1.12],0.4753543465126636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",4246,172,0.87 [0.65-1.15],0.329239070607408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYMP,Thymidine phosphorylase,4201,169,0.94 [0.76-1.16],0.5709833119058492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,4233,173,1.68 [1.06-2.66],0.0282093970164628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",3559,140,1.66 [1.27-2.17],0.0002349782438282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBAC1,Ubiquitin-associated domain-containing protein 1,4212,172,1.15 [0.78-1.69],0.489501094208701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,3659,142,0.69 [0.38-1.27],0.2364887653590993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,3670,144,1.18 [0.90-1.54],0.2311867894049995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,3559,140,0.86 [0.63-1.19],0.3755468952673757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBQLN3,Ubiquilin-3,3553,138,1.26 [1.04-1.53],0.0203384156493067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBXN1,UBX domain-containing protein 1,3611,140,0.99 [0.78-1.26],0.9402062419975052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,3652,139,1.00 [0.89-1.13],0.9899604162803688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UGDH,UDP-glucose 6-dehydrogenase,3553,138,1.05 [0.89-1.23],0.5780565774663831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,3553,138,0.71 [0.39-1.28],0.2523674562288444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ULBP2,UL16-binding protein 2,4194,169,3.80 [2.86-5.05],3.8744817674934734e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UMOD,Uromodulin,4271,174,0.47 [0.38-0.57],3.3119431743238015e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UNC5D,Netrin receptor UNC5D,3559,140,1.43 [0.83-2.47],0.2015440661959559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UNC79,Protein unc-79 homolog,3536,140,1.01 [0.76-1.35],0.9370216510478064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UNG,Uracil-DNA glycosylase,3659,142,1.07 [0.67-1.72],0.7757754247977746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UPB1,Beta-ureidopropionase,3670,144,0.98 [0.84-1.15],0.8346532168555323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UPK3A,Uroplakin-3a,3549,140,0.82 [0.60-1.12],0.2156836636489617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UPK3BL1,Uroplakin-3b-like protein 1,3612,139,1.12 [0.87-1.45],0.3753864391262076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UROD,Uroporphyrinogen decarboxylase,3611,140,0.98 [0.76-1.25],0.8427570477864823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UROS,Uroporphyrinogen-III synthase,3584,138,0.92 [0.71-1.20],0.5569487837992992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USO1,General vesicular transport factor p115,4212,172,1.01 [0.87-1.18],0.8649100104957885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,3659,142,1.07 [0.85-1.34],0.5732226847975853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,3657,142,1.68 [1.23-2.31],0.0012882271077505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,3553,138,0.96 [0.79-1.17],0.7195750391440532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,4152,167,1.04 [0.89-1.20],0.6460401178039479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UXS1,UDP-glucuronic acid decarboxylase 1,4103,164,1.17 [0.92-1.49],0.1903926170102549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAMP5,Vesicle-associated membrane protein 5,4152,167,1.20 [0.97-1.48],0.0988296510972875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAMP8,Vesicle-associated membrane protein 8,3559,140,0.93 [0.76-1.13],0.4474278933170316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,4226,172,0.99 [0.84-1.17],0.8893166927671912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASN,Vasorin,4169,168,2.91 [1.91-4.44],7.145837267783311e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASP,Vasodilator-stimulated phosphoprotein,3685,143,0.87 [0.70-1.09],0.2288616877204035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,4212,172,0.56 [0.28-1.11],0.0956132796986503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAV3,Guanine nucleotide exchange factor VAV3,3549,140,1.00 [0.85-1.19],0.9590970458245194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCAM1,Vascular cell adhesion protein 1,4245,171,3.66 [2.50-5.37],3.1891717435874916e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCAN,Versican core protein,4264,173,1.79 [1.16-2.76],0.0084277452599859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCPKMT,Protein-lysine methyltransferase METTL21D,3536,140,1.01 [0.83-1.23],0.9063505736771034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFA,Vascular endothelial growth factor A,4267,173,1.41 [1.14-1.76],0.001935856950145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFB,Vascular endothelial growth factor B,3559,140,2.80 [1.69-4.64],6.26406771352571e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFC,Vascular endothelial growth factor C,4238,174,1.10 [0.87-1.39],0.4225628193596582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFD,Vascular endothelial growth factor D,4273,173,2.67 [1.96-3.63],5.505979837953382e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VGF,Neurosecretory protein VGF,3668,142,1.68 [1.09-2.59],0.0198726609029626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VIM,Vimentin,4152,167,0.91 [0.81-1.01],0.0862337413816672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,3579,143,0.78 [0.38-1.63],0.5151748181696012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VIT,Vitrin,3670,144,1.39 [0.93-2.06],0.1085767132519735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VMO1,Vitelline membrane outer layer protein 1 homolog,4212,172,1.73 [1.39-2.15],9.950582214735672e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VNN1,Pantetheinase,3685,143,1.27 [1.01-1.58],0.0382065399054815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VNN2,Vascular non-inflammatory molecule 2,4212,172,1.29 [0.95-1.74],0.1002952507629018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,3618,140,1.08 [0.85-1.38],0.5138600963024367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS37A,Vacuolar protein sorting-associated protein 37A,4212,172,1.10 [0.93-1.30],0.2678678822895959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS4B,Vacuolar protein sorting-associated protein 4B,3659,142,0.94 [0.79-1.12],0.4627116844121847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,4212,172,0.99 [0.84-1.17],0.9158467427899536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,3659,142,1.27 [0.87-1.84],0.2133120783533627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,3553,138,1.62 [1.11-2.38],0.0130581044963125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,3659,142,1.93 [1.62-2.30],1.728742061689336e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,4237,169,3.16 [2.47-4.05],6.928134059029857e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,4226,173,1.00 [0.81-1.24],0.9967032579262632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSNL1,Visinin-like protein 1,3657,142,0.57 [0.38-0.85],0.006008251592935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM1,V-set and transmembrane domain-containing protein 1,4101,164,1.51 [1.17-1.96],0.0017574763596201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,3618,140,0.83 [0.53-1.28],0.3963696529168586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,4152,167,1.24 [1.01-1.53],0.0399739793636598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,4264,173,0.93 [0.77-1.13],0.4690088472084326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,4103,164,1.43 [0.96-2.14],0.081807034708429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,3611,140,0.97 [0.73-1.29],0.8395964938185356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWA1,von Willebrand factor A domain-containing protein 1,4259,175,1.55 [1.13-2.12],0.0065164713854141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWA5A,von Willebrand factor A domain-containing protein 5A,3536,140,1.04 [0.86-1.25],0.7205163731056169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2,Brorin,4178,168,3.00 [2.23-4.03],3.8011045420792906e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,3668,142,1.30 [1.00-1.68],0.0460023026420274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWF,von Willebrand factor,4283,174,1.26 [1.05-1.50],0.0114743204485175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",4246,172,1.00 [0.70-1.42],0.9998969646800824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WAS,Wiskott-Aldrich syndrome protein,4131,169,1.00 [0.81-1.23],0.9864125083110152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,4152,167,1.01 [0.87-1.17],0.8906847748237968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,4101,164,0.95 [0.81-1.12],0.5324766451605428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASHC3,WASH complex subunit 3,3657,142,1.02 [0.82-1.26],0.8641137090627372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASL,Neural Wiskott-Aldrich syndrome protein,3559,140,1.11 [0.87-1.43],0.4021792657443291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WDR46,WD repeat-containing protein 46,3659,142,1.17 [0.77-1.78],0.47491399089325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC1,WAP four-disulfide core domain protein 1,3588,139,1.25 [1.00-1.57],0.048844882683442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC12,WAP four-disulfide core domain protein 12,4260,174,1.31 [1.08-1.59],0.0063629892717002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC2,WAP four-disulfide core domain protein 2,4023,160,3.03 [2.46-3.73],3.5639833979118398e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",4180,169,0.81 [0.59-1.11],0.1859972463905286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",4235,170,2.09 [1.43-3.05],0.0001270741263583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WIF1,Wnt inhibitory factor 1,4267,175,0.82 [0.56-1.21],0.3202336348794925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WNT9A,Protein Wnt-9a,4131,169,2.64 [2.06-3.38],2.0504285592915394e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,4194,169,0.88 [0.68-1.14],0.3305365973195461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XCL1,Lymphotactin,4267,175,1.38 [1.14-1.68],0.0011286145140216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XG,Glycoprotein Xg,4258,173,3.40 [2.60-4.45],5.135369910002324e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XIAP,E3 ubiquitin-protein ligase XIAP,3559,140,1.11 [0.84-1.47],0.4606620779253488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XPNPEP2,Xaa-Pro aminopeptidase 2,4238,174,0.90 [0.79-1.02],0.0918037787984019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XRCC4,DNA repair protein XRCC4,4101,164,0.84 [0.57-1.24],0.3883702610529936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YAP1,Transcriptional coactivator YAP1,3657,142,4.68 [3.16-6.93],1.2968477171587712e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",3652,139,0.97 [0.87-1.09],0.6036681165211225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YES1,Tyrosine-protein kinase Yes,4212,172,1.07 [0.95-1.20],0.2498806257563215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YJU2,Splicing factor YJU2,3659,142,0.94 [0.56-1.59],0.8290083077077837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YOD1,Ubiquitin thioesterase OTU1,3553,138,0.90 [0.69-1.16],0.4214921215854671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YTHDF3,YTH domain-containing family protein 3,4131,169,0.99 [0.85-1.17],0.9368195069631648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YWHAQ,14-3-3 protein theta,3611,140,0.95 [0.76-1.19],0.6828294474576738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YY1,Transcriptional repressor protein YY1,3559,140,0.92 [0.51-1.66],0.7754120153848874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZBP1,Z-DNA-binding protein 1,3559,140,1.18 [0.79-1.75],0.4208399331416647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,4103,164,1.10 [0.91-1.33],0.3043555752977024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,4152,167,1.21 [0.90-1.62],0.2103753272944244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,3553,138,0.92 [0.70-1.21],0.56982920686256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZFYVE19,Abscission/NoCut checkpoint regulator,3652,139,0.93 [0.77-1.12],0.4600621761523216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZHX2,Zinc fingers and homeoboxes protein 2,3657,142,1.20 [0.80-1.82],0.3791684912552541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNF174,Zinc finger protein 174,3559,140,1.05 [0.66-1.65],0.8435950881116222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNF75D,Zinc finger protein 75D,3618,140,1.15 [0.92-1.42],0.212887319315767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNF830,Zinc finger protein 830,3659,142,0.90 [0.72-1.14],0.4020392897523268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNRD2,Protein ZNRD2,3652,139,1.17 [0.94-1.44],0.1595158259460726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,3659,142,0.88 [0.64-1.21],0.4341495074923012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZP3,Zona pellucida sperm-binding protein 3,3579,143,1.06 [1.00-1.13],0.0660445014030238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZP4,Zona pellucida sperm-binding protein 4,3536,140,0.67 [0.36-1.25],0.2081511906668551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZPR1,Zinc finger protein ZPR1,3549,140,1.02 [0.86-1.21],0.822024563245848
